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Foreword
This report on the governance of the health sector in Bangladesh is the third such report presented by the
Bangladesh Health Watch (BHW) on the state of health in Bangladesh. BHW, a multi organisation civil society
network, was formed in 2006 to establish a tradition of holding the state as well as non-state sectors accountable
for their performance in delivering quality health care to the citizens. BHW decided to produce an annual report
on the state of health in Bangladesh focusing on a theme that deserves priority attention. The report was
designed as an instrument of accountability for health care providers by and to the citizens of Bangladesh. As a
citizen's initiative, BHW needed to establish its credibility before both the public and the government through the
quality of its work and the independence as well as non-partisan nature of its contributions. These qualities have
now, hopefully, been established over the course of two successive reports, the first one focusing on the theme
of health equity and the second one on the status of the health workforce in Bangladesh. These two reports have
been widely used as objective measures of the state of health in Bangladesh by various stakeholders including the
government, professional and civil society organisations, service providers and users, media and the international
development agencies.
Our third report addresses the even more challenging theme of governance of the health sector in Bangladesh.
The issue of governance has in recent years been discussed extensively by political and civil society as well as
the international development community. The state of governance has emerged as a critical variable in
determining our developmental outcomes. The quality of public service delivery, which impacts on the lives of most
citizens, but particularly the financially deprived, is one of the most vital aspects of governance. Access to and
quality of health care is a critical element of service delivery; yet none of the existing reports on the state of
governance published by some of our institutions have put their spotlight on the delivery of health care. This
third report by BHW on governance of health is, thus, of special value because it addresses specific problems
facing a vital service sector and offers constructive suggestions as to how to improve its governance.
The issues addressed by the report cover some important overarching concerns such as the stewardship role of
the government as well as several micro level issues to illustrate the practical manifestations of the state of
governance on our daily lives. The stewardship of the government is analysed through a critical review of the
processes and politics involved in health policy formulation and implementation; the functioning of the various
statutory and regulatory bodies; and the ethical standards and practices maintained in the health sector. The
specific issues highlighted by the report, which impact on all those seeking health care, include blood supply,
availability and use of essential drugs, pharmaceutical promotion, quality of care, and hospital diet.
The report highlights many problems such as ineffectiveness of statutory and regulatory bodies; deficits in ethics
and standards; politicisation of health policy and its lack of continuity; partisanisation of the medical profession
and absence of accountability. However, the report also showcases several positive examples which can be
replicated and used as role models for good governance in the health sector. 
I hope this report will not only raise awareness about the many governance related problems of the health sector,
but more importantly it will catalyse concrete actions by government as well as non-government agencies to
address these challenges which will result in better delivery of health services to our citizens.
Rounaq Jahan
Convener, Advisory Board
Bangladesh Health Watch
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EXECUTIVE SUMMARY
mproved and sustained health of citizens depends
on a well functioning health system. The main functions
of a health system include service provision; generation
of funds for building physical infrastructure and creating
competent human resources for service delivery; and
stewardship, i.e. setting and enforcing rules of operation
and providing strategic direction for all the different
stakeholders to work effectively. These functions are
related to one another and stewardship is the most
critical one as it involves ensuring the implementation
of all the other functions and has direct effects on
health outcomes. The World Health Organization (WHO)
in its World Health Report (2000) stressed that the
"ultimate responsibility for the performance of a
country's health system lies with government.” The report
defines stewardship and its significance by stating that
"the careful and responsible management of the well-
being of the population is the very essence of good
government … How well or poorly a government
executes its stewardship role can influence all aspects
of the health system performance" (WHO 2000).
Stewardship includes the tasks of
defining the vision and direction of
health policy, exerting influence through
regulation and advocacy, collection of
intelligence, ensuring compatibility
between policy objectives and organisa-
tional structures, building partnerships,
ensuring tools of implementation and
accountability. Above all, the task of
stewardship is attributed primarily to the
Ministry of Health (MoH). Given the
importance of governance of the
health sector, Bangladesh Health Watch (BHW)
examined the status of health sector governance in
the country as its theme for the present report. BHW
commissioned six studies to generate evidence to
assess the status of governance. The studies were on
health sector governance in general and on critical
health care issues in particular. The focus of the
investigation on governance in general included the
national health policy, regulatory frameworks and ethics.
The manifestations of ineffective governance are usually
experienced in specific areas of the health care system.
The specific areas covered were: marketing of
pharmaceuticals, use of essential drugs, blood safety,
quality of hospital diets and services. The studies
attempted to assess the situation in critical elements of
health service delivery, interpret them in the light of the
key elements of governance, and identify actionable
points for the policy makers. This overview presents
key findings, messages emerging from the studies
and puts forth a few recommendations. 
An overview
Governance, policy and regulations
Bangladesh had formulated and adopted a National
Health Policy in 2000. Several attempts have been made
to update it since then. With subsequent changes in
political regimes, the 2000 health policy had never been
fully implemented. As this report was being published,
the Ministry of Health and Family Welfare had placed
a revised draft of the National Health Policy on its
website for further comments and consultation. The
draft was first formulated in June 2009 and shared in
the public domain. This draft was
subsequently revised based on
comments and recommendations
received from various quarters.
Several regulatory and statutory bodies
were established in order to develop
qualified health professionals, ensure
standard health services to the people,
protect peoples' rights to health and
ensure access to quality health services.
The statutory bodies include Bangladesh
Medical and Dental Council (BMDC), Bangladesh
Nursing Council (BNC), State Medical Faculty,
Bangladesh Pharmacy Council, (BPC), and Bangladesh
Board of Unani and Ayurvedic Systems of Medicine
(BBUASM). The Parliamentary Standing Committee
oversees all activities on behalf of the government and
citizens to ensure transparency and accountability of the
health sector in serving the citizens. The study findings
reveal that most of these statutory and regulatory
bodies have not being functioning to their fullest capacity
due to problems of politicisation, lack of democratic
practice, and lack of accountability.
The studies attempted to
assess the situation in
critical elements of health
service delivery, interpret
them in the light of the
key elements of
governance, and identify
actionable points for the
policy makers.
I
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Ethics
In Bangladesh, ethics in medical practice as a subject
has been taught to medical students in their third and
fourth years of MBBS classes since it was introduced
in 1988. The nursing diploma curriculum includes
content on nursing ethics emphasising the concept of
nursing self-management and accountability within
health care. The midwifery curriculum also has a small
section on ethics. Ethical issues in medical practice
comprise a small share in the course content compared
to other topics in the curriculum. It is therefore taken
casually by most students and it never received due
attention in the teaching of health care practice. The
course recommended by WHO on ethical standards
has been adapted for Bangladesh and approved by
BMDC. However, it is yet to be fully implemented by
the Centre for Medical Education (CME) for providing
short courses through medical colleges. So far, no
step has been taken to incorporate the course into
the medical, dental and nursing curriculum. 
It is important to note that a set of code of medical
ethics prescribed by BMDC is in existence in order to
ensure standard ethical practice in medical
interventions. In case of failure to adhere to the code,
the BMDC has the authority to suspend and/or cancel
the registration of a practitioner.
Code of ethics in professional conduct also exist for
Family Welfare Visitors. Despite their existence and
the authority granted to BMDC, there is no example
of any action taken so far for violations. This clearly
indicates the ineffective implementation of the code.
There are no organisational mechanisms in place to
monitor unethical practices by health professionals.
Findings on the symptoms of a weak stewardship in
areas of drug use, pharmaceutical marketing practices,
blood safety, quality of care and hospital diet as revealed
in the study are discussed in the following sections.
Essential drugs
Use of more than one drug per prescription was very
high and on the rise (33% from 5% in 1994) with wide
variation among groups of health care providers. The
proportion of prescriptions with three or more drugs
was highest (62%) among the prescriptions from
drugstores followed by urban clinics (46%) and Upazila
Health Complexes (UHC) (33%). On an average, the
number of drugs per prescription from UHCs had
increased to 2.2 in 2009 from 1.4 in 1994. Use of three
or more drugs increases the risk of drug interactions,
errors in dispensing and intake with adverse health con-
sequences and unnecessary household expenditure. 
Use of antibiotics was highest in the prescriptions 
from drugstores (60%), followed by urban clinics (45%)
and UHCs (43%). Prescribing of antibiotics by the UHC
providers has increased to 50% in 2009 from 25%
in 1994. 
Although the list of essential drugs was available in
47% of the UHCs (from 28% in 1994) and 55% of
the urban clinics, none of the facilities had all the 20
essential drugs listed. Only 6% of the UHCs and 15%
of the urban clinics had at least 15 of the 20 essential
drugs. The use of essential drugs by UHC has reduced
to 63% from 85% in 1994. None of the drugs dispensed
from any of the health facilities was labelled properly
with the name of the patient, generic name of the
drug and dosage.
A very wide variation in drug prices was observed.  For
example, the ratio of lowest to highest price for IFA
tablets was 1650%, for a bottle of B-Complex tablets
was 650%, for Mebendazole tablets was 900%, for
Benzylbenzoate lotion was 817%, for Chloramphenicol
ointment was 543%, for Miconazole ointment was
592%, and for Metronidazole tablets was 500%. 
Promotion of pharmaceuticals
The pharmaceutical companies in the country have
an estimated number of 20,000 medical representatives
(MR) to promote and market their products. The MRs
were found to be highly target oriented with attached
incentives to target fulfilment. This made the MRs highly
aggressive in marketing drugs. The MRs maintain a
high level of contact with physicians for sharing product
information and they manage to get easy access to
physicians. The physicians are somewhat dependent on
the MRs for product information. The pharmaceutical
companies maintain databases of physicians and
monitor the prescribing practices of doctors in terms of
use of drugs. The practice of a wide variety of "rewards"
for physicians from the pharmaceutical companies for
prescribing their drugs is prevalent. The MRs have also
started to include the village doctors (palli chikitshoks)
in their sphere of influence for marketing drugs.
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Blood safety
Blood transfusion is carried out in some facilities that are
not enlisted with the Directorate General of Health
Services (DGHS). Most of these unregistered facilities
are private commercial undertakings and some are
private non-commercial facilities. Only seven of the
enlisted 25 centres under the Safe Blood Transfusion
Programme (SBTP) of the DGHS included in the study
had facilities for preparation of blood components.
None of the non-SBTP centres had such facility. The
main reasons for not providing blood transfusion
services by the SBTP listed facilities were lack of
logistics support, reagents and trained manpower. 
Thirty-three out of the 37 centres (89%) reported
that they screened blood for Transfusion Transmittable
Infections (TTIs). However, only 18 centres reported
screening blood for all five TTIs as required under the
SBTP. Reasons for not screening blood included -- not
perceiving all diseases as important; lack of awareness
about the importance of blood screening among the
relatives/attendants of the patients; shortage of
trained manpower in the facilities; lack of funds; and
insufficient lab facilities and screening products.
Staff members of the majority of the centres included
in the study (76%) reported that they received special
training on SBT. Staff members at 88% of SBTP
enlisted centres reported that they had received
training, while staff members from 59% of the non-
SBTP centres reported that they received training.
Training on SBT had been provided to the staff of most
of the government facilities (90%) while the number
of trained staff in the private sector, whether commercial
or non-commercial, was reletively fewer (62%). 
Guidelines on screening and selecting donors,
collecting, testing, matching, transfusing and storing
blood, training staff, health and safety procedures,
use and maintenance of equipment, behaviour and
dress code were mostly absent in private (14 out of
19 functioning centres) facilities and in five out of 18
functioning government centres. None of the 18
centres could show the printed copies of the
guidelines which they claimed to have. Majority of the
managers who supervised blood transfusion system
did not have knowledge about SBT (31 out of 42).
Knowledge of various policies regarding blood
transfusion was also found to be deficient among the
key staff members of the centres.  Staff members of
only six centres had knowledge of at least three
components of blood collection policy, 15 centres had
knowledge of at least one component of blood supply
policy, six centres had knowledge of at least one
component of blood transfusion policy, and only 18
centres were aware of blood testing/screening policy,
i.e., blood must be screened for five TTIs. 
Majority of the centres (81%) did not have any
license/accreditation for Blood Transfusion Safety (BTS).
Some private centres reported having a BTS license
(63%) while none of the government facilities had a
license. The staff at the government and private non-
commercial centres (65%) did not perceive the need
to have a license and considered themselves above
such requirements. Though many of the centres were
supervised by DGHS personnel it was not clear why
most of them do not have a license yet.
The medical technologists/technicians in the centres
had to perform multiple tasks which hampered their
primary task of maintaining SBT standards including
adoption of universal precautions. Lack of practice 
of standard universal precautions was observed
among the majority of staff members of the blood
transfusion centres. Staff at only two centres wore
aprons while staff at only one centre were found to
wear gloves. Decontamination practice for reusable
materials was found to be practised in 14 centres out
of 15 (93%). 
Hospital diet
Ensuring appropriate dietary therapy is an important
component in the overall management of patients as
it influences the treatment and recovery process of
many illnesses. There is limited knowledge available
as to how the facilities are doing in terms of ensuring
appropriate diets for patients. According to some
earlier studies conducted, food served in hospitals in
Bangladesh was not nutritionally sound. Hospital
diets are not generally perceived as appropriate and
are seldom adjusted for the management of different
diseases.
The supply of a therapeutic diet was found to be
inadequate compared to Recommended Daily
Allowance (RDA) in all of the hospitals in the study.
For diabetes patients, diet contained 63% fat, 25%
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carbohydrate and 38% Kcal (Energy) less than the
RDA but 34% excess protein was supplied compared
to the RDA. For coronary heart disease patients,
hospital diet contained 6% protein, 27% fat and 30%
carbohydrate in excess of the RDA and contained 2%
less Kca than the RDA. For kidney disease patients,
hospital diet contained 71% fat, 34% carbohydrate
and 39% Kcal less than the RDA but protein content
was 163% in excess of the RDA. For liver disease
patients,  hospital diets supplied about 60% protein,
fat, carbohydrate and Kcal less than the RDA. The
appropriateness of diet given to diabetic, kidney, liver,
and malnourished patients in the specialised hospitals
were not any better than those in the general
hospitals. 
There may be several reasons behind this poor
application of therapeutic diet in the hospitals in
Bangladesh. Health systems administration of
Bangladesh may be one of them. Other reasons include
lack of dietary advisors and nutritionists, and
inadequate trained nutritionist etc. Although all of the
hospitals have reported that they have a budget for
dietary management, it may not have been properly
implemented due to poor design and inadequacies in
the system. Although there are dieticians in the
hospitals, they may not have been properly skilled and
were not adequate in number.
Qualitative study presents that most of the patients
were satisfied about the hospital diet but some of
them had a few suggestions regarding the adequacy,
quality, palatability and cleanliness. Patients suggested
bringing about variations in the menu to avoid
monotony. They also suggested proper monitoring and
planning of diets in accordance with the requirements
of the treatment been given to the patients.
Quality of care
The study investigated quality of care in public and
non-government facilities in terms of factors like
physical condition and amenities at the facility;
adequacy of providers and other staff; their attitudes
toward the patients/clients; condition of supplies,
drugs and other equipment; waiting time; client
satisfaction, role of management; compliance to and
awareness of the Citizens' Charter; condition of
emergency services and technical quality. In these
areas, it was noted that the situation in public
facilities was more compromised when compared to
the non-government facilities. Of the public facilities,
those in rural and remote areas suffered more in
terms of the staffing condition, access to resources,
and efficiency.
Number of patients admitted in the hospitals were
always outnumbering the beds available which resulted
in patients being on the floor. This was observed in all
the public facilities except a few in Dhaka. Privacy was
always compromised in overcrowded facilities.
Shortage of sanctioned posts of critical service providers
like doctors (including specialist), nurses, paramedics,
medical technologists, support staff (ward boy, aya,
sweeper) was a common problem in public facilities.
Exceptions were a post graduate hospital and a child
and maternal care hospital in Dhaka. 
In public facilities, providers were often not friendly
and responsive to patients. Providers did not feel that
they were accountable to the patient and were
unaware of the patients' rights, indifferent about
patients' expectations, need for confidentiality, respect
and dignity. The situation was better in non-
government facilities except in one children's hospital
in Dhaka city.
Patients usually had to wait a long time before being
attended by the right providers in all the public facilities.
The situation was worse in case of emergencies,
which defeated the purpose of having emergency
service in the first place. The situation was also worse
in rural facilities and in lower level facilities. Posters
displaying patients' rights and Citizen's Charter in
prominent locations were not found in all the facilities
visited. However, this is an action that all public
facilities are mandated to follow.
In terms of emergency services, non-government
facilities often were reluctant to treat emergency
cases, for example, victims of road traffic accident,
cases of trauma, etc., especially when there were
subsequent legal implications associated, such as
cases of poisoning. These patients are mostly treated
in public facilities.
Technical quality of care for indications of caesarean
sections was found to be satisfactory. Quality of care 
for management of pneumonia was found to be compro-
mised through conducting either excessive or inadequate
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investigations, by prescribing drugs with no indication,
not prescribing drugs with clear indication, and
inappropriately using third generation of antibiotics.
Main messages and recommendations
Based on the findings emerging from the above studies
and current debates on health sector governance,
BHW would like to provide some key messages for
policy makers. The perennial issue of poor quality health
care described in this report was mostly an outcome 
of either the lack of a regulatory framework or its
ineffective implementation.
Our first message is about strengthening the
regulatory/statutory bodies for the interest of
the people; and upholding patients' rights along
with the rights of the service providers. In the
absence of strong regulatory frameworks, institutions,
regulations and strict implementation of regulatory
measures, the quality of healthcare will continue to
be unsatisfactory. To treat patients effectively and
efficiently, hospitals will require adequate numbers of
quality health professionals and support workforce.
Thus the regulatory institutions responsible for health
workforce production require strengthening in terms
of course content, examination process, faculties,
registration of graduates, and periodic assessment of
performance of health care providers for renewal of
registration. Most importantly, they need to pave a
user-friendly way to address genuine grievances of
the patients and uphold patients' rights, if necessary
without waiting for further direction.  
In order to ensure the above, BHW recommends the
following actions:
z Carry out detailed review immediately on the
existing status of these regulatory bodies and
clarify their roles in order to 
 revitalise their existence, especially that of
the BMDC;
 update all the acts related to their formation
and proper functioning with extensive
consultation with the stakeholders and
based on evidence;
 strengthen their legal and logistical powers;
 enhance democratic practices through
ensuring participation of the relevant
stakeholders including representatives from
the civil society in these councils;    
 ensure a democratic process for council
governance and merit based recruitment; 
 enhance the mandates of these bodies; and
 implement the right to information act to
ensure free flow of information for the
common people.
z Develop accountability policies and processes
within regulatory bodies to ensure transparency of
information on the regulation of medical
professions and health care. 
z Strengthen management and administrative skills
and capacity to perform regular administrative
and supervisory functions. 
z Establish divisional monitoring units within BMDC
and BNC to oversee the activities of medical 
and dental practitioners and publish and update
the names of the registered medical, dental and
nursing professionals with respective specialties
and sub-specialties, if any, on their respective
websites. 
z Produce accessible, people-friendly annual
publications which will clearly feature how the
regulatory bodies have performed in their
supervisory and disciplinary roles and with what
outcomes, and what initiatives have been taken to
improve their accountability to the public.
z Encourage and strengthen the role of civil society
organisations, especially those focusing on the
rights of the citizens and consumers, to play an
active and vigilant watchdog role in monitoring
the functionality of the regulatory bodies for the
interest of the people.  
Our second message would be that inappropriate
use of drugs and lack of adherence to the list of
essential drugs is the result of weak supervisory
capacity of the regulatory mechanism and
aggressive push from the pharmaceutical
companies while marketing their products. 
In order to address the above issue, BHW recommends
the following actions:
z Completely reorganise and strengthen the
Directorate of Drug Administration (DDA) in terms 
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of human resource and technical capacity (e.g.
establishment of drug testing labs). Ensure a
rigorous approval process for product literature.
Reconstitute the Committee for Implementing the
Code of Pharmaceutical Marketing Practices.  
z Ensure that the Essential Drug List is on public
display in all the PHC level facilities in the country
irrespective of urban or rural locations or public,
NGO or private attachment of the facilities. MoHFW
should send an urgent directive to this effect.
z Make available Essential Drugs for common
illnesses as listed in the national EDL at PHC level
facilities, especially the public sector facilities
throughout the country.  DGHS should ensure the
supply and monitor this regularly through their
official chain.
z Make a clear commitment in the national health
policy to education and training combined with
managerial and regulatory interventions for rational
drug dispensing at the 80,000 plus drug shops in
the country as well as public and private sector
health facilities. Combine this with an explicit
commitment to an institutional mechanism of
implementation.
z Undertake further research to determine how to
promote rational prescription, avoidance of poly-
pharmacy and overuse and misuse of antibiotics,
generic prescribing, and prescribing from the
national EDL; and on how the consulting time can
be increased for quality provider-patient interaction.
z Bring gifts-giving practice by pharmaceutical
companies under strict regulation and ensure that
parity is maintained for all civil servants. Bring
visits by medical representatives under regulation,
especially in public hospitals. 
z Find ways to make the promotional budgets of the
pharmaceutical companies transparent so that it is
clear what percentage of the drug price is channelled
towards promotional efforts. Direct audit firms
responsible for auditing these companies to look
into the promotional practices and identify any
deviations from ethical practices in their audits. 
z Take appropriate regulatory action to ensure that
pharmaceutical companies comply with the 
 IFPMA1 Code of Pharmaceutical Marketing
Practices
 WHO Ethical Criteria for Medicinal Drug
Promotion2
z Undertake a comprehensive evaluation of National
Drug Policy using structural, process and outcome
indicators to have a state-of-the-art knowledge on
the Bangladesh situation. This will provide policy
makers the necessary guidance in improving the
present condition with respect to production and
rational use of drugs.
Our third message is on safe blood transfusion
and weak implementation of the safe blood
transfusion regulations.
In order to address the above issue, BHW recommends
the following actions:
z Widely disseminate blood transfusion policy to
providers as well as to the general public.
z Bring the functioning non-SBTP private commercial
centres immediately under strict regulations and
monitoring of the government and restart services
in the non-functioning SBTP-enlisted public
facilities without delay. 
z Make licences mandatory for blood bank operation,
with renewal of licenses conditional on the
performance of the centres. Licensing criteria should
be equally applicable to the government, non-
government and private entities.
Our fourth message is about adequacy and
appropriateness of hospital diets which are
neither on the hospital agenda nor on the list of
priorities in terms of patient management
protocol. This lack of prioritisation is evident from
the absence of dieticians and nutritionists in the
facilities and absence of guidelines to be followed by
the hospitals. 
In order to address this issue, BHW recommends the
following actions:
z Make the employment of qualified nutritionists
and dieticians mandatory in hospitals. 
z Introduce standard protocols for dietary manage-
ment in hospitals.
1 Codes promulgated by the International Federation of Pharmaceutical Manufacturers and Associations (revised in 2006). 
2 A document prepared and revised in 1985 and endorsed by the Third World Assembly in 1986.
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z Assess the status of diets in hospitals and clinics
at all levels and implement systematic monitoring
and evaluation of patients' diets in every hospital. 
The fifth message would be about adherence to
ethical practices by the health professionals and
addressing the prevailing weaknesses in the
course content in order to prepare future health
professionals to combat ethical dilemmas
successfully in real life at every level of health
service delivery.
In order to ensure the above, BHW recommends the
following actions:
z Emphasise and strengthen ethics training in
medical education at undergraduate and post-
graduate levels, particularly by familiarising
students with the practical and operational side of
medical ethics and incorporating the WHO module
into the curriculum. 
z Mandate the professional bodies to introduce ethics
into continuing professional education and make this
compulsory for all registered medical practitioners.
z Ensure that the Patients' Charter/Bill of Rights is
widely publicised by rights-based organisations
and by the regulatory bodies.     
z Encourage stronger participation by human rights
and consumers rights related civil society
organisations to play a more active watchdog role
in monitoring ethical practices in the health sector.  
Our final and overarching message is about the
national health policy which would govern the
entire health sector of Bangladesh. The revision
or formulation process should ensure participation
of all the important stakeholders for its consistent
implementation. To ensure continuity as a public
policy, health policy should not be narrowly conceived
as a "policy of the ruling party" rather it should be
viewed as the policy of the state.
In order to ensure the above, BHW recommends the
following actions:
z Develop a transparent mechanism for informing
people in general about the progress of the national
health policy revision or formulation process and
ensure participation of all the important stake-
holders so that it is implemented consistently.
z In order to develop a sense of ownership and to
avoid unjustified policy revisions, ensure adequate
engagement of the opposition political parties in
the policy process, particularly through the vital
role that the Parliamentary Standing Committee
can play as a cross-party parliamentary body.  
z Ensure that policy formulation or revisions are
research-based, need-based and participatory,
rather than mere expressions of the preferences
of the political regimes. In particular use the
mechanism of the Parliamentary Standing
Committee to organise public and specialist
hearings on the national health policy to optimise
stakeholders' participation.
z Recognising that a stronger civil society can play
an effective role in offsetting the arbitrary acts of the
ruling parties regarding policy revisions, encourage
NGOs, as a part of civil society, to act as  a watchdog
over government stewardship as opposed to remaining
in a mere complementary role.
z Undertake a critical review of the approved national
policies, e.g. health policy, population policy, nutrition
policy, drug policy to bring synergy in the sector; and
if possible-prepare a synthesised policy document.

1CHAPTER 1
Governance
In recent times, "governance" has occupied a centre
stage in the discourse on development, both as a
concept and as an instrument of development strategy.
According to the United Nations, "Good governance is
perhaps the single most important factor in eradicating
poverty and promoting development" (UNO 1998).
Accordingly, various states and international
organisations devised their development strategies
with due emphasis on governance. It is now well
recognised that overall development of a country
cannot take place as long as governance remains
weak and underperforming. Despite the growing
interest in governance there is no consensus on what
constitutes governance. Since its introduction, the
term "governance" has been interpreted in various
ways. The World Bank (1992) defines governance as
a combination of three factors: i) the form of a
political regime; ii) the process by which authority is
exercised in managing the country's economic and
social resources; and iii) the capacity of government
to design, formulate and implement policies and in
general to discharge governmental functions. 
Governance is therefore more than just the
government and efficient management of resources.
It refers to the role of government in creating a
framework of activities to be undertaken for economic
development and making decisions about the
distribution of benefits, as well as the nature of
relationship between the government and those
governed. According to the UNDP (1997), governance is
defined as "the exercise of economic, political and
administrative authority to manage a country's affairs
at all levels. It comprises of mechanisms, processes,
and institutions, through which citizens and groups
articulate their interests, exercise their legal rights,
meet their obligations and mediate their differences".
This definition of governance encompasses the
private sector and the society at large and not just
the government. Interactions among these three
actors are critical for sustainable human development
as government provides stable legal and political
environment to facilitate participation of civil society
and all other groups in socio-economic development
of a country. General attributes of governance include:
accountability, transparency, efficiency, effectiveness,
rule of law, participation, responsible and equitable
administration at all levels of a government.
Governance in health sector
The health sector is concerned with the provision,
distribution and consumption of the health services
and related products. It is made up of hospitals, private
nursing homes, medical and dental clinics, public health
interventions (including health promotion activities,
counselling, etc.), ambulance service, transportation,
complementary medicine and other human health
related activities, such as medical laboratories services
and health information across a range of organisations
within the public, private and voluntary sectors. 
In Bangladesh, health services are delivered by
multiple providers including public, private, non-
governmental organisations (NGOs), informal health
care providers and traditional healers (BHW 2007).
Public sector has a countrywide health infrastructure.
Although, in terms of service coverage, the private
sector, formal and informal combined, overrides the
public sector service provisions. Effective governance
is therefore challenged by the pluralistic and diverse
nature of the health system. Good governance
influences the functioning of a health system towards
better health outcomes. The World Health Organization
(WHO) in its World Health Report 2000 defines a health
system to include all the activities whose primary
purpose is to promote, restore or maintain health. It
further states that health systems have a
responsibility not just to improve people's health but
to protect them against the financial cost of illness and
to treat them with dignity. WHO identifies four major
functions of the health systems: service provision;
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generation of physical and human resources for
service delivery; raising and pooling of resources in
order to pay for health care; and stewardship, i.e.
setting and enforcing rules of the game and providing
strategic direction to the different actors. All these
functions are interrelated and stewardship is the most
critical amongst all as it involves overseeing of the
rest and directly or indirectly affects all the outcomes.
Stewardship includes: the tasks of defining the 
vision and direction of health policy; exerting influence
through regulation and advocacy; gathering
intelligence; ensuring compatibility between policy
objectives and organisational structures, building
partnerships, ensuring implementation tools and
accountability. Above all, it attributes the task of
stewardship primarily to the Ministry of Health (MoH).
Health sector governance in
Bangladesh
Over the past few decades, Bangladesh has made
great progress in terms of its social indicators (WHO
2007). Net enrolment in primary education has
exceeded 80 percent with girls and boys attending
schools in equal numbers. Infant mortality and fertility
rates have reduced to less than half since independence
in 1971. Extreme poverty has fallen from nearly 70
percent in the 1980s to less than 50 percent in early
2000. However, many challenges remain, such as
maternal mortality, which is alarmingly high, and
there is still widespread malnutrition among children
and lactating mothers.  Inequity in terms of health
status and access to services persists  (BHW 2006),
while the quality of essential and commonly used
medicines marketed particularly in the rural areas
remain questionable and has caused death among
children in the recent past. Service quality in the
public sector has been greatly compromised and the
problem is compounded by unfilled vacancies of huge
number of staff positions (World Bank 1992).
Moreover, mechanism of accountability of service
providers is seemingly ineffective.
The perspective of Bangladesh
Health Watch
During 2005-2006, a number of professional and civil
society organisations came together to discuss the
possibility of creating a civil society network to
regularly and systematically measure and monitor the
country's progress and performance in health sector.
As a result Bangladesh Health Watch was launched in
April 2006. It was decided that the 'Watch' would
annually publish one report on the state of Health in
Bangladesh, focusing on a different theme each year
and reporting on the performance of key indicators,
on a continuous basis.
The Bangladesh Health Watch is governed by an
advisory board consisting of eminent personalities in
the field of development, particularly in health. A
Working Group consisting of researchers and activists
from different organisations carry out the different
activities. The James P Grant School of Public Health
of BRAC University serves as its secretariat.
The theme of Bangladesh Health Watch report for
2006 was "Challenges of Achieving Equity". The report
identified income, gender and place of residence as
the major factors of inequity. It highlighted the
inequities that are most persistent and hence require
greatest policy attention. It also looked into policy
commitments made by the government and described
achievements and limitations. Finally it drew lessons
for wider application from selected successful initiatives
in delivering services as well as holding the health
system accountable. The report was formally launched
in December 2006 in Dhaka by renowned Professor
Amartya Sen, Nobel Laureate in Economics.
The theme of Bangladesh Health Watch report for 2007
was "Health Work Force in Bangladesh: Who constitutes
the Healthcare System?" The report documented the
issue of health workforce in the country, identified their
strengths and weaknesses and put forth recommen-
dations for improvement. It involved undertaking the
first ever national level study of its kind. The report
laid emphasis on  the profile and density of health
care providers of public, private, NGO, qualified and
informal sector; quality of services provided by
selected group of providers, training, production and
future challenges for healthcare providers. The report
was launched by the Health Advisor of the Caretaker
Government and was subsequently widely used by
various actors for policy and planning purposes.
The BHW decided to take up Health sector
governance as the theme for this year's publication
and for the purpose of this study defines governance as:
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"the manner in which political, economic and
administrative power is exercised by the government
in the management of the national health affairs at 
all levels.''
The present  report critically analyses how efficiently
and effectively Bangladesh manages its overall health
system-from policy development to organisation
and delivery of services and the dynamics of allocation
of resources. 
Objectives
The broad objective of the report is to provide a
situational analysis of the health sector governance in
Bangladesh and make relevant policy recommendations.
Specific objectives include:
a. Reviewing the current status of governance in the
health sector emphasising elements of governance;
the national health policy; functions of the statutory
bodies; and ethical standards and practices. 
b. Critically analyse the capacity of the health system
in Bangladesh for good governance in order to
identify the ways and means to further strengthen
it especially with regards to stewardship, regulatory
functions and setting standards. 
c. Highlight practical manifestation of governance by
critically assessing a few micro-level health system
issues like drug availability and promotion, blood
supply, and some  management system issues such
as quality of care and provider accountability.
d. Showcase a number of replicable best practices or
"positive deviances" to promote good governance
in the health sector.
Approaches to analysing
governance in the health sector
To achieve the above mentioned objectives, BHW
commissioned six studies under two broad clusters-
governance at macro level and manifestations of
governance in the day to day health care experience of the
people (both provider and recipient). BHW developed a
matrix (see Annex 1) to analyse governance and
synthesise the study results. However, due to time
and resource constraints, only a few aspects of the
matrix could be addressed by the studies undertaken
for this report. The issues addressed are grouped
under two broad clusters as described below: 
Study Cluster 1. Assessment of the
general situation of governance focusing
mainly on the stewardship function of the
government:
The government formulates a National Health Policy
which basically governs the entire health sector, and
sets up different statutory and regulatory bodies to
protect interests of the patients. This in turn
promotes ethical practices fundamental to quality
service provision.  This study covers these important
stewardship functions of the government.
It includes various aspects of national health policy
especially the politics in the policy formulation process,
roles of different actors and a content analysis of the
policy itself. Practices related to health policy
formulation in a few selected countries and their
relevance for Bangladesh are also reviewed.
In order to assess the statutory bodies, the study
analysed the functions and roles of the various
statutory and regulatory bodies; and offered insights
into the causes and suggests actions.  The study also
documents the situation of ethical standard and
practices in Bangladesh. 
Study Cluster 2. Reflection of governance
in a number of specific areas with
important implications for health:
The immediate and day-to-day challenges faced by
the citizens in order to maintain health exemplify the
status of health sector governance. BHW aimed to
Box 1.1: The elements of health sector governance
as perceived by BHW
BHW considers elements of health sector governance as
formulating strategic policy direction; generating
information and intelligence and making information
accessible; ensuring equity, inclusiveness, participation,
transparency, accountability, responsiveness; consensus
orientation;  enforcing the rule of law, regulatory
framework and ethical standards; effectiveness and
efficiency with active involvement of peoples'
representatives, civil society and private sector for
sustainable health development."
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explore some of these issues through special 
studies, case studies and secondary data analysis to
understand the magnitude of the problem, identify
weaknesses in governance and identify action points
for policy makers. The areas explored were as follows: 
Essential Drugs: National drug policy, one of the
most important ingredients of the health sector
governance, should have positive bearing on the
availability, affordability and rational use of drugs.
This part of the study assessed  the availability of
essential drugs in the public and private health care
facilities; the affordability of essential drugs by
exploring the price differentials of different brands of
drugs for the treatment of specific marker illnesses
(diarrhoea, dysentery, ARI, hyperacidity, fever, body-
ache/ arthralgia) and finally assess the rational use of
drugs by studying the prescribing behaviour of
allopathic health care practitioners (MBBS doctors,
Medical Assistant/SACMOs, and Village doctors) for
specific illnesses, dispensing practices of pharmacists/
drug dispensers and understanding compliance of
consumers (patient/attendants).  
Pharmaceutical promotion: This study investigated
the promotional practices of the pharmaceuticals in
terms of influencing non-compliance of the regulatory
guidelines, namely, the Drug (Control) Ordinance of
1982 and the Code of Pharmaceutical Marketing
Practices, promulgated in 1994. It also explores the
challenges in enforcing the regulations and the factors
that play into causing these challenges.
Blood Supply: Blood supply is usually required as a
critical life saving measure.  It is a proxy indicator of
organisation of emergency medical services in the
country. This study aims at understanding the
governance of blood banks in terms of how the
existing policy is implemented, where and how the
existing regulations have been failing, and what the
contributing factors are. The study identifies gaps,
weaknesses and positive deviances.
Hospital Diet: Appropriate dietary management is
an important component in the overall management
of patients as it influences the treatment and the
recovery process. This study was commissioned to
assess appropriateness of hospital diets provided to
patients and their intake compared to their therapeutic
recommendations in case of five specific disease
conditions, namely, diabetes mellitus, coronary heart
disease, renal failure, liver diseases, and severe protein
energy malnutrition in both urban and rural hospitals
in Bangladesh.
Quality of Care: Quality of services is the ultimate
element to influence health outcomes. The study
assessed the situation of quality of services and
related the findings to governance issues. Selected
public sector, NGO and private facilities at different
levels in both rural and urban areas were included in
this study.
This report has ten chapters. Findings from Study
Cluster 1 are reflected in chapters 2, 3 and 4, while
chapters 5 through 9 depict findings from Study
Cluster 2. Each chapter provides a brief description of
the methodology used and detailed methodologies are
given in Annex 2. The concluding chapter summarises
key findings and recommends priority actions.
This report's analysis and critique of the health
system recognises that a large number of medical
professionals and health workers continue to perform
with integrity, diligence and efficiency, often under
impossibly difficult conditions. Their commitment to
public service should not be undermined by the
inadequate and occasionally inappropriate conduct of
some professionals. It is in the interests of the
medical profession as a whole to therefore, enhance
the governance of the health system, through more
effective regulation. The report has attempted to
identify a range of corrective interventions that are
needed to improve the governance of the health
sector. The government is also committed to make
such improvements. It is in the interest of both the
people of Bangladesh as well as the medical
profession that attention is paid to this report's
constructive suggestions.
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Introduction
Universally, policies provide a broad guideline for realising
sectoral visions. As for the health sector “an explicit
health policy … defines a vision for the future … outlines
priorities and expected roles of different groups,
builds consensus and informs people, and in doing so
fulfils an important role of governance” (WHO 2000).
This chapter adopts the domain of stewardship as the
framework for analysis of the health sector governance
(WHO 2000) in Bangladesh as it provides a
comprehensive health-specific framework. Stewardship
includes: the tasks of defining the vision and direction
of the National Health Policy, exerting influence through
regulation and advocacy, generation of intelligence,
ensuring compatibility between policy objectives and
organisational structures, building partnerships,
ensuring tools of implementation and accountability. 
There have been several attempts to formulate a
National Health Policy in the past, and the first ever
formally approved health policy in Bangladesh was
formulated in August 2000, towards the end of the
Awami League's previous tenure. This chapter
examines i) the vision and directions of the health
policy of 2000 and its subsequent revisions till 2009; 
ii) vulnerabilities caused by frequent revisions,
discontinuation and reversals; iii) management of
policy implementation; and iv) the health policy
formulation process as practised in India and Pakistan
to learn from a comparative account.
National Health Policy 2000:
Vision and directions
The National Health Policy (NHP) 2000 had 15 goals
and objectives, 10 policy principles and 32 strategies.
The key policy objectives were to: i) make basic health
services accessible to all, particularly to the poor; 
ii) reduce the rate of maternal and child mortality and,
maternal and child malnutrition; iii) ensure availability
of doctors, nurses and the medical equipment required
to provide services at the upazila and union levels;
iv) make health services accountable and cost effective
and v) increase effectiveness and accessibility of the
family planning programme especially by the poor. 
The key principles adopted to achieve these objectives
included: i) extending primary health care services to all
ii) equity; iii) decentralisation of health service
management; iv) stakeholder participation in planning
and management; and v) public-private partnership. 
The major strategies to achieve the policy objectives
were: i) focusing on primary health care as the key
strategy to make health services cost effective; ii) a
need-based human resource development for health;
iii) involvement of the local government in health
service provisions; iv) strengthening and reforming of
the health regulatory bodies; v) ensuring professional
standards of the medical practitioners and their close
monitoring; vi) introducing minimum user fees in
public hospitals with safety nets for the poor and
disabled; vii) managing all the activities of the health
and family planning sector through a Sector Wide
Approach (SWAp); viii) delivery of Essential Service
Package (ESP)1 from a single service point known as
"one-stop service" as a cost effective mechanism of
providing primary health service to all; ix) establishment of
community clinics for every 6,000 population in order
to bring health services to the doorsteps of the
population and provision of doctors at the union
health centres; x) reallocation of public health
expenditure from district to the community level; 
xi) unification of health and family planning wings of
the Ministry of Health in order to avoid overlapping of
programmes and reduce wastage of resources; 
xii) discouraging private practice of public doctors
1 ESP includes five basic services: reproductive health services, child health, communicable disease control, limited curative care, and 
behaviour change communication. 
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through introducing non-practicing allowances or
special privileges for those willing to practice privately
in the public hospital premises; and xiii) recognition
of traditional medicine.
Thus, the NHP 2000 clearly spelt out its objective of
providing basic health services to all, proposed
strategies to achieve this objective, recognised the
role of policy actors (public, private, NGO, traditional
medicine), provided guidance for prioritising
expenditure (for ESP and rural health), indicated
organisational arrangements for service provision
through unified structure and regulatory controls for
ensuring quality.
Implementation of the Health
Policy 2000 and its partial reversal
As per the vision of NHP 2000, Health and Population
Sector Strategy (HPSS) and its programme implemen-
tation plan known as the Health and Population
Sector Plan (HPSP) for the period 1998-2003 were
the main vehicles of translating the NHP 2000 into
reality. HPSP had an ambitious plan of health sector
reform which warranted unification of health and
family planning (FP) services. The main demonstration
of the unification was planned through constructing,
equipping and staffing 13,500 community clinics
throughout the country from which comprehensive
health and family welfare services were to be
provided through the staff of health and family
planning services. Unification of the two wings was
undertaken in order to improve service efficiency by
minimising duplication and overlap of service
delivery. However, its implementation was obstructed
due to bureaucratic stringency. 
NHP 2000 had its setback when the implementation
of HPSP was slowed down due to the reduced pace
of health sector reform especially integration of the
two wings i.e. health and family planning and setting
up of community clinics. The integration was to take
place in stages. By early 2000, the two wings were
unified at the upazila (sub-district) level and below.
This was made possible because the Upazila Family
Planning Officers (UFPOs) were of a lower official
status than the Upazila Health Officers and therefore
it was easier to bring them under the supervision of
the latter (Osman 2005). Nonetheless, the UFPOs
resented the integration as it curtailed their authority
for managing family planning services (Hossain &
Osman 2007). However, officials of comparable
status at the district and directorate levels did not
want to compromise their positions and resisted the
process. Eventually the deteriorating morale of FP
officers led to disruption of the FP services and
together with several other factors resulted in
apparent stagnation of the total fertility rate.  
In 2001, the new BNP-led government came into
power and stalled the integration process and
functioning of the community clinics. It ultimately
reversed integration of the two wings and made 
the community clinics dysfunctional and redundant.
With the expiry of the HPSP in June 2003, a new
programme called the Health Nutrition and Population
Sector Programme (HNPSP) for the period of 2003-
2011 was developed to commence in 2003. The
government's policy reversal and specially its firm
stand against unification caused discontent among
the development partners which led to the World
Bank's temporary withdrawal of funds from the 
health sector. As a result, the HNPSP could not be
approved until December 2005. There was no policy
instrument or programme to guide the health sector
during this interim period and sector projects were
being implemented on ad hoc basis to fulfil essential
sector needs. The interim arrangement was to 
spend the unspent HPSP balance between 2003 and
2005. Priorities and investments supported by the
HNPSP were set out in the Sector Investment Plan
(SIP) and the revised HNPSP emerged from this
process in November 2005 though implementation
could not be started until 2006. Overall, the SWAp,
ESP and the client-centred approach to service
delivery system were continued while nutrition as a 
new component was introduced in the programme.
Other modifications to the programme included a return
to the previous system of separate health and family
planning wings and restoration of domiciliary
services, thus formalising the reversal of NHP 2000.
Politics of reversal: Role of 
the policy actors
During the period of 2001-2006 reversal of NHP 2000
became the centre of a whirlpool of conflicts, delays, 
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and disagreements among policy players. The key
players in this politics included the bureaucrats,
politicians, medical professionals and donors.
Incidentally, the civil society played a relatively passive
role during this critical period.
Bureaucrats
Bureaucracy played a dominant role in reversing the
previous policy. Bureaucrats who had been influential
during the period of 1996-2001 had little say in the era
of the new government. Successive health secretaries
were either explicitly against or remained passive
over the unification process and community clinic
programme, resulting in weak bureaucratic leader-
ship within the ministry (Osman 2005). This in turn led
to poor monitoring and supervision of the performance
of field workers, hampering the quality of family
planning services. In the early years of the BNP regime
the bureaucracy held considerable power and influence
over the implementation of NHP 2000. According to a
number of respondents "the final decision on reversing
unification was taken by the Health Secretary and the
Prime Minister". 
Political parties 
Politicians played an active role in the policy arena
during 2001-2006 than in the past. The partial rejection
of NHP 2000 can be attributed to the culture of
confrontational politics and intolerance that permeates
every level of the polity and not necessarily to the
ideological differences of the political parties. A close
liaison of the medical professionals (particularly
physicians) with the ruling party members was the main
source of power of the politicians. They were initially
influenced by the bureaucrats to reverse the reform.
Medical professionals
Medical professionals, particularly physicians, were in
favour of the implementation of major reforms under
the NHP 2000. Support of the professionals for the
two major elements of the NHP 2000 (unification and
establishment of community clinics) was reflected in
the policy document prepared by the Bangladesh
Medical Association (BMA), which later influenced the
preparation of NHP 2006. "Despite the fractious nature
of health politics, BMA, DAB (Doctors Association of
Bangladesh, aligned with the BNP) and SCP
(Shawdhinata Chikitshak Parishad, aligned with the
Awami League) held together considering the
benefits of enhanced role of doctors, from integration
and the community clinic programme", informed a
medical professional during an interview. He added
"however, the reservations of some key, top level
politicians and bureaucrats could not be overturned".
This phenomenon indicates the dominance of the
politicians and bureaucrats in the policy process over
the professionals. 
Donors 
Donors were in favour of unification as it was one of
the conditions of their support to the HPSP. The
decision to reverse integration of the two wings had
seriously affected cooperation between the
government and development partners (Sundewall,
Forsberg & Tomson 2006) resulting in temporary
suspension of funds. The World Bank and its co-
financiers promised to resume the credit as soon as
the government presented an alternative reform
agenda. Some of the senior ministers were quite
convinced that in the end the donor community
would have to reconsider its decision because of the
need for reporting back on spending levels. Finally,
the credit suspension was lifted after almost three
months and trust between the two parties was
restored somewhat when the Ministry presented a
comprehensive plan to carry forward reforms in order
to achieve some of the main objectives of the HPSP
(Sundewall, Forsberg & Tomson 2006). However, the
Ministry remained firm on its decision not to integrate
the health and family planning wings. 
Formulation of NHP in 2006 and
revision initiatives in
2008 and 2009
Formulation of NHP in 2006
It is interesting to observe that Bangladesh has had
only one formally approved National Health Policy, i.e.
NHP 2000, in its history of 37 years. With so many
changes and disruptions taking place in the health
sector programmes, goals and priorities, NHP 2000
was no longer considered as an appropriate policy
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document. In July 2003, under the initiative of the
MoHFW, a 58-member core committee headed by the
Health Minister was formed with the purpose of
updating the NHP. In August 2006, three years 
after the revision process started, the draft policy was
forwarded by the Ministry to the Cabinet but was
never finalised.  Formulation of NHP 2006 was largely
driven by the politicians and the medical professionals
who incidentally developed good nexus by then. 
The influence of the bureaucrats was somewhat
marginalised in the 2006 policy process while donors
and the civil society also had little involvement. 
Revision of NHP 2000 in 2008
The caretaker government of 2007-2008 decided to
update NHP 2000 to reflect the changes since it was
adopted. An advisory committee and a steering
committee led the revision process. The initiative to
revise the NHP 2000 came out more as a benevolent
autocratic decision of the caretaker government than
the demand of the sector. Despite wide consultation
through the Internet and meetings at divisional and
national level towards the end of 2008, the policy
revision was rejected by the BMA and most of the
civil society organisations although some appreciated
the contents of the revision. The revised draft
avoided all the potentially controversial issues such as
integration, community clinics and concentrated on
high level goals and objectives which anyone would
agree to in principle. Donors did not have much
influence over the process. However, it left out the
most important stakeholders of any policy process,
i.e., the political parties.
Revision of NHP in 2009
The current ruling party in its election manifesto
declared that "In order to ensure health services to
every citizen of the country, the health policy of the
erstwhile Awami League government will be re-
evaluated and adjusted according to the demands of
the time. It is in the light of this policy that the
18,000 community clinics, established during Awami
League rule, will be re established. 
Accordingly, the MoHFW took on the initiative to
revise the NHP 2000 and the revised draft has been
posted on the website of MoHFW for comments and
suggestions. It is unclear how this revision was done.
There had been hardly any initiative from the MoHFW
to engage the political parties, BMA, professional
bodies, intellectuals in the health sectors, bureaucrats,
donors and civil society in the process of revising 
the document. A general invitation to comment 
on the draft document placed on the website was
made. Civil society organisations have been active in
discussing the NHP 2009 and provided comments to
the MoHFW. It was expected that a revised draft of
the National Health Policy will be further shared for
final round of consultation by October 2009. In
January 2010, the Minister announced that the
comments received from various interest groups
would be incorporated and a final policy document
would be ready for approval by three months time. 
The MoHFW has also taken the initiative to revise 
the National Population Policy and it is expected 
that the policy will be processed along with the 
health policy. The National Drug Policy and Nutrition
Policy are already in existence. A critical review of 
all the policies under the broad umbrella of the National
Health Policy is required urgently in order to bring
synergy and proper coordination in the health sector.
Commonalities of NHP initiatives
of 2006, 2008 and 2009
There had been three distinct initiatives to revise the
NHP 2000 in the years 2006, 2008 and 2009 under
various governments led by the BNP, the caretaker
government and the current Awami League
government respectively. While in power, different
parties or interest groups have attempted to adjust
the NHP according to their ideologies or interests
and/or of their party's election manifestos and
somewhat indicate the various political standpoints.
The authors had the opportunity to review the
content of the revised draft NHPs of 2006 and 2008.
The revised draft document of NHP 2009 was on the
website for public consultation when this report was
written. A critical review of all the drafts and NHP
2000 shows the following commonalities:
i. The policy documents state generic, broad and
lofty goals without specific and pragmatic
strategies to attain them. Thus, policy directions
have most often remained vague.
11 Health policy
ii. Increased budgetary allocations have been
promised at different times but how the
resources will be managed has never been
clarified and therefore lacking realistic guidelines
for resource allocation.
iii. The policy makers have failed to draw attention
to some of the significant supply-side barriers,
including unofficial and out-of-pocket (OOP)
expenses incurred by patients seeking health
care, non-availability of drugs, absenteeism of
doctors, and unprofessional attitude of health
care providers, mostly faced by the poor.
iv. The need for human resources for health has
been raised in each of the policy documents but
a clear strategy to do so has never been spelt out.
v. Performance is another issue that is neglected in
all the policy documents. A realistic incentive to
providers to reward good performance and
sanction against bad performance and more
importantly, an acceptable incentive package for
professionals for working in rural areas has not
yet been suggested. 
vi Although the policy documents give recognition
to all kinds of providers including private sector,
NGOs and traditional medicine but no clearly
delineated roles with financing mechanisms and
service provision, were assigned to them and are
barely recognised in legislation and regulation. 
NHP 2000 and its subsequent revisions thus still
remain a mere "wish list" accompanied by the
uncertainties of implementation. More importantly,
they lack continuity and pose serious challenge to
governance in the health systems.
NHP formulation in neighbouring
countries: Involvement of
stakeholders
Process of NHP formulation:
Experience of India 
To date, India has adopted two NHPs. The first NHP
was launched in 1983 and then updated in 2002. India's
health policy targets are aimed at providing health
care to all, especially to the poor, and the guidelines
are kept broad on purpose, similar to Bangladesh's
NHP 2000. The policy update involved a rigorous
three-year revision of the NHP which began in 1999.
The process involved all the stakeholders including
research institutions. While small working groups
prepared the terms of reference, 14 Indian institutions
were engaged to conduct research. The findings were
discussed at a series of regional and national seminars
and 21 research reports were circulated in print 
and on the website. A revised draft of the NHP was
formulated and distributed for public comment. The
revised document was consequently presented and
endorsed in the parliament. In the formulation struggle
four key players were involved: politicians,
bureaucrats, health professionals (predominantly
physicians) and the civil society. The bureaucrats
were the real policy movers and to a large degree,
determined as to whether there would be a status quo
or a reform. The civil society and the bureaucrats
continuously interacted with each other and were the
most influential. Politicians and health professionals
(dominated by the physicians' voice) engaged in the
policy discourse only when their interests and
mandates were affected. 
Process of NHP formulation: Experience of
Pakistan
In Pakistan to date, three NHPs have been formulated
in 1990, 1997 and 2001 while a fourth, health policy
of 2009 has been finalised. Successive governments
have made attempts to streamline health policies to
their ideologies. Bureaucracy played a dominant role in
policy making in Pakistan. The Federal Ministry of Health, 
Box 2.1: Experience of India
z Policy is research and evidence-based.
z Policy enjoys continuity and sustainability.
z Policy revision is not politically motivated; rather the
intention has been protecting national or
professional interest. 
z Civil society is highly influential in policy making in
case of idea generation, holding the government
accountable and above all, performing the role of a
watch dog in the policy arena, which in effect
prevents arbitrary actions of government.
z Decentralised health planning allowing deeper
involvement of stakeholders.
z Medical profession is not politically motivated rather
focused on professional interests.
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which oversees the provincial government offices, dealt
with all stages of the health policy formulation process
such as setting agenda, articulating the policy, planning,
implementation, monitoring and evaluation (Khan
2006). The uncertain nature of Pakistan's political
environment particularly the frequent change of health
ministers bringing in changes in the health plans, made
it difficult to effectively implement the health policy. 
Physicians as well as the civil servants within the
Ministry of Health assumed a dominant role in setting
the health care agenda as reflected in the strong
focus on clinical health care in all the NHPs. Role of
the civil society in policy making in Pakistan is quite
restricted due to limited access of the public to
knowledge and information regarding the development
process of the health policy (Khan 2006).
Box 2.2: Experience of Pakistan
z Policy lacks continuity or sustainability.
z Policy revision is highly politicised as health plans
get altered with change in the government.
z Policy formulation and implementation process is
decentralised but it has failed to produce the
desired result due to lack of coordination.
z Over dominance of physicians in the policy process
has made the policy a "clinical" one while the
influential bureaucracy prevented the policy
formulation process from being a transparent one.
z Weak civil society including media resulted in lack of
stakeholder participation and created scope for
arbitrary actions by the government and frequent
policy revisions.
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Introduction
Stewardship as an essence of good governance refers
to the careful and responsible management of the
responsibility entrusted to one's care (WHO 2007).
Stewardship functions imply the ability to ensure
good regulations and the tools for implementing it and
provide the necessary base to ensure accountability and
transparency. In the context of the health system, one
of the functions of stewardship involves influencing
policies and regulatory actions that may affect health
of the population. Therefore the role of the regulatory/
statutory bodies is critical to ensure good governance
in the health sector. Under the tutelage of the regulatory
bodies, necessary regulations on health education,
training and professional practices can be ensured to
maintain quality of care in health. These bodies are
also expected to set clear policy priorities in order to
reflect public interests and maintain ethical standards
to defend people's health rights. 
Different categories of service providers (physicians,
nurses, midwives, pharmacists, medical technologists
etc) are supposed to operate under certain legal
obligations while the regulatory/statutory bodies are
mandated to oversee their compliance to the rule of law
(exhibiting good stewardship) thus supporting the health
system to work better. When these bodies remain
dysfunctional, poor management and weak supervision
leads to bad governance in the health system.
The Government of Bangladesh has established
different professional regulatory and statutory bodies
with the objectives of:
i. developing competent health workforce (doctors,
nurses, midwives etc.)
ii. ensuring provision of standardized health services  
iii. protecting people's right to health, and 
iv. ensuring access to health services as and when required.
Bangladesh Medical and Dental Council (BMDC),
Bangladesh Nursing Council (BNC), State Medical
Faculty, Bangladesh Pharmacy Council and Bangladesh
Board of Unani and Ayurvedic Systems of Medicine
were formed to play the stewardship role in the health
sector governance. In addition, the Parliamentary Standing
Committee is expected to play important overseeing
function to ensure transparency and accountability of
the sector. 
It may be noted that the Director General of Health
Services (DGHS) performs registration and overseeing
functions for private clinics and hospitals, pathological
laboratories and blood banks while the Director General
of Family Planning (DGFP) performs registration function
for the NGOs determining eligibility to receive family
planning commodities at designated working areas.
This chapter focuses on the organisational arrangement
and functionality of the statutory bodies, except the
DGHS and DGFP, in terms of six broad themes i.e.
independence, democratic norm, rule of law, capability,
efficiency and accountability. The objectives of this
chapter are to: i) examine the functioning of the
statutory bodies, and ii) identify the factors/
determinants of their functionalities. 
An analysis of the statutory bodies
Bangladesh Medical and Dental Council
(BMDC)
Bangladesh Medical and Dental Council emerged as a
statutory body under the Medical Council Act in 1973
later repealed in 1980. BMDC regulates registration of
physicians and dentists and monitors medical
educational institutions for the purpose of establishing
uniform standard of basic and higher qualifications in
medicine and dentistry.
According to the Act, the Council is composed of a
number of representatives from the Ministry of Health,
medical education, nursing services, medical colleges
(both public & private), professional associations,
members of the Parliament, Bar Council and each
CHAPTER 3
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administrative division in Bangladesh. The Council is
headed by a President and a Vice President elected
by the members of the Council from amongst the
members. The Council is a supreme body that takes
all major decisions and executes its functions through
various committees, namely the Executive Committee,
Standing Recognition Committee, Disciplinary Committee
and office of the Registrar. The Registrar is the Chief
Executive of the Council and is responsible for all
administrative activities including implementation of the
decisions of the Council.
Functionality of BMDC: There is widespread
frustration about the functionality of BMDC and apathy
of the Government towards it. Although no study has
been conducted, it is well known that BMDC is virtually
an ineffective body except for its registration function. 
BMDC has failed to promote and protect patients' rights.
A common allegation against the health professionals
(mainly doctors and nurses) is that they are not aware
of the patients' rights and do not behave appropriately
towards them. Some of the other allegations commonly
made include negligence of duties, absenteeism,
malpractice, incorrect treatment, demand for extra
payments, etc. The Ain-O-Shalish Kendra (ASK), a
leading human rights organisation reported that
between January and October 2007, over 70 deaths
were recorded due to negligence or malpractice
(Doctors' impurity must stop 2008), but BMDC failed
to address any of them. Every year many complaints
are filed with BMDC but most of these are rejected by
the Council with the pretext of the complaints containing
"incomplete information". According to key informant
interviews conducted for the present study, BMDC
approved investigations for 25 and 17 complaints in
2007 and 2008 respectively against the medical and
dental practitioners. However, not a single investigation
report was finalised or made public. In fact no report
has been finalised by BMDC since 1994. 
According to Clause 30 of the BMDC Act No. XVI of
1980, only registered dental and medical practitioners
are allowed to practice in Bangladesh. However, in
the recent past foreign doctors were found practising
without any registration with the BMDC; taking the
quality of training of other countries as granted. The
case of the alternative medical health care providers
is also similar. 
BMDC rules require registered dental and medical
practitioner not to use misguiding designation,
description or symbol. Yet most physicians, even
professors are found to use descriptions and symbols
in business cards and signboards that are not permitted
by the rules.
In terms of ensuring quality of medical education and
accreditation of the medical education institutions in
the country, BMDC's role has been taken over by the
MoHFW and Director's office of Medical Education 
of DGHS.  
Lack of independence: Prior to formation of the
Council, BMDC is required to seek approval from the
Ministry of Health and Family Welfare regarding its
potential members since some members are nominated
by the Government. The Government can thus influence
the council formation and have the main authority
within BMDC and hold unconditional power in its
functioning. 
BMDC's independence is somewhat compromised by
the presence of the Government nominated members
as in case of initiating independent investigations
against doctors working in government/public
hospitals. In such cases, BMDC can only issue "show
cause" notices to the directors of the hospitals; in
response the hospitals form their own committees to
conduct investigation of the complaints. BMDC has no
option but to follow the decision of these committees
thus making its role as a regulatory body ineffective
and redundant.
BMDC is administered by professional and practising
doctors who play a key role in the formulation of
regulations and conducting investigations. This
sometimes hampers independent investigations and
objectivity of judgments due to professional bias
towards their fellow colleagues.
There is no coordination between BMDC and the
MoHFW regarding jurisdiction and authority for
registration of foreign doctors or doctors trained abroad.
Currently these doctors are required to get permission
from the Ministry and subsequently register with BMDC.
In most cases, these doctors avoid registration at BMDC
and only seek permission from the Ministry. 
Democratic deficit: The composition of the
"Council" of the BMDC does not incorporate relevant  
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stakeholders from the health sector. For example,
Medical Council Act of 1973 provided that "two
members from each administrative divisions of
Bangladesh of whom one shall be a government
medical official to be nominated by the Government
and other shall be a private medical practitioner to be
elected by the registered medical practitioners other
than teaching staff of the medical college in each
division". Later this provision was changed in the
BMDC Act (Act No XVI of 1980) so that both members
from each administrative division of Bangladesh are
to be nominated by the Government only thus removing
the provision for electing private medical practitioners
by the registered practitioners. 
It is important to note that the council election has
not taken place in the last 18 years suspending any
chances of running of BMDC in a democratic way.
Several governments have witnessed this situation
but paid little attention in addressing the issue.   
Bypassing rule of law: The existing Act (Section
88, Act No, XLV of 1860) in the Penal Code of 1980
depicts "Nothing, which is not intended to cause
death, is an offence by reason of any harm which it
may cause, or be intended by the doer to cause, or
be known by the doer to be likely to cause, to any
person for whose benefit it is done in good faith, and
who has given a consent, whether expressed or implied,
to suffer that harm, or to take the risk of that harm".
This provides ground for the doctors to avoid
responsibility claiming they believed they acted in the
best interest of the patient when the error was
committed. Many human rights groups and activists
are concerned about this act, as it allows doctors to
escape responsibilities for causing harm or death to
the patients.
Capability deficit: It is pertinent to note that BMDC
is mandated to initiate investigations about malpractices
in order to take disciplinary actions which may require
criminal conviction of serious professional misconduct
of medical and dental practitioners. Any individual or
citizen of the country can send complaints to BMDC
to inform them about professional misconducts by
medical and dental practitioners. Many such complaints
are filed at BMDC every year. However, BMDC does
not have enough human resources to respond to all
complaints and investigate properly. As mentioned
earlier, not a single investigation report has been
finalised since 1994.
Lack of efficiency: The lack of efficiency of the
regulatory authorities is phenomenal. The complaint
process of BMDC is cumbersome, lengthy and difficult to
avail for the common people; even the most aggrieved
person or family member often resigns pursuing their
case with BMDC. Hence, lack of an efficient process
discourages the citizens from claiming their right to
lodge complaint-the primary purpose for which this
body was formulated.
Another mandate of BMDC is to maintain standard of
medical education and training. According to a health
professional, 13 out of the 17 government medical
colleges have shortage of senior level medical
academics. BMDC has failed to address the issue which
is essential in maintaining the standard of education.
While BMDC maintains the authority to provide
permanent registration to doctors, it does not have
any process for revalidating the registration. Lack of
such provision prevents them from ensuring updated
knowledge and standard performance of the doctors. 
Lack of accountability: All the officials of BMDC
are accountable to the Registrar who in turn is
accountable to the Council. However, the Council is
currently non-functional since no election has taken
place in years. It has failed to meet and review its
administrative activities and recommendations made
by the Council members. 
BMDC is also unable to seek death audit from both
public and private hospitals and in case of public
hospitals needs to refer the case to the Director of
the hospital. The general public is not at all informed
of the activities of BMDC as it does not have any
regular public relations activities. 
Bangladesh Nursing Council (BNC)
Nursing is an important pillar of the health system of
a country. In order to ensure the standard of nursing
education and practice, Bangladesh Nursing Council
(BNC) was constituted in 1983. BNC acts as a national
education board to ensure good quality education for
the nurses. It regulates nursing practices to ensure
clinical standard and also protects people from
inappropriate nursing services in Bangladesh. The
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current Council consists of top level government
officers (rank of Secretary and Director General) from
the MoHFW, health and family planning departments
and professionals such as doctors, nurses, educationists
and social workers. The Council has a Registrar and
two Deputy Registrars to perform administrative
functions. The Council comprises three committees i.e.
Executive Committee, Examination Control Committee
and Accreditation Committee.
Functionality of BNC: Bangladesh Nursing Council
has been unable to meet the need of protecting the
rights of the common people as well as that of the
nurses. Similar to BMDC, the Council is also an authority
that exists on paper and performs no other function
except registration of nurses.
The quality of nursing education and training does
not meet the demand of the health sector in Bangladesh
and is far from availing the opportunity of the demand
for nurses in the international market. As a result, many
private hospitals with specialised services rely on
nurses from abroad.
According to BNC, 21,815 midwives are currently
working in different hospitals in Bangladesh playing
an important role in the health sector, especially for
maternal health services. However, in Bangladesh,
midwifery is still not recognised as an independent
vocation though BNC has been trying for the recogni-
tion and integration of midwives into the mainstream
nursing profession. 
BNC does not have any mechanism to identify or take
any action against unregistered nurses who graduate
from formal nursing institutes of the country. Also the
number of expatriate nurses working in Bangladesh
without any registration with the BNC is unknown.
There is no clear provision or guidelines for lodging
any complaints against poor nursing by the general
public at BNC and little or no evidence of the Council
taking corrective measures against such complaints.
Lack of independence: Similar to BMDC, BNC has
to seek approval from the Ministry of Health and
Family Welfare for council formation. Most of its
members are required to be nominated by the MoHFW.
BNC ordinance in 1983 empowered the Council to
elect the President from amongst the council members
provided that the Secretary of the Health Ministry is
the first President of the Council. As such there is no
opportunity for potential or qualified professionals to
contribute in a leadership role in the council.
There is no effective coordination between Bangladesh
Nursing Council and the Government. The Government
is not obligated to share any information with BNC
pertaining to nursing in the public sector. BNC cannot
take measures against the unregistered (and often
un- or semi-qualified) nurses who are currently working
in many hospitals and clinics. 
Democratic deficit: According to the Act of BNC,
the Government nominates three members from the
nursing profession. This limits the ability of the nursing
professionals to elect their own representatives to appro-
priately serve the interests of the nurses in the country.
Capability deficit: Since its formation, the Bangladesh
Nursing Council has been encountering shortage of
human resources to carry out its activities especially
in the field of monitoring, inspection and investigation
of misconducts by nurses. Moreover, there is no legal
protection in BNC to provide legal aid to nurses accused
of professional misconduct. The disciplinary committee
of the Nursing Council has very little power and
insufficient budget allocation preventing it from fulfilling
the very purpose of its existence. 
Lack of efficiency: According to the findings of
Bangladesh Health Watch report 2007, the nurse-to-
patient ratio is very poor with a shortage of 280,000
nurses compared to the standard requirement. The
recent changes in the qualifying requirements for
admission into the nursing course (HSC qualified as
opposed SSC qualified) has restricted the entry of
women from rural areas in nursing profession. There is
also a sustained cultural notion that this profession is
not for men. On the other hand, some private institutions
have expressed interest in setting up nursing institutes
with high standards, catering to the needs of the
international market. However, the bureaucratic
mechanisms have slowed down such initiatives.
Parliamentary Standing Committee
The Parliamentary supervision is designed to prevent
unlimited exercise of power of the executive branch,
ensure proper use of public resources and accountability
of the state agencies. Members of the Parliament act
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through different Parliamentary Committees to exercise
these overseeing functions. Formation of Parliamentary
Committees, their powers and responsibilities as well
as functioning procedures are regulated by relevant
provisions in the constitution, the rules of procedure,
Parliamentary conventions and rulings of the Speaker.
The basic functions of the committees are to examine
draft bills and other legislative proposals; review the
enforcement of laws and propose measures for such
enforcement; investigate and inquire about the
activities or administration of the concerned Ministry
and perform any other function assigned by the
Parliament. Every Standing Committee as referred to
in Rule 246 "shall consist of not more than ten members
including the Chairperson. Members including the
Chairperson shall be appointed by the House so that
a Minister shall not be the Chairperson of the Committee
and each committee shall meet at least once a month".
Functionality: Parliamentary Standing Committee
on MoHFW has mandate to investigate and inquire
into the activities of the Ministry. But the Committee
remains largely ineffective in playing stewardship role
for a number of reasons. First, the ruling party usually
occupies committee chairmanship and dominates
committee proceedings and ignores the opinions of the
opposition party. Second, the formation of Standing
Committees is frequently delayed. For example, the
Standing Committee on Health for the 8th Parliament
was formed two years after the first session of the
Parliament. Thirdly, Committee meetings are neither
held regularly nor are they attended by all the members.
However, the 9th Parliament is an exception where
the Standing Committee was formed during the first
session and started functioning immediately.
Lack of independence: The Parliamentary Standing
Committee on MoHFW in the 8th Parliament was
supposed to play important overseeing functions to
ensure transparent and effective health care delivery
system for the common people. However, its indepen-
dence was curtailed by the Government. The rule
[clause 188(2)] mentions that "no member shall be
appointed to a committee who has a personal,
pecuniary or direct interest in any matter [that] may be
considered by the committee". In the 8th Parliamentary
Standing Committee on health, the Chairperson was
from the treasury bench and the minister in charge of
the Ministry was a member of the committee. The
minister's membership in the committee provided the
avenue to exert executive influence over the committee
ultimately curtailing the objectivity, impartiality and
independence of the committee. The Standing
Committee of the 9th Parliament shows similar traits.
Democratic deficit: Parliamentary Standing Committee
also faces the problem of democratic deficit. Until the
7th Parliament, the concerned Minister or State
Minister was the chairperson of the Standing Committee
which ultimately affected the democracy of the
committee. Later on, the 7th Parliament made the
provision of making any member of the Parliament,
other than the Minister, the Chairman of the Committee.
According to the rules of procedure, each committee
will consist of ten members of Parliament but there is
no clear indication of the distribution of the committee
membership to the various parties. As a result, the
ruling party takes up majority of the memberships. 
Bypassing rule of law: All the committees on
relevant ministries should be formed in the very first
session of the Parliament. In the 8th Parliament, all
the Standing Committees were formed 18 months
into its first session while the Standing Committee on
MoHFW was finally formed in the 13th session of the
8th Parliament on 16 September, 2004, almost three
years after the first session of the Parliament. Thus,
there was hardly any effective Parliamentary supervision
of the activities of the Health Ministry for a long
period of time. Attendance of committee members
per meeting was only 4.68% (TIB 2006). As mentioned
earlier, the 9th Parliament is an exception in terms of
quick formation of the Standing Committee.
The Standing Committee has so far failed to ensure
compliance of the Health Ministry. There is no time
limit for the concerned ministries, persons and executive
branches to respond to committee recommendations
and decisions. In the 7th Parliament, the Estimate
Committee identified gross irregularities in accepting
a tender worth Taka one billion by the Ministry (Rahman
2008). A three member sub-committee headed by the
Health Minister investigated the matter and recommen-
ded cancelling the tender order. However, the Ministry
authorised the original bidder defying the committee's
recommendations. The tendency to bypass committee
recommendations thus creates lack of institutional
accountability, transparency and perpetuates irregular
practices and corruption in the health sector.
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Capability deficit: Although the Parliamentary
Standing Committee is the apex body of performing
Parliamentary overseeing functions on relevant Ministries,
the committee is seriously handicapped by lack of
resources. The committee wing of the Bangladesh
Parliament secretariat is divided into 15 sections. It is
stated that "each section is composed of one Assistant
Secretary/committee officer and four other personnel
who work under the supervision of a joint secretary/
additional secretary through four deputy secretaries
of the wing" (Rahman 2008). The committees have
no research staff or policy aides. Although several
steps had been taken in the 8th Parliament, through
the project "Strengthening Parliamentary Democracy"
to improve the logistics of the committee offices,
these were mostly cosmetic changes to the office of
the committee's chairperson. The sections of the
committees which did the actual work to make the
committee functional were subsequently ignored.
Once again, the 9th Parliamentary Committee has so far
been an exception in this respect.
Lack of efficiency: The Parliamentary Standing
Committee on the MoHFW has not been very effective
in ensuring people's right to access health care services.
In the 7th Parliament only 6.46% (Rahman 2008) of
the required committee meetings were held each
year. In several cases the committee recommendations
were either overlooked or bypassed by the concerned
ministries and government agencies. In the 8th
Parliament, 217 decisions were made by the
Parliamentary Standing Committee on the Ministry
but only 55 decisions, i.e., less than 30% were
implemented (TIB 2006). 
Lack of accountability: Article 70 of the
Constitution actually prevents MPs from voting
against their own party and defying party directives.
They are expected to listen to what is discussed in
the committee meetings and follow the party
directives. It is reported that in the 7th Parliament fifty
four assurances were given by the Health Minister but
only nineteen were fulfilled (JS body unhappy at
health ministry work 2003) yet the committee
members were unable to take any stern action
against the Ministry. All the meetings of the committee
were held in private with no scope for outside
participants (depicted as strangers in Rule 201) to
attend the meetings. Such tradition has led the
committee activities to operate in secretive and non-
transparent manner.  
State Medical Faculty 
The State Medical Faculty was established during the
British period in 1914 for the purpose of holding
examinations and awarding diplomas to LMF doctors.
After the partition of India in 1947, the State Medical
Faculty (SMF) of East Pakistan was created with the
same objective. Due to the growing demand for health
services the mandate of the SMF was broadened to
include coordination of diploma courses on LMF,
compounder, LDS, nurse, midwives and dressers;
conduct paramedics course since 1952, conduct medical
assistant course since 1976 and coordinate palli
chikishok (village doctor) course for the period of
1979-1983 and award diplomas and certificates to
the successful candidates.  
Bangladesh Pharmacy Council
Soon after the independence of Bangladesh in 1971,
the Government stepped up to establish Pharmacy
Council to regulate the practices of the pharmaceuticals.
The Pharmacy Council Ordinance was enacted on 4th
March, 1976 to establish the Council. According to
the Act, the Council consists of government officials
including Secretary of the MoHFW, Director of Health
Services, head of Drug Administration, one nominated
person each from Bangladesh Oushadh Shilpa Samity,
Bangladesh Medical Association and Bangladesh
Chemists and Druggists Samity and three persons
nominated by the pharmaceutical society. The main
functions of the Council include regulation of
registration and monitoring of educational institutions
for establishing a uniform standard of basic and
higher qualifications in pharmacy.
Bangladesh Board of Unani and 
Ayurvedic Systems of Medicine
After the country’s independence, the country inherited
the Pakistani Board of Unani and Ayurvedic Systems
of Medicine. Later, a new law titled "Bangladesh Unani
and Ayurvedic Practitioners Ordinance of 1972" was
enacted to restructure this body as the Board of Unani
and Ayurvedic Systems of Medicine, Bangladesh
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(WHO 2001). The Board is responsible for maintaining
educational standards at teaching institutions;
arranging registration of qualified persons (including
appointing a registrar) and arranging the standardisa-
tion of unani and ayurvedic systems of medicine. 
In 1983, another law entitled "The Bangladesh Unani
and Ayurvedic Practitioners Ordinance, 1983" was
passed to regulate the qualifications and registration
of practitioners of Unani and Ayurvedic system of
medicine. According to the ordinance, the Board of
Unani and Ayurvedic Systems of Medicine is headed
by a Chairperson who is appointed by the Government.
The ordinance also has the provision for the board to
be consisted of two members from hakims and vaids,
one member from each administrative division, to be
elected by the registered practitioners of Unani system
of medicine, two members from teachers of recognised
teaching institutions of unani and ayurvedic system 
of medicine. 
All the three institutions i.e. State Medical Faculty,
Bangladesh Pharmacy Council and Bangladesh Board
of Unani and Ayurvedic Systems of Medicine have
similar characteristics as BMDC and BNC. Their analyses
have not been presented in order to avoid repetition.
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Introduction
Traditionally, medical profession is the only profession
which directly deals with the life and death of a person.
Medical ethics refer to the moral principles which should
guide the members of the medical profession in the course
of their practice of medicine and their relationship
with their patients and other members of the profession
(Nandy 1996). It is defined as a set of principles and
moral values to guide proper medical conduct
(Answers.com n.d.). Ethics has been considered as
an indispensable part of medical profession from
ancient time with universally accepted codes of ethics.
However, the implementation of such codes varies
from country to country. 
Although ethics as a concept has been developed in
different parts of the world over a long period in
history, the Babylonians were the first to codify the
rules. The Code of Hammurabi is the first code of
ethics which was articulated around 2200 BC. Ethical
principles were also followed in ancient Egypt, India,
Greece, Persia and China (Huq 1999). The Hippocratic
Oath incorporated the comprehensive concept of
medical ethics during the Greek-Roman era. The Geneva
Declaration of medical ethics, which is a revised
version of the Hippocratic Oath, was formulated by the
General Assembly of the World Medical Association at
Geneva in September 1948 (see Box 4.1). The code is
commonly known as the International Code of Medical
Ethics, which has been amended several times between
1948 and 2006. The Geneva Declaration is adopted
by the Bangladesh Medical and Dental Council with a
few modifications. While the oath states a promise to
show utmost respect for human life, in Bangladesh it
is modified so as to protect the human life in all
circumstances and to rescue it from death, malady,
pain and anxiety. In Bangladesh, instead of taking an
oath for not using medical knowledge to violate the
human rights and civil liberties, it states, that as an
instrument of Allah's mercy, medical care will be
extended to everybody and everywhere. 
This section of the report deals with the ethical issues
related to the medical professions in Bangladesh,
looking specifically at doctors, dentists and nurses. 
The objectives are to: i) examine how ethics is taught
in medical education in Bangladesh; ii) discuss how
ethics is practised in reality and iii) formulate recom-
mendations thereof. 
Ethics in medical education
Ethics was introduced as a part of the formal medical
curriculum for the first time in 1988. No formal ethical
education is included in the post graduate medical
Box 4.1  Geneva Declaration
1. I solemnly pledge myself to consecrate my life to
the service of humanity;
2. I will give to my teacher the respect and gratitude
which is their due;
3. I will practice my profession with conscience and
dignity;
4. The health of my patient will be my first
consideration;
5. I will respect the secrets which are confided in me,
even after the patient has died;
6. I will maintain by all means in my power, the
honour and the noble traditions of the medical
profession;
7. My colleagues will be my sisters and brother and I
will pay due respect and honour to them;
8. I will not permit considerations of age, disease or
disability, creed, ethnic origin, gender, nationality,
political affiliation, race, sexual orientation, or
social standing to intervene between my duty and
my patient;
9. I will maintain the utmost respect for human life;
10. I will not use my medical knowledge to violate
human rights and civil liberties, even under threat;
11. I make these promises solemnly, freely and upon
my honour.
Source: Geneva Declaration 1948.
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education. It is taught during the third and fourth
year of medical education (Huq 1999). A core course
on Medical Jurisprudence is taught only under
forensic medicine for which as few as 12 lecture hours
are allocated. Para-clinical teaching session also
contains limited discussions on medical ethics.
Compared to the medical curriculum, the dental
curriculum includes a more detailed discussion on
Dental Jurisprudence and allocates more lecture and
tutorial hours on this topic. The nursing diploma
curriculum includes a section on nursing ethics which
defines nursing ethics, discusses the concept of
nursing self management and accountability within
health care system. A small section on ethics is also
included in the midwifery syllabus. 
A review of the medical, dental and nursing curricula
shows that these largely include discussions on ethics
as a concept and its definition, state rules and laws for
regulating the profession, professional code of conduct
and a brief historical context of the medical ethics. A
critical assessment of the curricula reveals several
problems in relation to inclusion of ethics. These are
issues that are presented in the following section.
Ethics taught superficially
Ethics is taught from a theoretical perspective. Medical
education experts assert that the major objective of
teaching ethics should be the development of medical
professionalism. They also argue that ethics should be
taught in an integrated manner rather than a separate
course (key informant interviews). The curriculum is
largely theoretical and is only concerned with defining
and elaborating terms without referring to the clinical
topics or problems. As a result the physicians and
dentists find it difficult to exercise ethical rules in
practice as they do not receive any applied knowledge.
No prior attention given to
habit formation
It is argued that habit formation should be a major
concern of overall medical education and which must
be maintained while teaching medical ethics. The
ethical problems that the students might face in their
day to day practice should be taught emphatically and
under varying circumstances in order to develop
expertise in handling such emergencies with efficiency.
It is suggested that a course on ethics should be
designed in such a way that it is spread through the
years of medical education. 
Lessons on ethics are ignored by medical
students
Medical ethics as a topic is not paid much attention
by medical students. Students tend to memorise the
chapters which are more likely to be asked in examina-
tions. As ethics comprises a very small section of the
whole syllabus, there is little or no chance of it being
included in examinations. As such it is neither properly
taught by the teachers nor studied by students. The
lack of education on ethics is also reflected in the
quality of the teachers who often do not have proper
training in medical ethics, etiquette and code of conduct
(Huq 1999) and hence fail to ensure proper deliverance
on ethical issues. 
WHO course on ethical standard is not
mandatory
The World Health Organisation (WHO) concerned over
the lack of adequate teaching expertise on ethical issues
began working on developing guidelines for teaching
health ethics in the countries of South East Asian
Region (SEAR) since 1996 (WHO 1999). Bangladesh was
the first among SEAR countries to complete the country
specific version of the module. It has been approved
by BMDC as an additional resource module. The Centre
for Medical Education (CME) is currently arranging
orientation workshops to introduce the material to
teachers; the module will be disseminated in every
medical college and each and every department will
be advised to organise three or four teaching sessions
on this module. The module is generic in nature and
CME recommended it for dentists and nurses as well.
However, no steps have yet been taken to make it
mandatory and to incorporate it within the medical,
dental or nursing curricula. This leaves the use of the
module entirely at the discretion of the teachers with
the risk of being under or never utilised. 
State of ethical enforcement
As a signatory to the international code of medical
ethics, Bangladesh has adopted the standard code of  
25 Ethics in the health sector
medical ethics. BMDC is responsible for maintaining
the standards in the medical profession and is supposed
to publish and disseminate Code of Ethics among the
registered doctors and dentists to familiarise them
with the professional regulations. The Code of Ethics
provides a set of regulations prescribed by BMDC to
maintain a standard in ethical practice in the medical
profession. If any medical or dental practitioner violates
the guidelines, BMDC can either suspend or permanently
cancel his/her registration as a practitioner.
Similarly Bangladesh Nursing Council is responsible to
maintain ethical standards in nursing and is supposed
to collect, publish and disseminate the Code of Ethics
among the nurse. In reality, no doctor or nurse ever
received any communication from BMDC or BNC on
ethical standards.
Code of ethics and professional
conduct for the nursing, midwifery
and FWVs
The code of conduct also provides a detailed list of
do's and don'ts for the nurses, midwives and Family
Welfare Visitors (FWVs). The codes are depicted under
three major sections. The first section gives a guideline
about how they should behave with patients; the
second section provides guidelines on their practice
and the third section states a set of rules in order to
maintain a standard in their practice. 
The code approved and prescribed by BMDC and BNC
are of international standard, but are still merely on
paper. One may also question the applicability of 
the code given the realities in the health sector and
the level of preparedness among the concerned 
health professionals. It will be revealed from the
upcoming sections and chapters that physicians
frequently engage in unethical practices that are
completely contrary to the provisions made in the
Code of Ethics. In terms of the BNC approved 
codes, it may be argued that they are not
contextualised according to the general qualifications
of the nurses and the real life conditions in which
they work. 
Ethical standard in practice
Bangladesh is plagued by deteriorating of quality
health service  accompanied by increased corruption
and medical malpractices. People are extremely
concerned about the conditions and performance of
public hospitals where the bulk of the responsibility
lies with the physicians. The 2007 corruption survey
report of Transparency International Bangladesh
(TIB) reveals that two out of five patients faced
harassment in receiving service from public hospitals
(Table 4.1).
Almost half of the patients among them reported that
they had to pay a bribe at the hospitals to get service.  
Box 4.2  BMDC approved codes
1. The nurses/midwives/FWVs should treat patients
as clients and show them respect.
2. They should be sympathetic and sensitive in their
attitude towards the patients. 
3. They have to maintain professional secrecy at 
all times.
4. Patients should be served irrespective to their
religion, gender, age, race, nationality and class. 
5. They are to advice patients in all matters related
to the care.
6. Nurses/midwives/FWVs are to inform patients
about all the related issues of treatment because
it is the legal right of the patient. 
7. Maintain a safe environment to promote recovery,
prevent complication and ensure wellbeing of
patients.
8. Maintain and ensure a basic professional standard.
9. They are not allowed to undertake any nursing
practice without authority. 
10. They are prohibited to do any practice about
which they do not have the required skill. 
11. They are not allowed to participate or assist in
any unethical medical and nursing practice.
12. They are not allowed to restrain a patient unless
they become harmful to others or themselves.
13. To maintain the professional standard, they are
not to accept money from the patient, patient's
family or relatives. 
14. They are also responsible to extend their
professional knowledge through training. 
15. They are not allowed to misuse the property of
hospital or property under anybody's control.
16. They should not have any engagement in activities
which might disgrace the profession itself.
Source: BMDC 1983
26Bangladesh Health Watch Report 2009
Doctors are reported to be the highest bribe takers
followed by nurses (Table 4.2).
Public physicians are not very attentive to
maintaining regular attendance in their work place
either in the public health complex or in the public
hospital. Private practice is the major reason behind
this as confirmed by a TIB survey (Zaman & Abdul
2006). A World Bank study (Chaudhury & Hammer
2003) reports that the absentee rate of physicians 
in public health centres is more than 40 percent 
on average. In larger hospitals it is 40 percent
compared to 74 percent in small health centres 
(such as the Union centre) that are often run by one
doctor only. 
The existence of illegal contracts among doctors and
dentists with pharmaceutical companies and diagnostic
centres is another widely reported complaint against
physicians, irrespective of whether they are private or
public practitioners. The TIB Corruption Survey 2007
found that 22.7 percent of the patients of public
health services reported that they were advised to
visit the private chamber/clinic of the doctor. The
Table 4.2: Status of service recipients reported 
to be harassed
Faced  % of households members
harassment 
Rural Urban Overall 
Yes 39.8 37.5 39.0 
No 60.2 62.5 61.0 
Total 100.0 100.0 100.0 
Source: TIB Corruption Survey 2007
Table 4.1: Types of bribe takers 
% of households members  
paying bribe
Rural Urban Overall 
Doctors 47.6 33.9 42.2 
Nurses 20.0 32.2 24.8 
Employees 5.2 14.8 9.0 
Ward boy 2.8 4.4 3.4 
Brokers 17.0 12.4 15.2 
Others 7.4 2.3 5.4 
Total 100.0 100.0 100.0 
Source: TIB Corruption Survey 2007
Box 4.3  BNC approved codes
1. No registered medical and dental practitioners are
allowed to issue false certificate.
2. Doctors and dentists are not allowed to accept
any illegal gratification from the patient.
3. Professionals are not allowed to engage in illegal
abortion or prescribing drugs which violate the
Dangerous Drug Act. BMDC can also suspend or
cancel their registration if doctors or dentists are
convicted of driving under the influence of alcohol
or found to be addicted to drugs.
4. a) Medical/Dental practitioner is not to have any
kind of improper relationship with his patient or
any person with whom he has professional
relationship. If a doctor is found guilty in divorce
proceedings s/he will be subjected to suspension
or cancellation of registration. b) Medical
professionals are required to maintain
professional secrecy.  
5. Any gross negligence will be counted as
professional misconduct. If a doctor/dentist assist
any unregistered person, it will be considered as
a professional misconduct. 
6. The Council may take disciplinary action against
the professionals who are convicted of offences
such as false pretences, forgery, fraud, theft,
indecent behaviour or assault. 
7. Professionals are not allowed to share any fees
with other professionals or other persons as
commission. 
8. Doctors and dentists are prohibited to use any
false titles which make people infer that the
professional holds any additional qualification
unless it is conferred by a legal authority. They
are also not permitted to use any sort of
advertising and canvassing to attract patients. 
9. The medical/dental practitioners who are actively
involved in private practice are not allowed to
disclose their identity when they appear in radio
or television. Such appearance should be limited
to health education only. 
10. All registered doctors/dentists must inform the
medical association if they change their address
or make any changes in the hours of private
practice. They should also publish the
announcement of address change in local
newspapers, either simultaneously in three
papers, or consecutively over three days in the
same newspaper. 
11. BMDC also expects that a medical or dental
practitioner will not charge fees from one another
for their service.
Source: BNC 2003
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study also reported that 39.5 percent of sample
households were asked to do pathological tests when
their family members consulted with the public
physicians. The 2007 report by Consumer International
(CI) shows that doctors are the main targets for the
promotional activities of the drug companies in the
developing world. This report was complemented by
a month long investigation by the Daily New Age which
revealed that as incentive for prescribing medicines of
selected pharmaceutical companies, physicians get a
wide range of returns including monthly payments,
air ticket, and payment of mobile phone bills etc.
Popular and well-known doctors often get laptops, air
conditioners, televisions and even cars in return to
prescribing selected medicines (Hayat 2008). Doctors
even welcome medical representatives of the
pharmaceutical companies to be present during the
office hours making the patients suffer. More
elaborate discussion on pharmaceutical promotional
practices can be found in Chapter 7 of this report. 
Another report found that doctors of Dhaka Medical
College Hospital (DMCH) referred half of their patients
to the private diagnostic centres in spite of having
laboratory facilities at the hospital where 90 percent
of the pathological tests and other investigations are
available (Ashraf & Mollah 2008). 
Patients' satisfaction highly depends on the service
orientation of the physicians and nurses; but this
issue does not get proper attention in Bangladesh.
The 2002 TIB report card survey depicts that half of
the patients felt they did not receive proper attention
of the doctors in the public hospitals. 
Problems with enforcing mechanisms 
Doctors and nurses who are liable for poor ethical
standard in medical profession are not the only 
actors to blame. The professional regulatory 
bodies responsible for enforcing ethical standards in
the profession are equally responsible for not
preventing these malpractices from taking place. The
problems of the enforcement mechanisms of the
regulatory bodies have been discussed in the
previous chapter.
Ethics in theory (Code of Ethics, BMDC 2002)
Registered doctors/dentists are not allowed to take any gratification from patients.
No registered doctors/dentist will issue fake certificate.
Doctors will not be engaged with any improper abuse of his skills, such as abortion,
prescribing dangerous drugs etc.
Doctors will not have any improper relationship (for e.g. adultery) with the patient or
his relatives. The secrecy should also be maintained. 
Disregard of professional responsibility to the patient, i.e. he will not show any gross
negligence to patient or will not assist an unregistered person. 
No medical/dental practitioner shall commercialise any secret remedy or share any
professional fees with any other medical/dental practitioner or other person in the
form of a commission.
Doctors are not to use false title, do any sort of advertisement or canvassing. 
When announcing their appearance on the radio or the television on professional
subjects, medical/dental practitioner shall not disclose their identity or allow it to be
disclosed.
Any change of address or of the hours of practice have to be announced in advance
thrugh proper notice.
Ethics in Practice 
Not Practiced in reality. 
Not maintained. 
Not practiced in reality. 
No report on improper relationship or secrecy
violation has been ever found.
Least practiced in reality. 
Not practiced. 
Not practiced by professionals. Title is
widely used without taking permission from
the authority.
Not practiced. 
Not practiced.
Box 4.4: Code of ethics: Theory vs. practice
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Introduction 
An essential drug is a medicine considered as
indispensable for treatment of a disease. The availability
and accessibility to essential drugs are crucial for
successful functioning of any health systems
(Chaudhury et al. 2005). The National Drug Policy (NDP)
of 1982 was instrumental to improve the supply of
quality essential drugs in Bangladesh at an affordable
price (Islam 1999). An Essential Drug List (EDL) initially
identified 150 (45 for rural PHC facilities) drugs with
controlled price which was later reduced to 117 in
1993. The EDL has been revised and updated recently
after 25 years to reflect advancement in medical
science and now contains 209 drugs (Khan 2008). 
The pharmaceutical industry in Bangladesh has
developed rapidly following the implementation of
the National Drug Policy of 1982 (Reich 1994). In
2005, the pharmaceutical market was worth US$ 504
million and has been increasing at a steady average rate
of 17.2% annually (Begum 2007). In 1980, eight
multinational companies manufactured 75% of all
products (by value) while indigenous or local pharma-
ceuticals now claim a market share of more than 75%
(Ahmed & Hossain 2007). Out of the top ten
pharmaceutical companies now, eight are local. 
The local pharmaceutical industry is capable of
producing all the 209 items under the EDL and can
meet the demands of the country.  As per the existing
drug policy, 60% of the production capacity of a
company should be invested in producing medicines
under EDL. 117 items out of 209 of the EDL are
amenable to price control. 
One of the main objectives of the Drug Policy of 1982
was to make available quality essential drugs at an
affordable price. Thanks to the policy of buying raw
materials from international competitive markets
under the NDP of 1982, the prices of the essential
drugs fell sharply in the following years (Ahmed 2004).
From 1981 to 1991, retail price of drugs increased by
only 20% in local currency. Before the Drug Policy,
the retail price of drugs was fixed by the Ministry of
Trade upon discussion with Directorate of Drug
Administration. Following recommendations of the NDP,
a pricing committee with experts from stakeholder
groups decides on the price of the locally produced
drugs, and also endorse prices of imported drugs/
non-essential drugs produced locally after review.
In other words, Government of Bangladesh has set out
the policy in such a way that essential medicines should
be made available to the population of Bangladesh at
an affordable price. Only good governance can
ensure proper implementation of such policy. This is
of particular importance since Bangladesh is one of
the few countries where there is high out-of-pocket
(OOP) expenditure on drugs by households which
amounts to around 70% of the total OOP expenditure
on health (GoB 2003).
In this year's report, Bangladesh Health Watch
attempts to study governance issues related to the
functioning of health systems in Bangladesh. This
particular section documents the achievements of the
three outcome objectives (out of four; quality of drug
excluded) of the National Drug Policy of Bangladesh
with respect to availability, affordability, and rational
use. So far, no comprehensive study on the effectiv-
eness of drug policy have been done in Bangladesh
except a study on drug use at public sector PHC
facilities about 15 years ago (Guyon et al. 1994). This
study is intended to fill in the knowledge gap by
exploring the current state of Essential Drug use in
the country.
BHW commissioned a research team to examine how
far the outcome objectives of the National Drug Policy
in terms of availability, affordability, and rational use
have been achieved with respect to essential drugs in
the public and private sectors PHC facilities in both
rural and urban areas of Bangladesh. Availability
refers to geographical access, i.e., whether the full
range of essential drugs are available throughout the
CHAPTER 5
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country, and whether private pharmacies or other
licensed drug outlets are accessible to the majority of
the population. Affordability refers to financial access,
i.e. whether drugs that are needed can be obtained
at a price affordable to the majority of the population
and how the poor gains access. Rational use refers to
whether drugs are prescribed, dispensed and
consumed in a therapeutically rational manner;
whether private health providers, pharmacists,
pharmacy aides and other dispensers are providing
good advice on consumer purchases; and whether
patients and consumers are buying therapeutic
quantities of prescribed or recommended drugs
(Bennett, Quick & Velásquez 1997). The study
covered a representative sample of UHCs (30) and
drug shops (30) in the rural areas and a sample of
urban clinics (20) in the Dhaka City Corporation
(DCC) area for observation, exit interview and a mini-
market survey. The details of the study objectives
and methodology are provided in Annex 2. 
Findings
Polypharmacy on the rise
Polypharmacy or prescribing three or more drugs
increases the risk of drug interactions, dispensing
errors and proper comprehension of correct dosage
schedules (INRUD & WHO 1993). The study found
polypharmacy to have been practised in a greater
extent, at a staggering 33%, than in the past (5%
reported by Guyon et al. 1994) in the UHCs.  On an
average, the number of drugs prescribed per visit of
patients in the UHCs (2.2) was higher than that in the
past (1.4) (Guyon et al. 1994). 
Only 5% of the prescriptions from the drug shops
contained a single drug compared to 15% from the
urban clinics and 18% from the UHCs (Table 5.1)
Prescriptions having two drugs were mostly from
UHCs (49%) compared to drug shops (33%) or urban
clinics (39%). Polypharmacy such as three drugs
(43%), and four or more drugs (19%) was most
prominent in prescriptions from the drug shops. 
Insufficient use of essential drugs
Average number of drugs prescribed per encounter
(prescription) was highest for the drug shops (3) and
lowest for the UHCs (2) (Table 5.2). The drug shops
also prescribed injection in 4% of the encounters
compared to none for the UHCs and urban clinics. In
44% of encounters in UHCs and urban clinics, an
antibiotic was prescribed while the proportion rose to
60% in case of drug shops. In more than 60% of the
encounters in the UHCs and the urban clinics, drugs
were prescribed from the essential drug list (EDL) while
the proportion was only 44% in case of drug shops.
Antibiotic use on the rise
The proportion of antibiotics prescribed in the UHCs
irrespective of any specific disease (45%, see Table
5.2) was higher than 25% reported by Guyon et al.
(1994) and also other earlier studies (Karande, Sankhe
& Kulkarni 2005; Hamadeh et al. 2001; Shankar et al.
2002; Massele et al. 2001). Antibiotics prescribed
were even higher in the drug shops (60%) where
unqualified and semi-qualified providers like palli
chikitshoks and medical assistants attended patients.
This is not surprising as in rural Bangladesh, the
provider/prescriber and the dispenser, are often the
same person thus giving rise to conflict of interest
(Axon 1994). To maximise profit, they might prescribe
drugs in stock whether it is needed or not, especially
the more expensive ones like the antibiotics. The
situation is made worse by the aggressive marketing
strategies of the pharmaceutical companies especially
for the unqualified/semi-qualified providers. They are
easily influenced by these efforts since they don't
have any other channel of information from the
formal sectors approaching them. Thus, irrational use
of antibiotics is noticed across a broad spectrum of
providers (Trap & Hansen 2001; Ahmed & Hossain
2007; Kristiansson et al. 2008; and Rahman et al.
2009) and is responsible for development of antibiotic
resistance (Larsson 2003).
Table 5.1: Polypharmacy by study areas
Rural Urban
Prescription
containing no.
of drugs
One
Two
Three
Four or more
Total number
UHCs
(%)
18.1
49.0
27.0
5.9
900
Drug Shops
(%)
5.4
33.1
42.8
18.7
900
DCC/NGO
Clinics
(%)
14.8
38.9
30.0
16.2
596
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Performance of Bangladesh in terms
of rational use of drug
The Essential Drug List comprises of a core list of
minimum medicine that satisfies the health care
needs of the majority of the population in a particular
country, and should be available at all times in
adequate quantity and in appropriate dosage
(Brudon et al. 1999). The latest updated and revised
EDL in Bangladesh was released on 8th April, 2008
(GoB 2008). Only 47% of the UHCs and 55% of the
urban clinics had a copy of the Essential Drugs List
(Table 5.2).  None of the facilities had all the 20 listed
drugs (reference list prepared from the EDL for this
study) for common illnesses. However, 6% of the
UHCs and 15% of the urban clinics had at least 15 of
the 20 listed drugs. An alarming decrease in the
proportion of drugs prescribed from the EDL in the
UHCs was observed (from 85% in 1994 to 63% in
2009) compared to the earlier study by Guyon et al.
(1994). Similar level of prescription from EDL (around
60%) was reported in Serbia (Jankovic´ et al. 1999)
but higher level was reported in India (Karande,
Sankhe & Kulkarni 2005), Laos (Keohavong et al.
2006), Tanzania (Nsimba 2006) and Cambodia
(Chareonkul et al. 2002). It is clear that Bangladesh
is behind other low-income countries in the aspect of
rational drug use.
Consulting and
dispensing time
The quality of care provided
was measured by the time
spent in consulting with the
patient and dispensing the
prescribed drugs which
includes providing instruc-
tion on how to take the
drugs. Average consulting
and dispensing time in the
UHCs appeared to have
increased from what was
found by Guyon et al. (1994),
from less than one minute
to two minutes and from 23
seconds to about 60 seconds
respectively (Table 5.2).
However, it still lacks behind other countries such as
Serbia (Jankovic´  et al. 1999). Such a short time is
neither adequate for history-taking and examination
of the patients nor for providing sufficient information
on drug dosage schedule, and the necessity of
completing the dosage as per instruction. The drug
shops and the urban clinics performed better than
the UHCs in this respect. It was revealed in the study
that 73% patients in rural UHCs and 76% patients in
urban clinics knew the correct dosage prescribed.
Drug dispensation quality shows
mixed scenario
The proportion of drugs dispensed out of the ones
prescribed, was much higher in the UHCs (76%)
compared to the urban clinics (44%) (Table 5.2).
None of the drugs dispensed from any of the facilities
was labelled properly (name, generic name of drugs
and dosages). In the present study, drugs were
considered labelled if the drug could be identified by
either the inscription on its body or the name printed
when available in the original package. Even with this
proxy indicator, it was found that the UHCs and the
urban clinics were performing poorly in this aspect.
Only 65% of the drugs dispensed in UHCs and 43%
in the urban clinics were labelled. Poor labelling of
drugs dispensed was also seen in India (Karande,
Sankhe & Kulkarni 2005), Tanzania (Nsimba 2006)
and Cambodia (Chareonkul et al. 2002).
Rural Urban*
Average number of drugs per encounter
% of encounters with an antibiotic prescribed
% of encounters with an injection prescribed
% of drugs prescribed from essential drugs list 
Average consultation time (min)
Average dispensing time (min)
% of drugs actually dispensed
% of drugs adequately labelled
% patient's knowledge of correct dosage (self-reported)
% facilities having a copy of essential drugs list
% facilities where at least 15 essential key drugs (from
the reference list) are available
UHCs
2.2
45.0
0.0
63.0
1.8
0.9
76.3
65.4
73.0
47.0
6.0
Drug Shops
2.8
59.8
4.2
44.4
5.1
NA
NA
100.0
90.0
NA
NA
DCC/NGO
Clinics
2.5
42.7
0.0
66.1
5.8
2.1
44.0
43.0
76.0
55.0
15.0
Table 5.2: Core drug use indicators by study areas 
* Dhaka City Corporation areas; NA=not applicable
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Patients' knowledge of correct dosages was estimated
in this study by self-reporting since proper labelling
was mostly absent and instructions on how to take the
drugs were given verbally. An improvement in the
knowledge of correct dosages since 1994 (Guyon et
al.) was observed in case of UHCs (from 57% to 73%
in this study), comparable to other studies (Karande,
Sankhe & Kulkarni 2005; Keohavong et al. 2006), while
a lower level of such knowledge was observed in
studies by Nsimba (2006) and Chareonkul et al. (2002).
Availability of essential drugs reduced
The facility indicators presented a mixed picture. While
comparing with the previous study on UHCs (Guyon
et al. 1994), an improvement was observed regarding
the presence of the copy
of the EDL (from 28% to
47%) but availability of
essential drugs for treatment
of common illnesses had
deteriorated (from 63% to
6%, Table 5.2). Thus
availability of essential
drugs appeared to be a
major constraint in rational
management of common
illnesses. This is also
consistent with the common
complaint of lack of
medicines (other complaints
being bad staff attitude,
bad service, difficulty to
reach, extra payment,
non-availability of doctors,
etc.) leading to further
reduction in the use of
government health services
during 1999-2003 (Cockcroft
et al. 2007).
Anarchy prevails
in drug price 
Table 5.3 presents the
results of the mini-market
survey for the lowest and
highest price of selected
essential drugs for common illnesses. The anarchy
prevailing in the drugs market is well amplified by the
wide variation found in the price of drugs based on
brands, sometimes the difference ranging from an
overwhelming 500 to over 1000 percent. For example,
the price of tablet IFA was amplified by a 1650%, one
bottle of tablet B-Complex by 650%, tablet Mebendazole
by 900%, Benzylbenzoate lotion by 817%, Chloram-
phenicol ointment by 543%, Miconazole ointment by
592%, and tablet Metronidazole by 500%.
The anarchy prevalent in the prices of essential drugs is
a result of poor regulatory and supervisory activities by
the Drug Administration authority. The prescribed drugs
at the facilities are not always available and out-of-
pocket expenditure for drugs is high in Bangladesh.
Current market price (Taka) % 
Sl Essential drug list
1 ORS (Oral Rehydration Solution 
2 Cotrimazole single table 
3 Cotrimazol syrup
4 Amoxycline syrup
5 Ciprocine tablet
6 Ciprocine syrup 
7 Aluminium hydroxide+ Magnesium hydroxide tablet 
8 Aluminum hydroxide +magnesium hydroxide  
9 Tab Ranitidine (150 mg)
10 Tablet Paracetamol (500 mg)
11 Tablet Acetylsalicylic cyclic (Aspirin 300mg)
12 Tablet IFA (Iron + Folic Acid)
13 Tablet B complex per bottle 
14 Tablet Ascorbic acid
15 Tablet Mebendazole
16 Tablet Albendazole 
17 Tablet Atenolol 50mg
18 Tablet Prednisolon
19 Benzylbenzoate lotion 25%
20 Chloramphenicl eye drop 
21 Chloramphenicol ointment 
22 Nasal drop 
23 Miconazol ointment 
24 Tablet Metronidazole 400 mg 
2.00
0.80
11.0
20.0
4.0
37.0
0.50
11.0
1.00
0.50
0.50
0.20
12.00
0.50
0.50
1.00
0.70
0.50
6.0
10.0
7.0
6.0
13.0
0.50
5.00
2.50
26.65
60.0
16.0
95.00
1.50
65.00
4.00
2.00
2.00
3.50
90.0
2.00
5.00
6.00
4.00
1.50
55.0
35.0
45.0
35.00
90.0
3.00
150
213
142
200
300
157
200
491
300
300
300
1650
650
300
900
500
330
200
817
250
543
483
592
500
Lowest
price (Tk.)
Highest
price (Tk.)
difference 
Table 5.3: Lowest and highest price of selected essential drugs for 
common illnesses (Taka) 
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These factors contribute to the catastrophic health
expenditure for the poor households (Xu et al. 2003;
Doorslaer et al. 2007).  
Weak state of drug 
governance and inadequately
equipped infrastructure
The Directorate of Drug Administration (DDA) is the
supreme regulatory authority in the country for drug
related affairs such as licensing, production, import,
export, quality control, and pricing. (ddabd.org n.d.).
DDA is headed by a Director who is assisted by three
Deputy Directors (one each for registration and quality
control, inspection and licensing, and drug testing).
There are 37 District offices staffed by 41 Superintendent
of Drugs and 12 Drug Inspectors who are responsible
for field level regulatory activities. A number of
committees, such as the Drug Advisory Committee,
Drug Control Committee, Pricing Committee, and
Standing Committee for procurement of raw materials
and import of finished drugs etc., comprising of
experts from appropriate disciplines, advise on
relevant matters to the licensing authority. Besides,
there are two drug testing laboratories: one in
Chittagong under the DDA and another in Dhaka under
the Institute of Public Health (IPH) of the DGHS.
These laboratories test the quality of the pre-
registration as well as post-marketed drugs. The
regulatory mechanism for the production, marketing
and use of drugs is limited by the Drugs Act 1940
(rules made in 1946) and the Drugs (Control)
Ordinance 1982 (ddabd.org n.d.).
New products enter the market everyday. With the
meagre resources (such as two drug testing labs and
around fifty drug inspectors/superintendents) at
hand, it is very difficult for the DDA to supervise and
monitor such a large sector. As a result, many drugs
are entering the market without proper quality
assessment procedures. This has resulted in flooding of
the market with counterfeit drugs, sub-standard drugs
and expired drugs (Fake drugs flood Bangladesh 2004).
These fake and low-quality drugs are frequently
responsible for poisoning, sometimes death of people
(UNHCR 2006), and development of resistance to
life-saving antibiotics (Okeke et al. 1999).  
Drugs in the public sector hospitals and facilities are
distributed by the central medical stores (WHO 1985).
Outside this sector, the retail distribution seems to be in
a chaotic condition whereby no regulatory enforcement
is in place. According to law, the persons dispensing
drugs at drugstores should have at least a short training
of eight weeks duration (certificate course) conducted
by the Bangladesh Pharmaceutical Society (BPS) in
cooperation with the Bangladesh Chemist and Druggist
Samity (BCDS) through 45 tutorial centres before
applying for a drug shop (pharmacy) license. But in
practice, this is hardly followed. According to BCDS,
there are about 64,000 licensed (14,000 member of the
samity) and around 70,000 unlicensed drugstores in the
country involved in selling drugs 'over-the-counter'
(Zahedee 2008). Most of the sales people at these drug
stores do not have training in either dispensing of drugs
or in diagnosis and treatment. Since they have no other
channel of information from the formal sectors, they fall
easy prey to the aggressive marketing strategies of the
pharmaceutical companies (Appalbaum 2006).
Irrational use of drugs such as over prescribing, multi-
drug prescribing, use of unnecessary expensive drugs
and overuse of antibiotics and injections are the most
common problems found with these retailers (Ahmed &
Hossain 2007).
Drug retail shops are often the first and only source
of health care outside home for majority of the
patients in developing countries (Kamat & Nichter
1998) and Bangladesh is no exception. Anybody can
buy any drug in any amount including addictive drugs
without prescription from these drug stores. In reality,
there are no 'prescription-only' drugs in Bangladesh.
There is no monitoring and supervision system in
place to regulate these drug stores.
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Introduction
Pharmaceutical products play a critical role in health
care everywhere in the world. Prescriptions are only
effective if quality drugs are taken by the patients in
proper dosage and schedule. Dependence of health
care on pharmaceuticals has created a substantial
market for drugs worldwide and the industry has
been very aggressive in marketing and promoting
their products. Like any other profit making industry,
push for introducing new drug and/or increasing sale
of drugs in order to maximise revenue is an obvious
course of activity for all pharmaceuticals. Physicians
are positioned between the industry and the patients
through whom the drugs are brought to the end-
users, especially when promotion through mass media
is restricted for all pharmaceutical therapeutic products.
Thus, they shoulder a major responsibility in all societies
including Bangladesh where the regulatory framework
for drug dispensing is weak. It is important to under-
stand how drugs are marketed and promoted in such
countries and the role of regulations in this transaction.
In the backdrop of these realities, a study on the topic
was conducted under the auspices of the Bangladesh
Health Watch. The study investigated i) the extent to
which pharmaceutical promotional practices influence
non-compliance of the regulatory guidelines, namely,
the Drug (Control) Ordinance of 1982 and the Code
of Pharmaceutical Marketing Practices, promulgated
in 1994; and ii) explored the challenges in enforcing
the regulations and the factors that play into causing
these challenges. The study primarily used qualitative
tools, such as in-depth interviews with medical representa-
tives, physicians, RMPs and palli chikitshoks, observation
of health care facilities, and focus group discussion (in
the form of a roundtable) with CEOs and other top
management staff of prominent pharmaceutical companies.
Interviews and observations took place at various sites
in Dhaka, Bogra and Chittagong. A brief prescription
survey was also conducted for triangulation of the
information gathered from the qualitative investigations.
This chapter presents the findings of the study. 
Promotional practices
Medical representatives
meeting targets
In 2005, the pharmaceutical market of Bangladesh
was worth US$ 504 million and has been increasing at a
steady average rate of 17.18% annually (Begum 2007).
In 1980, eight multinational companies manufactured
75% of all products (by value) while indigenous
pharmaceuticals now claim a market share of more
than 75% (Ahmed & Hossain 2007). Out of the top ten
pharmaceutical companies now, eight are indigenous.
There are over 20,000 medical representatives currently
employed by the entire range of pharmaceutical
companies who basically promote pharmaceutical
products. The companies seek fresh graduates in
science with good academic records and select some
of the smartest candidates through a rigorous screening
process, following which the selected candidates
have to undergo a two-month training course. Each
medical representative (rep) is assigned a particular
area and given a target calculated based on the
annual sales target of the company and the number
of doctors in that territory by the pharmaceutical
company. Medical reps receive an increment or incentive
based on the target achieved on top of their monthly
salary. Doctors often give in to their persistent
requests of "filling up targets". According to one
physician:
"Reps are always anxious about meeting their targets …
there are several reps who I know closely. One of them
requested me the other day, 'Sir, I need your help in
fulfilling my target. If I can make it this time, I'll be able
to go to China.’ I thought I should support him.”
Blurring lines of professional boundaries
At present, it is a common practice for the MRs to interact
with the doctors at a personal level and  physicians are
generally comfortable with this approach. It was
mentioned in several interviews that the professional
CHAPTER 6
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distance that used to be maintained between the
physicians and MRs is gradually diminishing.
Aside from visits, medical reps also make it a point to
do a close study of the personalities and preferences
of each doctor. They call it "taking history" of the
doctor to know what their "demands" are like. In the
process of gathering background information on the
doctors, they try to know their financial conditions,
their past interactions with pharmaceutical companies,
whether they have contracted with a specific
company or not, and often about their families and
their health conditions. This information helps them
become intimate with the doctors and interact with
them in capacities beyond professional boundaries.
Common examples include medical reps running
personal errands for doctors, doing household chores,
arranging for transportation for the physicians' personal
and family use, sending birthday and anniversary
greetings and presents, bringing sweets and medicines
as "gifts" for members of the doctors' family and
loved ones.
"Gifts and inducements"
The code of pharmaceutical marketing defines the
gifts for medical professionals. In clause 19-1 under
the section on 'gifts and inducements', it is mentioned
that subject to Clause 19-2, 'no gift or financial
inducement shall be offered or given to members of
the medical profession for proposes of sales promotion.'
"Shudhu kothay chira bhije na" ("Just words
are not good enough to convince")
The title of this section is a statement made by a
medical representative. This represents the sentiment
of a medical rep based on their experience in dealing
with physicians. The most commonly used promotional
materials are literatures, journals, notepads, pens
and drug samples. However, there is an increasing
tendency of the pharmaceutical companies to give
almost anything as gifts. Gift items are not necessarily
for professional use; personal and household items
are also quite common. A wide array of items from
showpieces, torches, books, stethoscopes, money
bags, belts, dinner sets, tiffin boxes, calendars,
mobile cards, body sprays, ties, coat pins, key rings,
bed sheets, suit pieces, tissue boxes, and tea bags to
expensive gifts like ceiling fans, TVs, fridges, air
conditioners, generators, IPSs, mobile sets, cars, and
apartments are all examples of what is included in the
list of gifts and inducements offered by the companies.
"Pharmaceutical companies have been providing
everything except for grocery (kaacha bajaar). During
the last Eid they provided perfumed rice (polao er chal),
sugar, vermicelli (semai) etc. So it's not easy to say
what they don't offer us." - A doctor
Induction at an early stage
Doctors shared in their interviews how they started
receiving small gifts from pharmaceutical companies
since the time of their internships. Gifts offered at
that time ranged from mobile cards, crockery, shirts,
wrist watches, to medical books and journals.
Contracts with companies
Companies get into contracts with the doctors that
vary according to the popularity of the doctor and the
capacity of the company. The duration of these
contracts can be from one month to one year and the
amount may vary according to the popularity
("potentiality", as referred to by the MRs) of the
doctor. The study findings revealed that the amount of
money varies from one thousand taka to ten lacs taka
per month. These deals can also be made in exchange
of expensive items such as TV, fridge, laptop, air
conditioner, interior decoration service for the chamber,
or even cars or apartments. Doctors can get into such
contracts with several companies at the same time
according to their "potentiality". One MR shared:
"I know a very potential doctor of my territory whose
chamber rent is provided by one company while his
driver's salary and attendant's salary are paid by two
other companies."
While companies push their products and offer rewards
to contracted doctors based on prescriptions written for
their products, they also proactively offer commissions
even when the doctor prescribes drugs without any
particular obligation or allegiance to the company.
Targeting the informal sector
There are small-scale local pharmaceuticals in the
market who are unable to compete with the market
leaders in terms of quality of drug or the promotional
offers for medical professionals. Therefore, they target a 
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variety of other actors in the health care system like
the LMFs, Rural Medical Practitioners-Palli Chikitshaks
(RMP-PC), chemists, or even the attendants of the
doctors and security guards of private and public
facilities. According to an official at the DDA:
"Many small companies with no promotional workforce
or field force get into contract with fixed pharmacies
and drug shops or clients for selling their drugs in lieu
of payments."
The study findings revealed that the market leaders
don't have much promotional activities with chemists.
Drug sellers can earn a better profit by selling drugs
of a small local company since the purchase prices
are much lower than that for the same generics
produced by multinational companies. Chemists are
more likely to sell these products when a client comes
without a prescription. MRs mentioned that sometimes
the chemist altered the prescriptions on purpose in
order to dispense the brand of a company with whom
he has an "agreement". In our in-depth interviews
with the MRs of large or medium range companies, it
was revealed that their primary target is to promote
drugs to the doctors while the MRs of smaller and
more inconspicuous companies said that their prime
targets are the chemists. 
The RMPs usually have good relationship with small
companies. Names of some companies mentioned by
them were never mentioned by the doctors or MRs
interviewed in the urban sites. The RMPs claimed that
they prescribe the drugs of these small companies
because they came to them on a regular basis to
promote their drugs and they entertained the RMPs
with “cha-nashta” (tea and snacks). The market
leaders in the pharmaceutical industry don't visit them
as much. All the RMPs interviewed in the study were
owners of drug stores. The other reason they
mentioned for selling drugs of these small local
companies was the low price of their products, however,
the quality of which may be questionable.
Aiding the knowledge base of practitioners
The most conventional method used by pharmaceuticals
to promote their brand is product detailing. This is a
process by which a MR describes his product in terms
of its pharmacological properties, indications, dosages,
side effects, price, and benefits over other generics or
other brands. They use "literature" or "journal" that
are produced by their own companies upon consulting
books, journals, internet sources, etc. According to
them, this is a process of sharing scientific information
on a drug with the doctors and orienting them to 
their brands. The doctors also valued this service 
in general:
"Medical reps provide important information which
helps us in staying up-to-date as we ourselves remain
busy and sometimes fail to collect the information.
They are also a good source of information about
new drugs because we don't get them from the
textbooks". - A doctor
However, since there are a number of pharmaceutical
companies manufacturing the same drug, the doctors
often have to listen to the same information from
different MRs. They generally pay more attention when
there is information on a new drug. The study revealed
that doctors are generally not that interested in
receiving literature from medical representatives. It
was noted during several observations that doctors
were mainly interested in the sample drugs that the
MRs brought, and often kept the literature aside.
The doctors acknowledged the role of pharmaceutical
companies in disseminating new information, but
they also added that the quality of information
provided by some companies was questionable. The
doctors often rely on the information provided by
reputed companies since they don't have the time to
verify the information. In case of doubt, they ask the
companies to provide supporting documents. The
doctors also complained about the information
synthesis and non-disclosure of full information. 
A study conducted in 2005 by the Department of
Pharmacology at the Ibrahim Medical Hospital
revealed that prescribing information of drugs
presented in the manufacturers' product literatures
contained 70% more indications than recommended
in BNF (British National Formulary) 47, 77.5% fewer
cautions, 71.25% less side effects and 55% fewer
contraindications. This data was based on an analysis
conducted for 80 different drugs (Haque 2005). The
study also revealed that while side effects are
understated, possible indications of drugs tend to be
highly overstated for most drugs.
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While manufacturers tend to exaggerate the claims in
the literature, there is little capacity of the DDA to
monitor the volume of literature produced every month
by the industry. Moreover, the BDNF (Bangladesh
National Formulary) also struggles to stay up-to-date
with the most current information that can be matched
with the literatures produced by the drug companies.
"We have updated the BDNF from Volume I to
Volume III. But we do not have the manpower for
continuous updating and we get no support from the
Ministry either. We have only one doctor to review
the literature. There are around 800 companies and
most of the big companies produce more than 30
literatures every month. It is not possible for one
doctor to check all the literatures thoroughly. We try
to check the doses, indication and side effects in
most cases." - Official at the DDA
Which factors determine prescription?
All the doctors agreed that getting into contract with
one or more pharmaceutical companies influences the
prescription pattern of the doctors and unnecessary
drugs can be prescribed due to obligations created
through contracts or by receiving other benefits. A
doctor commented:
"When a company makes a contract with a doctor
they give him a specific target. To achieve the target
sometimes the doctor prescribes drugs, that are not
necessary. I saw some of my colleagues prescribe
antibiotic where only Paracetamol could do." 
The study also revealed that the irrationality was not
only in prescribing unnecessary drugs; it also exists in
the dosage prescribed. Doctors usually don't prescribe
drugs of small or unknown companies because of the
questionable quality. However, there are some doctors
who prescribe the drugs of unknown local companies,
knowing fully well that the efficacy of these drugs
may not be up to the standard. It was also revealed
in the study that doctors still prescribe these drugs by
increasing the number of dosages or increasing the
frequency of intake. A medical representative shared
in his interview:
"I have seen a doctor prescribe Cap. ciprofloxacin
500 mg, two tabs twice daily for seven days. But the
recommended dose is one tablet twice daily for seven
days. He actually prescribed the drug of a small
company. When I asked him about the dose he said,
do you think companies like this really provide 500
mg in their tablet? I gave two tablets so that they
actually get 500mg."
There is no way for doctors to verify the accurate
amount of active ingredient in these drugs and therefore
their prescribing pattern is also based on assumptions.
Adverse drug reaction or other harmful health outcomes
are possible due to such practice. A recent example
of the effects of substandard drugs was the case of
Rid Pharma illustrated in Box 6.2.
Irrational use of drugs can also occur as a result of the
constant persuation of the MRs. Doctors who usually
don't receive any benefit from the companies may also
become susceptible to favouring a medical representa-
tive and succumb to prescribing additional drugs even
when they are not necessary. One doctor admitted this
while talking about his own prescription habit:
"There are some MRs who are very courteous and
visit me regularly. But I usually don't prescribe their
drug because they work in a small company and I am
not confident about the quality [of drug]. But as they
come regularly I sometimes prescribe their vitamins."
Box 6.1: 25% savings of the patients 
compromised in lieu of gift
The researchers collected a list of some "loyal"
cardiologists of one leading pharmaceutical company
(Company X). During data collection a commonly
prescribed cardiac drug (anti-hypertensive) was being
specially promoted to the doctors by giving a desktop
worth Tk. 220 to each.  The study team visited 20 of the
doctors targeted for this special promotional scheme
and collected 102 prescriptions for analysis. 
The analysis revealed that among the 102 patients, 98
were prescribed an antihypertensive. Among these 98
patients 79 (80.6%) were prescribed the
antihypertensive brand of Company X that was being
promoted while the rest 19 (19.4%) got other anti-
hypertensive brands.
Anti-hypertensive drugs are usually prescribed for
lifetime. This ensures life-long sales of that particular
anti-hypertensive brand of Company X for at least the 79
patients whose prescriptions were collected. An analysis
of the market price of some other brands of the same
anti-hypertensive revealed that the patients could buy
the drug of another reputed company for 25% of the
cost if the doctor had prescribed it, or if a generic was
prescribed and the patient had the option to buy a
cheaper drug.
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Investing in intelligence and competition   
It was interesting to observe that while the MRs are
active in the field to promote the products of their
respective companies, the company headquarters are
also putting in a lot of efforts in gathering intelligence
about the doctors, especially their prescriptions.
Maintaining doctors' database
Companies maintain extensive databases of doctors
and other health care providers in order to keep track
of who prescribes what and also their mobility. The
databases are constantly updated with information
gathered from medical reps and regional sales offices.
Companies also offered training on personality types of
doctors in order for the MRs to tailor their strategy
accordingly.
Engaging in fierce competition
There has been a sharp increase in the number of
pharmaceutical companies in the last two decades, from
110 companies in the 1990s to about 800 manufacturers
that are currently operating, of which 237 are allopathic
(KII 2009). Local companies over these years have built
capacity to manufacture some expensive drugs at cheaper
rates. A significant change in the promotional strategies
of the pharmaceutical companies is also noticed. In
certain locations that are of significance to the industry,
e.g. near medical college hospitals and popular clinics,
top companies may assign up to five MRs, whereas
medium size companies may assign one or two. 
Prescription monitoring
Companies have to ensure that their drugs are not
just prescribed once or twice, rather that doctors
make it a habit of prescribing their products. To keep
track of the physician’s prescription patterns, the top
companies purchase prescription survey reports from
a research firm called 4P Market Research and
Consultancy.1 From this data, they generate a region-
wise list of which doctor is prescribing which particular
brands. It costs about taka two hundred thousand per
year to purchase the report (KII 2009). On top of the
4P report, some large companies also have their own
prescription survey team monitoring the performance
of their brands.
Besides the prescription share report, pharmaceutical
companies also purchase data from an international
organisation called Intercontinental Marketing
Services (IMS)2. The study revealed that currently
nine companies are purchasing IMS report at 
Tk. 1,100,000 per report.
Issues in drug governance
Inadequate staff 
It is evident from the above findings that pharma-
ceuticals are not abiding by any code or norm and there
is serious lack of regulatory intervention.  As per the
existing National Drug Policy, Directorate of Drug
Administration (DDA) is the authority to oversee these
issues. There are plenty of governance issues which
need to be addressed by the DDA.  Interview with the
official at the DDA revealed the following:
"Shortage of manpower is one of the main constraints
that we are struggling with. In 1982 we had only 110
manufacturers in the country while at present there are
around 800; out of these 237 are Allopathic, 266 Unani
around 170 Ayurvedic and rest are others. Annually the
manufacturers produce medicines worth 5,000 crore
taka. The pharmaceutical market has expanded but not
our manpower and resources to cope with this market.
Currently we have only 52% of the allotted workforce.
Since 1982 only two new appointments were made. On
the other hand many of our staff have retired making
the workforce crisis more acute. We sent a proposal to
the Ministry of Health in 204 to appoint new staffs and
proposed for a total of 389 staff in the department to
increase our capacity. Ministry of Health accepted our
proposal and sent it to The Ministry of Establishment; till
now it is in the Ministry for approval. The governments
1 4P Market Research and Consultancy is a research firm based in Dhaka that specialises in pharmaceutical consultancy. They audit brand performance by means
of prescription survey and publish a report every month. Although it was revealed from the KIIs of this study that each of these reports cost the pharmaceuticals
about two lacs taka per month, 4P representative refused to disclose the price of the research reports.
2 IMS Health, Inc., founded in 1954, is the leading provider of global market information to the pharmaceuticals and health care industries. Compiling
information into more than 10,000 reports, available on a regularly updated basis, IMS Health provides a wide variety of market knowledge to support strategic
decision-making in all aspects of pharmaceutical company operations. The company uses the latest information technology to provide real-time information
and rapid results. The company operates in more than 100 countries around the world, collecting information from more than 29,000 data sources, including
drug manufacturers, wholesalers, retailers, pharmacies, hospitals, managed care providers, and long-term care facilities. Customers include the major
pharmaceutical companies, as well as government and regulatory agencies, financial analysts, researchers, and educators (IMS Health n.d.).
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have changed over the past years but the proposal is
lying unapproved." - An official at the DDA
The situation in the district offices is even worse.
There is only one staff per office with very little logistics
support. Requests for increasing the workforce has
been falling into deaf ears for the past six years. 
Regulation of the informal sector
While government regulatory authorities have the
power to intervene only in case of registered
physicians, there is a vast number (nearly 80%) of the
health workforce who remain outside their jurisdiction.
However, pharmaceutical companies have identified
the huge potential in the informal sector and moved
ahead to "build capacity" of the rural medical practitio-
ners (RMPs) and polli chikitshoks (PCs) regarding
their products and prescriptions. The companies
consider their initiative of educating the RMPs and
PCs as a part of their ‘corporate social responsibility’.
Varying meanings of "ethics"
Despite the existing code and ordinances governing
their practices, the medical representatives were
completely unaware that any such provision existed.
Most doctors also mentioned that they were unaware
of any code for promotional practices. The way "ethical
behaviour" was described by various stakeholders
and players in the industry significantly varied from
one another. According to the medical representatives,
an "ethical" doctor was the one who is "loyal" to one
particular company and prescribes only their drugs,
whereas an "unethical" doctor was the one who
maintained contracts with several companies and
even bargained with the medical reps for benefits by
quoting offers of other companies. While only a few
medical reps considered both behaviours as unethical,
they agreed that the latter behaviour was worse.
Resignation to status quo
Across most of the interviews with doctors and officials
in regulatory bodies, there has been an undertone of
powerlessness and resignation regarding the current
practices and an acceptance of the status quo. While
there is despair, there is also hope regarding the "new
generation" and speculations of the ethical and moral
values to be changing towards the right direction.
"Nothing will change by making laws or talking about
ethics… Do you think doctors don't know what's right
or wrong? To whom are you going to teach this? In
the end, if someone doesn't want to go by certain
principles, no one has anything to do about it! It's a
matter of conscience." - An official at BMDC
Who bears the cost?
Financial cost: There are over 20,000 medical
representatives currently employed by the entire
range of pharmaceutical companies. From the
discussions so far, it is clear that the promotional budget
of the industry allocated to gifts and inducements is
quite high. Interviews with all stakeholders indicated
that the high price of drugs and the push for achieving
targets for selling drugs is an effort towards recovering
the investment made by the companies in producing
and marketing the drugs. The cost is eventually
recovered by raising the drug prices and by having
end-users purchase more drugs than necessary.
Health cost: Besides bearing the financial cost of
over-prescription by doctors, patients are also
exposed to contraindications and side-effects of the
drugs that are unnecessarily prescribed. Physicians
mentioned that they test the effectiveness of new
drugs by giving samples to poor patients. For many
drugs, the effects may not be immediate but may
manifest in the long run. These health costs are also
borne by patients who don't have a choice but to
trust the doctors' prescriptions. Another common
phenomenon is prescribing antibiotics and vitamins
regardless of the patients' condition. There are risks
of developing resistance to antibiotics to say the least
while doctors have mentioned in their interviews that
they often prescribe antibiotics and vitamins of
companies with whom they have "good relationship".
The interest of the patients’ health in such cases 
is secondary.
Cost of time: According to Bangladesh Health
Watch report 2007, there are only 7.7 formal
healthcare providers (physicians, dentists and nurses
combined) per 10,000 people. This already indicates
the immense pressure doctors undergo in managing
patient load on any given day, especially in public
facilities. In addition, patients have to travel for several
hours in rural areas to get to health care facilities by
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foregoing other daily household/work responsibilities.
If on an average 15-20 medical representatives visit
a doctor on any given day and do not maintain their
assigned visiting hours, this automatically means
taking time away from what should rightfully be
dedicated to the patients.
Lessons from local and
international initiatives
No Free Lunch: A potential model for
monitoring and advocacy
With the leadership of an Internist doctor Bob
Goodman, "No Free Lunch"-a US based not-for-
profit organisation (sometimes in collaboration with
the American Medical Students' Association) organises
outreach sessions on convincing physicians to refuse
gifts, money, or hospitality from pharmaceutical
companies. The group believes marketing tactics of
drug companies influence prescribing behaviour of
doctors. The members of the group are also health
care providers (No free lunch n.d.).
Healthy Skepticism
Healthy Skepticism, established in 1983 as Medical
Lobby for Appropriate Marketing (MaLAM) in Austria,
is an international non-profit organisation for health
professionals and includes everyone with an interest in
improving health. Its objective is to work on misleading
promotion in developing countries where the consequ-
ences may be worse because of weak regulatory
mechanisms and lack of independent information.
Gifts ban in Massachusetts
Massachusetts has issued a regulation implementing
a sweeping new regime affecting the way biotechnology
pharmaceutical and medical device companies can
market their products within the Commonwealth.
Among other things, the regulation significantly limits
the promotional gifts, including meals that companies
can provide to doctors and other health care
practitioners as part of their promotional programmes.
Initiative of the Consumers'
Association of Bangladesh
The Consumers' Association of Bangladesh is
currently undertaking a research as part of an
international study being conducted by the
International Consumers' Association (based in Kuala
Lumpur) to gather information from doctors about
the various types of promotional items offered to
them by the pharmaceutical companies. The study is
using a tool called the "Doctor's Diary" whereby
doctors have to note down the name of the companies
and gifts/samples and different kinds of promotional
offers (such as seminar, conference, and workshops)
they get from the pharmaceutical companies over a
certain period of time. In their experience, it was
extremely challenging to enrol doctors to participate
in the survey; according to the Association:
"Some doctors initially agreed to participate in the
research but later withdrew saying 'we are not the
right people to speak out.' We are having difficulty in
getting their written consent. We all know about the
unethical practices but hardly any doctor is willing to
talk about it. No doctor will admit to the fact that they
receive even household gifts and foreign trips from
the pharmaceutical companies."
Local initiative on promoting rational use
of medicine
The pharmacology department of Bangabandhu
Sheikh Mujib Medical University organised a 3-day
conference in mid-2009 with mid-level faculty members
of pharmacology from various medical colleges to
share knowledge on Rational Use of Medicine and to
dissect the factors that affect rational prescribing.
Regular initiatives like this can equip medical college
faculty with the knowledge to impart to their students
on ethical practice related to drug use.
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Box 6.2: Paracetamol syrup killing children: Who is to be accountable?
Between June and August of 2009, death incidences of over 27 children from kidney failure were reported
and intake of toxic paracetamol syrup produced by Rid Pharmaceutical Company was attributed to cause
these deaths. Similar incidents had taken place in the early 1990s and in 1996. The Health Minister
announced that "maximum punishment as per law" would be given to persons responsible for this fatality.
Several committees were formed to investigate the issue, including a four-member committee by the health
ministry and a seven-member investigation body. Interestingly, none of the committees included a pharmacist.
While fingers are being pointed at pharmaceuticals engaged in low quality production of drugs in order to
minimise cost and maximise profit, the Directorate of Drug Administration's role is also brought under
scrutiny once again. With two ill-equipped laboratories in Dhaka and Chittagong for testing drugs and
inadequate human resources to follow up on pending cases, the DDA continues to prove it's inefficiency in
carrying out its responsibilities. There are drug superintendents in only 27 of the country's 64 districts. The
DDA has even been ineffective in preventing banned and low quality medicines from the neighbouring
countries being sold in Bangladesh medicine shops.  DDA administrative officials reported to the media that
about 200 pharmaceutical companies are manufacturing sub-standard medicines. Although hard evidence is
not available, a state-appointed public prosecutor shared with the media that most inspectors are engaged
in corruption and receive monthly allowances from blacklisted companies.
Besides the pitiful state of the DDA, there are also challenges to people's right to seek justice for their
children falling victim to pharmaceutical malpractice. The current law does not allow members of the public
to file cases directly if affected by adulterated drugs. The police can file a case in exceptional circumstances,
but they too have to obtain permission from the Drug Administration for investigation. The Drug
Administration responded to the problem by suspending manufacturing and marketing of the products of Rid
Pharmaceutical Company in Brahmanbaria and published an announcement in three daily newspapers.  But
existing drugs in the market were not withdrawn or recalled resulting in additional deaths even after the
public announcement.
The repeated instances of fatal outcomes and a careless and reactive approach of the administration once
again points at the chronic inefficiency and disrespect towards governance and civil rights. No clear directives
are available yet to indicate the way forward to prevent any further instances of this nature and to bring the
offenders to justice.
Sources: Zannat 2009; Rid's paracetamol claims another kid 2009; and Ahmed 2009
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Introduction
Blood transfusion is a critical life-saving procedure.
However, if not carried out properly, it can lead to
immediate or delayed life threatening complications.
According to the World Health Organization (WHO)
"inappropriate use of blood and blood products, coupled
with transfusion of unscreened or improperly screened
units, particularly in countries with poor blood safety
programmes, increases the risk of transfusion-
transmissible infections (TTIs) to recipients" (WHO
2009). Transfusion-transmissible infections (TTI) are
common in many countries including Bangladesh because
of weaker blood transfusion policies and/or their enfor-
cements resulting in unsafe practices.
The World Health Organization recommends 
(WHO 2009) ensuring:
z availability of adequate supplies of blood and blood
products and their accessibility to all patients
requiring transfusion, 
z safety of blood and blood products, and 
z safe and appropriate clinical use of blood and
blood products. 
The Blood Transfusion Safety (BTS) guideline of WHO
further recommends, establishing sustainable national
blood safety programmes that ensure provision of
safe, high quality blood and blood products accessible
to all patients requiring transfusion and their safe and
appropriate use. 
The Centers for Disease Control and Prevention 
(CDC 2008), USA, also recommends reducing the 
risk of transfusion-transmissible infections, especially
HIV, by restricting blood donations to volunteers,
non-remunerated donors, and imposing mandatory
blood screening. CDC, however, indicated that a 
slim chance of human error during screening, viz.,
false negatives in case of HIV and transmission 
of infections from donors during the window 
period remains.
This chapter presents findings from a study carried
out during the first half of 2009 to ascertain the
current policy and practices governing blood
transfusion in Bangladesh. Forty two facilities with
provision of blood transfusion were selected for this
study. The facilities belonged to one of the following
six categories: 1) government and private medical
college hospitals; 2) district hospitals, specialised
hospitals, and MCWCs; 3) upazila health complexes;
4) non-commercial blood banks; 5) commercial blood
banks; and 6) private clinics and pathology centres.
Sampling was done in such a manner so that two
third of selected facilities were part of government's
safe blood transfusion programme (SBTP) while the rest
were not. Details of the study methodology are given
in Annex 2.
Blood transfusion in Bangladesh
The annual demand for 'whole blood' in Bangladesh
is estimated to be about 250,000 to 350,000 units
(350 to 450 ml). Voluntary donations, exchange
transfusions and commercial blood bank are the
major sources of blood supply in the country. Only a
decade ago, professional blood donors were the source
for about 90 percent of the total blood supply in
Bangladesh. However, the situation eventually changed
with approximately 20 per cent of the required blood
being procured through exchange donations, another
20 per cent from voluntary donations and the remaining
60 percent from professional donors (Hossain, Bhuiya
& Streatfield 1996). According to a recent study
(Hossain 2008), approximately 70 percent of
transfused blood came from professional blood
donors. It is perceived that only 40 to 50 percent of
the transfused blood is screened for transmissible
infections like HBsAg (hepatitis B), hepatitis C, VDRL
(syphilis), and malarial parasites while the rest 50 to
60 percent remains unscreened in the supply. This
poses great risks of TTIs to the already ailing patients
who receive the blood.
CHAPTER 7
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Blood transfusion policy 
Bangladesh did not have any policy on mandatory
blood screening for TTIs for either public or private
health facilities, prior to 2000.  Professional blood
donors were the major source and accounted for
approximately 70 percent of transfused blood
(Hossain 2008). A study estimated that 29 percent of
these professional donors suffer from hepatitis-B, six
percent from hepatitis-C, and 22 percent from
syphilis (Khan et al. 1993; Daily Ittefaq, 10 January
1993, p.1; and Hossain 1994). The situation of blood
screening, collection and handling had also been very
dismal in the nineties despite rules in place regarding
blood donation (Bhuiya, Hossain & Streatfield 1995).
It is ironic that despite having the capacity, government
blood banks rarely perform the required screening
tests (Hossain, Bhuiya & Streatfield  1996). It is
estimated that 100,000 people get infected with
hepatitis B and syphilis every year through blood
transfusion in Bangladesh (Hossain 1994).
Government of Bangladesh, in line with the WHO and
CDC recommended guidelines, enacted the Safe
Blood Transfusion Law in 2002 and the Act was
passed in June 2008. 
In addition, the Bangladesh Gazette (2008) listed
rules that ensure good laboratory practices in all
aspects of blood grouping, compatibility testing,
component preparation, storage and transportation
of blood and blood products for both government and
non-government transfusion centres. However, it is
commonly believed that in most cases this policy is
not followed due to cost considerations and shortage
of reagents, apparatus, and lack of skilled workers
(Hossain 1994).  
Implementation of blood
transfusion policy
The alarming situation of blood transfusion practices
led the government to undertake the Safe Blood
Transfusion Programme (SBTP) in 98 blood
transfusion centres in the year 2000, with the
assistance from UNDP. The aim of the programme
was to screen all donated blood for TTIs, enhance
voluntary blood donation, and ensure rational use of
blood. Since 2004, the SBTP was implemented under
HIV/AIDS Prevention Project (HAPP) with the
financial assistance of World Bank and DFID and
continued up to December 2007 (Hossain 2008).
From January 2008 the programme has been shifted
under the Health, Nutrition and Population Sector
Programme (HNPSP) of MoHFW. 
The existing blood collection and blood transfusion
centres in the country can be grouped into three
categories. These are: 1) government blood banks
comprising of medical colleges, super specialist
colleges/centres, district hospitals, upazila health
complex, MCWC etc., 2) private non-commercial blood
banks, such as the Red Crescent, Sandhani, Lion, and
Quantum, and 3) private commercial blood banks,
including private hospitals/clinics/medical colleges
and private laboratories/pathology centres.
All medical college hospitals fulfil their needs from
their own blood banks and Sandhani. The private
hospitals depend on their own collection, commercial
blood banks and Sandhani. Commercial blood banks
collect blood mainly from professional blood donors.
There is option for exchange transfusion in all facilities
however, not many people are motivated to do so.
Moreover, the private and commercial blood banks
screen blood "on demand" considering recipients'
ability to pay.
Box 7.1 June 2008 Act listed the following
rules and regulations
1. Prohibition of collection and distribution of blood
from professional donors and convicted prisoners 
2. Mandatory blood cross-matching, screening and
testing for HIV/AIDS, hepatitis B (HBsAg) and C,
syphilis (VDRL), and malarial parasites 
3. Maintaining specific health requirements for
donors, such as: 
z Donor's age to be within 18-60;
z Minimum weight to be 100 pounds; 
z Normal body temperature, pulse rate, blood
pressure, and 75 percent hemoglobin; 
z No respiratory illness or skin disease; and
z No scar or marks showing sign of addiction or
professional blood donation.
Source:  Bangladesh Gazette 2008
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The indiscriminate use of blood makes the situation
critical as it increases the risk of patients acquiring
TTIs like hepatitis B, hepatitis C, syphilis, malaria, and
HIV due to the reasons mentioned in the earlier section.
Among the numerous hospitals and clinics in the
country, only four percent implement "Safe Blood
Transfusion Programme" of the government (Hossain
2008). However, it is not clear how these blood banks
are governed and operated, and what the quality of
their services is. The situation is equally unclear in
case of transfusion services of hospitals with no "safe
blood transfusion" programme.  
Current practices in blood
transfusion
Among the total 42 centres sampled in this study, half
were government operated centres. Of the rest, 15
were private commercial and six private non-commercial
centres. As per sampling design of the study, 25
centres were under SBTP and rest 17 were non-STBP.
Of the 21 public centres all except one, were enlisted
under the SBTP. Four out of the six private non-
commercial centres were enlisted under SBTP and
only one out of the 15 private commercial centres
was under SBTP (Table A3-7.1 in Annex 3). 
Services and facilities
Despite being non-enlisted, it appeared that one
public, 12 private commercial as well as two private
non-commercial centres were providing one or more
of the transfusion services such as collection, testing,
supply, transfusion, and separation of blood
components. On the other hand, three public centres,
despite being enlisted under SBTP, were not providing any
of the transfusion services. Only seven SBTP enlisted
centres had facilities for preparation of blood
components. None of the non-SBTP centres reported
having such facility (Table A3-7.1 in Annex 3).
The main reasons mentioned for not providing blood
transfusion services were unavailability of logistic
support including reagents and lack of human
resources. However, findings suggest that there were
more doctors, lab technicians, and MLSS in SBTP
enlisted centres than in the non-SBTP centres.  
Screening for TTIs
More SBTP enlisted centres (20 out of 22) reported
screening blood for various TTIs than the non-SBTP
ones (13 out of 15). All private commercial centres
reported screening for various TTIs, while 17 out of 19
public and four out of six private non-commercial
centres did so. Majority of the centres reported
screening blood for Hepatitis B (89%) followed by
HIV/AIDS (86%), Hepatitis C (76%), Syphilis VDRL
(76%), Malarial parasites (57%) etc. Although 89%
centres reported screening blood for various TTIs, it
was found that less than half (18 centres) screened
blood for all five TTIs while 29 screened blood for at
least four TTIs (Table A3-7.2 in Annex 3).
Many factors contribute to unsafe blood transfusion
practices. Some of the most important reasons cited
were: ignorance, lack of awareness, manpower shortage,
lack of funding, insufficient lab facilities and screening
products, dishonest proprietor, etc. One of the reasons
cited by a respondent of private commercial centre for
not screening all five TTIs was-"Hepatitis C was not
seen as an epidemic, so at present it is not screened
by our centre." On the other hand, lack of awareness
about SBT among the public also allows for unsafe
blood transfusion. An RMO in charge of UHC said: 
"We are always under tremendous pressure by the
relatives of the patients to transfuse blood without
screening. They even come to beat us if we don't
listen to them. Thus, even knowing that we can lose
our jobs for not screening, we are forced to do so."
"The mindset of staff members of blood banks/
centres is that there is no need to test blood donated
by patients' relatives." -mentioned staff members of
transfusion centres.
Staff training status
Staff of the majority of the centres (76%) reported
that they received special training on SBT. Staff
members at more SBTP enlisted centres (88%) reported
having received training compared to the non-SBTP
centres (59%). Training on SBT had been provided
mostly to government staff (91%) compared to the
number of trained staff in the private sector whether
commercial or non commercial (62%) (Table A3-7.3
in Annex 3).
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Presence of guidelines
Guidelines on relevant issues like screening and
selecting donors, collecting, testing, matching, transfusing,
and storing blood, training staff, health and safety
procedures, use and maintenance of equipment,
behaviour and dress code were mostly absent  in
private (74% of the functioning centres) facilities and
in some (28%) functioning government centres. None
of the 18 centres could show the guidelines they
claimed to have.
Knowledge of key staff
Majority of the managers (74%) who supervise blood
transfusion system did not have knowledge about
SBT. The knowledge of various policies regarding
blood transfusion was also inadequate among the key
staff members of the centres. Out of the 42 centres,
staff members of only six centres (14%) had know-
ledge of at least three components of blood collection
policy, and staff member of only 18 centres (43%) were
aware of blood testing/screening policy, i.e. blood must
be screened for five TTIs (Table A3-7.4 in Annex 3). 
Sources of blood collection
Five most common sources of blood collection were
identified during the study. Family and relatives were
the most frequent donors. Based on multiple choice
questions, respondents from 34 centres out of 37
mentioned that they collected blood from family and
relatives (92%), 27 centres from voluntary donors
(73%), 11 centres from voluntary collection (30%),
two centres from professional donors (5%), one centre
from exchange donation (3%), and 17 centres from
private blood banks (46%). Public facilities reported
collecting blood mostly from family/relatives followed
by voluntary donation and collection, private blood
banks and exchange donation. Private non-commercial
centres collected blood from family/relatives, and
voluntary donation and collection while private
commercial centres collected blood from professional
blood donors and family/relatives. Eight centres out
of 17 (47%) reported that they only transfuse blood
after appropriate testing and cross-matching of their
own blood bank (Table A3-7.5 in Annex 3). However,
the same proportion of centres (47%) reported
transfusing without any screening.
Communication programmes
Fifteen out of 37 centres (41%) reported having
communication programmes for motivating people 
for voluntary blood donation. Twelve centres out of 
37 (32%) had advocacy activities for safe blood
transfusion, and only six out of 37 centres (16%)
mentioned providing training to other centres on safe
blood transfusion. The SBTP enlisted centres had
more of such activities compared to the non-SBTP
ones. The centres that had activities to motivate people
for voluntary blood donations reported having 
higher percentage of volunteers (87%) donating
blood compared to those that did not have 
such activities.
License/Accreditation
Majority of the centres (81%) did not have any
license/accreditation for BTS. Some private centres
(63%) reported having license for blood transfusion,
while none of the public facilities had license. The
staff in government and private non-commercial
centres (65%) did not perceive the need for having a
license and considered themselves above such
requirements. Though many of the centres are
supervised by DGHS personnel it is not clear why
most of the centres (81%) do not have a license yet.
More investigation is needed before conclusions can
be drawn in this regard (Table A3-7.6 in Annex 3). 
Staffing
The blood transfusion centres were commonly staffed
by nurses, receptionists, trained volunteers, peons,
laboratory technicians, messengers, office assistants,
accountants, managers, supervisors, counsellors,
medical students and so on. These centres had shortage
of office assistants and nurses. However, the medical
technologists/laboratory technicians were found to
perform multiple tasks which hampered their primary
task of maintaining the SBT standards including adoption
of universal precaution. A medical technician said:
"I have to do all the tasks starting from donor
selection to blood collection, testing and even
maintaining the patient registration. There are so
many patients!  How can I wear gloves? If I wear gloves
I have to take them off every time I register a patient."
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Lack of compliance with the standard universal precaution
was observed among majority of staff members of
the blood transfusion centres. Staff at only two
centres wore apron while staffs at only one centre
were found to wear gloves. Decontamination of
reusable materials was found to be practised in 14
out of 15 centres.
Policy-practice gap
The above scenario shows: 
z The government has formulated necessary policy
with regards to safe blood transfusion, but proper
implementation, enforcement and necessary super-
vision are yet to be in place. 
z Blood transfusion centres screen blood based on
their inadequate knowledge/awareness and
sometimes deviate from the mandatory screening
requirements. They are often driven by commercial
motive and tend to skip screening. They decide
whether to screen or not based on their assessment
of the patients' ability to pay.
z Blood collection and transfusion centres are not
ready to make the minimum investment required
to follow the policy guidelines properly. There is no
compulsion from the government for doing so and
current supervisory mechanism cannot even ensure
licensing or accreditation to run blood transfusion
centres. There is no clarity as to whether government
run facilities require license or at least meet the
minimum standards set by the relevant Act.  
z Common citizens and even the key staff members
of blood transfusion centres are not aware of the
consequences of unsafe blood transfusion on
health. While the staff members are not capable
of delivering quality services, people are also
unable to demand the level of service they can
rightfully claim from these facilities.
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Introduction 
Hospital diets are expected to comply with patients'
needs and the recommended dietary allowances.
Ensuring appropriate dietary therapy is an important
component in the overall management of patients as
it influences the treatment and recovery process of
many illnesses. Diet therapy is the process by which
food is used to help manage disease and promote
health. When patients with diseases such as diabetes
mellitus or chronic renal failure seek advice, it is necessary
to ensure the help of the professional nutritionist or
dietician to determine the composition, proportions and
quantities of the diet. 
Limited knowledge was available as to how the
facilities were doing in terms of ensuring appropriate
diet to patients. According to some earlier studies
conducted, diet services in hospitals in Bangladesh
are not nutritionally sound (Begum et al. 1994). Hospital
diets are generally perceived to be in appropriate and
not adjusted for management of different diseases.
Quality of diet was expected to improve since budget
allowance for hospital diets has been increased to Tk.
75.00 per patient per day from Tk. 43.00 (DGHS 2008).
Appropriate dietary management for patients is as
important as medical treatment and is different for
different diseases. Efficient dietary management can
help early recovery and better health with well-
prepared and appropriate diets.
This study is an attempt to assess the appropriateness
of diet supplied to the patients and their actual
intakes in a selected number of facilities in the country.
Quantity of diet provided and the actual consumption
of patients suffering from five specific diseases i.e.
diabetes mellitus, coronary heart disease, renal failure,
liver diseases, and severe protein energy malnutrition,
were compared to their respective therapeutic
recommendations in urban and rural hospitals in
Bangladesh. The study was a prospective cross-
sectional study conducted in several hospitals of
Bangladesh. A total of 250 patients of both sexes were
selected from the districts and specialised hospitals of
all the six divisions of Bangladesh from various socio-
economic groups through a stratified random sampling
procedure. The diet was measured in terms of the
amount of carbohydrate, fat and protein taken by 
the patients. Anthropometric measurement (weight,
height, MUAC) of the patients were taken. Data was
collected by direct weighing method of meals
(breakfast, lunch, dinner and other time) given to
patients from the hospital.
One large medical college hospital and one large
district hospital was identified from each division of
Bangladesh. Subjects were selected randomly for
each group in all hospitals. The hospitals included
were BIRDEM, NIKDU (National Institute of Kidney
Disease and Urology) and NICVD (National Institute
of Cardiovascular Disease) for patients with the relevant
conditions. Protein energy malnourished patients
were selected from Dhaka Shishu Hospital and liver
disease patients from Bangabandhu Sheikh Mujib
Medical University (BSMMU) Hospital. Detailed method-
ology is given in Annex 2.
The findings are discussed in light of the challenges
in governance of the dietary provisions in the facilities.
Findings
Diabetic patients
The present study revealed that diabetic patients in
the hospitals were supplied 25% less carbohydrate
than the Recommended Dietary Allowance (RDA) and
the intake was even lower (55% shortfall) than the
RDA (Table 8.1). Amount of protein in diets supplied
to diabetic patients was 34% higher than the RDA
and the amount of intake was 18% less than the
RDA. This implied a significant loss between supply
and intake of the protein.  In absolute terms, the
average amount of protein in the supplied diet was
67 grams and the intake was only 42 grams resulting  
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in a loss of 25 grams of protein per patient per day
(see Annex 4 for detailed table). The status of fat
content in diet was even worse with an average
supply of 22 grams compared to the RDA of 60 grams
per day. With a loss of nine grams from the amount
supplied, the actual intake of fat (13 grams) was 80%
less than the RDA. In some instances, the patients
had to take the food supplied from their respective
homes in order to compensate for the deficiencies.
In total, 1,114 Kcal was supplied to the diabetic
patients for energy while the average energy intake
was only 633 Kcal, amounting to a wastage of 481g.
The percentage shortfalls of energy (Kcal) in supply
and in intake were respectively 38% and 65% lower
than RDA (Table 8.1). 
Coronary heart patients
Table 8.2 shows the excess supply of protein, fat and
carbohydrate compared to the RDA for coronary
heart patients in the study hospitals. However, the
intake of nutrients was substantially lower than the
RDA. On an average, the intake of protein, fat, and
carbohydrate were 24g, 6g and 79g respectively. The
shortfall of intake was nearly 50% of the RDA. 
The average intake of energy was 446 Kcal, which
was 55% lower than the RDA. Nearly 50% of 
the nutrients were wasted before intake (see Annex
4 for detailed table). Therefore, there is a tendency of
over supplying nutrients to the coronary heart patients.
Kidney patients
The kidney patients in the hospitals were over
supplied with protein, nearly six times than that of
the RDA, and under supplied with other nutrients
(Table 8.3). However, the real intake was short of the
RDA by 27% for protein, 91% for fat, 79% for
carbohydrate and 82% for Energy (Kcal). A
significant part of the nutrients supplied to the kidney
patients was wasted (see Annex 4 for detailed table).  
Liver patients
Liver patients were supplied with diet containing
lower amount of nutrients than the RDA. The shortfall
was 56% for protein, 76% for fat, 63% for
carbohydrate and 61% for Energy (Kcal) (see Annex
4 for detailed table).
Table 8.2 Shortfall/surplus of nutrient supplied for 
and consumed by coronary heart 
patients (n=50)
Protein(g) + 6 -52
Fat(g) + 27 -45
Carbohydrate(g) + 30 -43
Energy(Kcal) -2 -55
Nutrients
and Energy 
Supply/RDA
(% shortfall/surplus
from RDA)*
Intake/RDA
(% shortfall/surplus
from RDA)*
* + indicates surplus, - indicates shortfall
Table 8.4 Shortfall/surplus of nutrient supplied for 
liver patients (n=50)
Protein(g) -56 -82
Fat(g) -76 -91
Carbohydrate(g) -63 -85
Energy(Kcal) -61 -86
Nutrients
and Energy 
Supply/RDA
(% shortfall/surplus
from RDA)*
Intake/RDA
(% shortfall/surplus
from RDA)*
* + indicates surplus, - indicates shortfall
Table 8.1 Shortfall/surplus of nutrient supplied for 
and consumed by diabetic mellitus 
patients (n=50)
Protein(g) +34 -18
Fat(g) -63 -80
Carbohydrate(g) -25 -55
Energy (Kcal) -38 -65
Nutrients
Supply/RDA
(% shortfall/surplus
from RDA)*
Intake/RDA
(% shortfall/surplus
from RDA)*
* + indicates surplus, - indicates shortfall 
Table 8.3 Shortfall/surplus of nutrient supplied for 
and consumed by kidney patients (n=50)
Protein(g) +163 -27
Fat(g) -71 -91
Carbohydrate(g) -34 -79
Energy(Kcal) -39 -82
Nutrients
and Energy 
Supply/RDA
(% shortfall/surplus
from RDA)*
Intake/RDA
(% shortfall/surplus
from RDA)*
* + indicates surplus, - indicates shortfall
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Dietary management of malnourished
patients 
The mean weight of the malnourished children
included in the study was 7.2 kg with a mean age of
17.6 months. Malnourished patients were supplied
with diet containing nutrients that were lower than
the RDA. The shortfall was 33% for protein and 48%
for energy (Kcal).  
Quality of diet in specialised hospitals
The quality of diet in hospitals specialised in managing
diabetic, coronary heart disease, liver, kidney and
PEM patients included in the study also deviated
significantly from the RDAs.  The following discussion
depicts the findings from these hospitals.  
Figure 8.1: Deviation of supply and intake of nutrients by
diabetic patients from disease specific RDA in a specialised
hospital for diabetes
The above figure shows that supply of protein was
44% higher and the intake was 2% lower than the
RDA in a specialised hospital for diabetes in
Bangladesh. The supply and intake of fat,
carbohydrate and energy were lower than the RDA.
The shortfall of intake of nutrients and energy was
more than the shortfall of the supply. 
Figure 8.2: Deviation of supply and intake of nutrients by
coronary heart patients from disease specific RDA in a
specialised hospital for coronary heart disease
The above data shows that supply of nutrients and
energy was more whereas the intake was lower 
than the RDA in a specialised hospital for heart
disease (Figure 8.2). The surplus of supply was 12%
for protein, 27% for fat and 30% for carbohydrate
while the shortfall of intake was 48% for protein,
18% for fat, 22% for carbohydrate and 39% for
energy.    
Figure 8.3: Deviation of supply and intake of nutrients by
kidney patients (renal failure) from disease specific RDA in
a specialised hospital for kidney
In a specialised hospital for kidney disease, protein
supply was more than the RDA, while intake of
protein among kidney patients was 13% lower than
the RDA (Figure 8.3). Supply and intake of fat,
carbohydrate and energy were lower than the RDA
among kidney patients.
Table 8.5 Shortfall/surplus of nutrient supplied for 
PEM patients (n=50)
Protein(g) -33 -39
Energy(Kcal) -48 -60
Nutrients
and Energy 
Supply/RDA
(% shortfall/surplus
from RDA)*
Intake/RDA
(% shortfall/surplus
from RDA)*
* + indicates surplus, - indicates shortfall
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Figure 8.4: Deviation of supply and intake of nutrients by liver
patients (liver cirrhosis) from disease specific RDA in a
specialised hospital for liver diseases 
Supply and intake of all the nutrients and energy were
lower among liver disease patients in a specialised
hospital for liver diseases. Overall, the shortfall of intake
was lower compared to the shortfall of supply. The
shortfall of supply was 54% for protein, 73% for fat,
69% for carbohydrate and 62% for energy, whereas
the shortfall for intake was 83% for protein, 91% for
fat, 88% for both carbohydrate and energy.
Figure 8.5: Deviation of supply to and intake of nutrients by
PEM patients from disease specific RDA in a specialised
hospital for PEM 
Figure 8.5 presents the shortfall of supply and intake
of protein and energy in the diet of a specialised
hospital for PEM. Shortfall of energy was higher
compared to the shortfall of protein. The supply of
protein was 33% lower while its intake was 39% lower
than the RDA. The supplied energy was 48% less and
intake was 60% less than the RDA.
Patients' perspective and
suggestions on diet management
While some patients in the study expressed that 
they were satisfied with the quality and quantity of the
food served at the hospital, most patients expressed
dissatisfaction on various grounds. Most common
complaints about the diet served were: 'food is not
very palatable; does not taste good due to excessive
use of water or lack of salt and oil; menu is often
monotonous'. Some patients complained that they
could not eat properly because of loss of appetite.
The wastage of food that took place between supply
and intake of diet was primarily due to the reasons
mentioned above. However, patients suggested bringing
in variations in the menu and proper monitoring and
planning of diet as per disease requirement.
Nutritionist and dietician in the
health facilities
To assess the situation of governance and supervision
of hospital diet, regulation about diet, workforce for
dietary management and funding, further information
on management and supervision of diet therapy at
hospitals were collected and analysed. The study
revealed that about 12% of the public general hospitals
appointed 5-10 persons on an average for dietary
management; about 17.6% of the public specialised
hospital and only 5.9% of the public general hospitals
had nutritionist for dietary management. Among these
hospitals, about 23.5% of the public specialised hospital
had trained nutritionist with educational background
in nutrition. However, about half (47.1%) of the public
hospitals depended on doctors for diet therapy. In
most (52.9%) of the public general hospitals, diet
was supplied by commercial suppliers and only 17.6%
had diet supplied by the hospital management. This
indicates their inability to ensure quality and
appropriateness of the food supplied. Overall, the
supply of therapeutic diet was not adequate compared
to the RDA in any of the hospitals.
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CHAPTER 9
Introduction
Quality of care has been identified as one of the
macro-level management system issues to highlight
practical manifestation of the state of governance in
health sector. Quality of care is an overwhelming
issue in the context of health services of developing
countries including Bangladesh. Performance of
health care professionals and institutions determines
the quality of care provided by the health facilities
which in turn depends on governance. As Goldfield
(1996) notes, many factors outside the health service
influence health status and it is therefore reasonable
that social policy makers consider the impact of the
policies on health and health status. Policies manifest
governance of health system and eventually impact on
services. The efficiency of the governance system has
been blamed for the poor quality of care in facilities in
Bangladesh as well as in other developing countries. 
Accountability, transparency of the system and
dignity, respect and sense of responsibility towards
the patients are preconditions to an ideal state of
quality of care in health services. Patient satisfaction
with medical care involves excellent interpersonal
communication of care providers, technical quality of
services, accessibility, finances, outcomes, continuity
of care, physical environment and availability of medical
care resources (Ware et al. 1983).
This chapter reports the findings from a study carried
out in selected public, private and NGO facilities in
Dhaka and other districts providing different levels of
services. A number of cases of caesarean section (CS)
as an example of maternal health services, pneumonia
as an example of child health services, and a number
of emergency care cases were reviewed by senior
professionals to ascertain the technical quality of care
provided in the facilities included in this study. Six
distinguished medical professors in teams visited nine
facilities in Dhaka, Sylhet, and Khulna to see the
physical condition of the facilities, review and observe
the procedures adopted, diagnoses made and use of
drugs, and other aspects of patient care.  Assessment
of the quality of the services was made by reviewing/
observing 20 elective CS, 20 emergency CS, and 30
pneumonia cases among children. Key informant
interviews were also conducted to understand the
policy implications, effect of organisational structure,
service delivery system and resource allocation in
delivering quality of services. Further detail on the
methodology can be found in Annex 2.
Findings
Physical facilities
Overall physical condition in terms of cleanliness,
availability of essential infrastructure such as water,
electricity, wash basin etc. in all the facilities studied
was found to be reasonably satisfactory with some
variations; particularly the private facilities were better
maintained than the public-sector ones. All the facilities
had electric connections but not all had back-up
power support due to limited or non-availability of
fuel for the generators. Again, non-government
facilities were better than public facilities while
secondary and tertiary level public facilities were
better than primary level ones. This indicates that
facilities in the urban areas were better maintained
than the rural ones. Except for the MCWCs included
in the study, all facilities had running water supply.
Adequacy of space compared to patient load was
severely constrained in public facilities, and was a
common feature across all the levels of primary,
secondary and tertiary facilities. The situation was
better in private facilities followed by non-government
and public facilities. General tidiness was again
compromised in public facilities at all levels and better
maintained in non-government facilities and was
significantly better in the private ones. In all the
facilities, toilets, particularly for females, had varying
degree of cleanliness and user-friendliness, whereas 
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non-government facilities were better than the public
facilities with the exception of a paediatric hospital.
Reception/registration service was better organised
and client-friendly in non-government facilities compared
to public facilities and the Maternal and Child Welfare
Centres (MCWCs) visited. 
Number of patients greatly outnumbered the availability
of beds and resulted in patients being on the floor in
all the public facilities with a few exceptions. Privacy
obviously was compromised in overcrowded facilities.
Public facilities suffer from lack of adequate number of
mattresses and cleanliness of the available mattresses,
sheets, pillows, pillow covers, mosquito nets, blankets
etc. The situation was better in non-public facilities. 
Providers
In most of the public facilities, unfilled vacancies in
positions of important service providers, like doctors
(including specialists), nurses, paramedics, medical
technologists, support staff (ward boy, aya, sweeper)
aggravated the situation. Shortage of staff was more
common in lower level rural facilities than upper level
urban facilities. This resulted in paramedics running
emergencies in the upazila health complexes and
MCWCs. However, the scenario was much better in
non-government facilities. 
Equipment, drugs and reagents
Shortage and non-availability of drugs, reagents and
other supplies coupled with absence or non-functioning
of equipment plagued almost all the public facilities.
Situation was worse in lower level rural facilities
compared to upper level urban facilities. Most of the
non-government facilities did not have such problems
except in a children's hospital in Dhaka.   
Providers' attitude
In public facilities, providers were often found to be
unfriendly and non-responsive to patients. Providers
did not consider themselves accountable to the
patients and were unaware of patients' rights,
expectations, need for confidentiality, respect and
dignity. The situation was found to be better in non-
government facilities except in one children's hospital
in Dhaka. However, providers' attitude towards clients/
patients also varied in non-government facilities and
was relatively more positive in the private facilities
than in the NGOs.
Waiting time  
Patients usually had to wait for long durations before
being attended by the appropriate providers in all the
public facilities studied. Waiting time was even longer in
case of emergencies, which is quite contrary to what
is expected. Situation was worse in rural and lower
level facilities compared to urban and upper level
facilities. Non-government facilities were much better
in this regard-providers attended to the patients on
time. However, the situation in a children's hospital in
Dhaka was similar to the public hospitals. 
Clients' satisfaction
In majority of the cases, clients were satisfied with
the services of the facilities and satisfaction was
somewhat more in non-government facilities than in
public facilities. Interestingly, satisfaction was
observed to be higher in lower level public facilities
than in the upper levels. However, clients at most of
the facilities expressed their concerns about costs,
except in one facility in Dhaka. 
Role of management
Management initiatives to promote and ensure
quality of care was absent in all the facilities visited.
Adoption, promotion and compliance of the standard
treatment protocols were generally not maintained,
with the exception of some isolated initiatives taken
by few providers but not by the management. Auditing
of deaths, reviewing of cases etc. are examples of
standard practices that were not promoted by the
management. However, some attempts to control
promotional activities of pharmaceutical companies
were noticed in some facilities.  
Citizens’ Charter
Boards or posters displaying patients' rights and
Citizens' Charter in prominent locations were not found
in all the facilities visited. Presence of such boards/
posters on patient's rights was sporadic and no sign
of awareness or compliance to the provisions of the
Charter was observed among the patients and providers
of any of the facilities in the urban or rural areas.
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Health promotion
Health promotion activities being carried out by the
facility attendants was not observed in the public
facilities except in one upazila health complex.
However, health promotion was done in varying degrees
by almost all the non-government facility providers.
Citizens' participation
Participation of citizens/community in running the health
facilities, irrespective of public or non-government
sector was primarily absent with the exception of one
upazila health complex and a 250-bed district hospital.
In the upazila health complex, local people contributed
volunteers, additional support staff and fuel for the
generators, while a civil society initiative supported
patients who required drugs in the district hospital. 
Emergency services
Although non-government facilities welcome patients
at any time, most of the emergency cases, such as
victims of road traffic accident, trauma victims and
other cases particularly with subsequent legal
implications were mostly taken to the public facilities.
Private clinics and hospitals hardly treated accident
and trauma victims. 
Technical quality
In general, technical quality of care was found to be
satisfactory in all the facilities visited, based on the
observations of caesarean sections and management
of pneumonia cases. Of the 40 CSs observed the quality
of services was satisfactory for all the cases. In case
of management of pneumonia, improper investigations
were carried for eight (27%) out of 30 cases. Improper
treatment was carried out among 16 (53%) out of 30
pneumonia cases. However, quality was also compromised
due to excessive or inadequate investigation and
choice of drugs in pneumonia management. Instances
of prescribing drugs with no indication and not prescribing
drugs with clear indications as well as prescribing third
generation antibiotics were noticed in teaching/
specialised public sector facilities.
Most of the findings of the study was found to be in
line with other recent studies conducted on quality of
care. Bangladesh Health Watch Report 2007 also
indicated the poor quality of care at various public
facilities manifested through rude behaviour of health
providers, limited contact time with patients or rushed
consultations, unavailability and inapproachability of
providers in times of emergency or other needs etc.
The health facilities have been plagued with these
problems and are failing to improve in any of the key
areas of quality of care. As the present study indicates,
lack of appropriate service providers, both in number
and skill mix contribute to compromised quality of
care rendered by the public facilities; in the absence
of dedicated posts of physicians to provide emergency
services in district hospitals, MCWCs and upazila health
complexes, these services are provided by paramedics
thereby affecting the quality of care. Similarly, health
promotion activities were not carried out in most of
the public facilities for lack of human resources.
Weak supervision
Centralised management limited the ability to ensure
the display of Citizens' Charter and information about
patients' rights in many of the public facilities. Weak
supervision resulted in irregularity in the formation of
management committees and necessary meetings
that are mandates of the MoHFW for different levels
of facilities where citizens' participation were to be
ensured. Role of the Upazila Parishad (UP) is yet to be
clarified in terms of their engagement in the local health
systems. Similarly, regulatory roles of the public sector
over non-government sector failed to materialise due
to limited capacity of the public sector.
Resource allocation
Uniformity in allocating human and other resources
without considering the actual need, resulted in great
inefficiency in service delivery. Some of the facilities
are overcrowded while others are underutilised. District
hospitals vary in terms of bed capacity and may be
equipped with anywhere between 50 and 250 beds.
Resources are allocated on the basis of number of beds.
Upgrading the capacity of district hospitals or increasing
the bed number was usually a political decision rather
than a planned action based on population increase,
disease burden, availability of other facilities (non-
government), and transportation link with the facility
etc. Lack of proper planning and coordination led to
mismatch of allocation and requirements of the
facilities; thus shortage of drugs, non-functioning of
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equipment, unavailability of service providers etc. are
commonly seen in public facilities.
Higher level facilities (district hospitals, medical college
hospitals, tertiary/specialised hospitals) fare better in
competing for resources than the lower level facilities
(upazila health complex) because of their proximity to
the power structure (decision makers). Resources are
allocated centrally from MoHFW and the Directorates
that are often not well aware of the local realities.
Problems are further aggravated by the limited authority
of the facility manager who are unable to sanction
necessary expenditures for repair of generators, water
pumps and other utilities that are essential for day-
to-day operations.
Existing Recruitment Procedure
Existing recruitment process of the public sector
facilities has not been able to address the chronic
issue of vacant positions. Doctors and other Class I
and Class II officers are supposed to be recruited by
the Public Service Commission (PSC). PSC is entrusted
with the responsibility of recruiting government
officers of all categories and cadres and usually an
average of two years lead time would be required to
complete one cycle of recruitment. By the time the
PSC clears one batch of officers for recruitment,
additional vacancies are created at the concerned
entities due to natural attrition caused by retirements,
resignations, deaths, migrations, etc. Although the
Directorates and district-level authorities can recruit
Class III and Class IV employees, they would still
require permission from the Ministry of Establishment
for these recruitments. Moreover, the Ministry does
not allow more than 80 percent recruitment to the
existing vacancies. Recently, the Ministry of Finance
has asked all ministries to leave 10 percent posts
vacant as an austerity measure of the government to
face the global recession. The entire recruitment
process, starting from compiling vacancy requests to
screening and placement, is time consuming and can
hardly catch up with the demand at any point in time.
Vacancies exist more in lower level facilities and facilities
of hard-to-reach areas. 
Strategic solutions and challenges of
staffing crisis 
Staffing situation has improved significantly at the
Bangabandhu Sheikh Mujib Medical University (BSMMU)
and Institute of Mother and Child Health (IMCH) since
these institutions became autonomous and have the
authority to recruit staff on their own.
Another strategy for addressing the issue within the
purview of the MoHFW is to diversify the service
provision. This is reflected in various strategy documents
of the government, such as the Strategic Investment
Plan (SIP) and the Revised/Programme Implementation
Plan (R/PIP) of the Health, Nutrition and Population
Sector Programme (HNPSP). These commitments are
Box 9.1  Poor governance hampers quality of care: Case of an MCWC
Current staffing patterns of the public sector facilities limit their capacity to provide good quality care. In MCWCs, the
job of an anaesthetist is filled by a Medical Officer (MCH-FP) of the Sadar upazila, which in itself demands full-time
commitment. This additional responsibility interferes with the assigned staff’s primary role as a Medical Officer (MCH-
FP). Moreover, in some cases, they are required to attend to children in the outpatient department of the MCWCs and
are expected to be available round the clock. While the number of beds in the MCWCs are being increased from 10 to
20, the number of designated posts has not been increased. MCWCs are equipped with four support staff (two posts of
family welfare visitors and two posts of dai-cum-nurse/nursing attendants) to deliver outpatient services for women
requiring antenatal and postnatal care, and children with ailments. They are also responsible for patient registration;
dispensing of drugs; immunisation; family planning services, including sterilisation, Intra-uterine Device (IUD) insertion,
implant insertion, administering injectables; menstrual regulation; indoor services for managing complicated
pregnancies; abortions; normal delivery; assisted delivery; and comprehensive emergency obstetrical care. The stark
mismatch between the long list of service requirements and the number of staff available to carry out these
responsibilities offers a clear indication as to why quality of services is often compromised in these facilities.  Moreover,
only one sweeper is entrusted with the responsibility of cleaning the entire facility premises round the clock, including
the outdoor, indoor, and operation theatre. Initiatives taken to outsource cleaning services could not be materialised due
to non-availability of funds. 
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yet to be fulfilled while the programme term is nearly
coming to an end.
There are four posts of sweeper/cleaner in a 50-bed
district hospital, and five posts in similar positions in a
31-bed upazila health complex for keeping the facility
premises clean round the clock. The criteria for
determining the optimum number of sweepers for
different facilities was not known. Similarly a 31-bed
upazila health complex has only one post of Medical
Officer to attend to the outdoor patients. Altogether,
there are eight posts in the health wing. One Upazila
Health and Family Planning Officer (UH&FPO) is the
manager-incharge of the upazila health programme as
well as the hospital, while four posts are for junior
consultants in medicine, surgery, gynae/obstetric 
and anaesthesiology. They take care of referred
patients in the outpatient area. There is one resident
medical officer who usually takes care of inpatient,
one dental surgeon dedicated for dental care, and one
Medical Officer for the outdoor patients. According to
Bangladesh Health Facility Survey, one Medical Officer
has to attend to 176 patients a day on an average
(BHFS 2009).
However, mere placement of additional medical officers
may not be enough to address this issue. Motivational
factors required for satisfactory performance of staff
is severely missing for all tiers of the service providers
in the sector. Lack of career prospects for majority of
the physicians, nurses, technicians, and paramedics,
excessive workload, poor compensation package, lack of
service support mechanisms leads to frustration, poor
performance, lack of initiative and is manifested in their
interaction with patients (limited caring, misbehaviour
with poor patients, not maintaining privacy,
confidentiality etc.). In addition, lack of continuing
medical education in the face of rapid advancement
in medical science, and aggressive promotion from
the pharmaceuticals resulted in compromised quality
of services provided by the public sector physicians.
Low expectations from citizens
One of the interesting findings of the study was 
that clients were generally satisfied with the services
they received. Satisfaction was also higher in primary
level facilities than in tertiary levels. A study by Creel
et al. (2002) depicted that satisfaction does not
necessarily indicate that quality is good; it may only
mean that expectations are low. Bangladesh Health
Watch Report 2007 also showed that while patients
were happier when providers behaved politely with
them, they often did not complain about unprofes-
sional or rude behaviour and accepted it as normal
since they deemed doctors to be "superiors" and
therefore entitled to treat them as they wished. Such
low expectation from the common citizens is another
reason for not making the providers accountable for
poor quality of care. While the Citizens' Charter lists
the rights that people are entitled to, awareness of
those rights may not be adequate.
Cases of positive deviance
Despite the grim situation portrayed by the study
findings, there are examples of well-performing
health facilities, both in the public and private sector.
Experiences from these model facilities may offer
lessons to be learnt for future improvement.
Box 9.2  Chowgacha Health Complex: An example of people's participation contributing 
towards better quality care
Chowgacha Upazila Health Complex has already earned its reputation as a model health facility in the public sector. The
main essence of its success has been spontaneous participation of the local community and the facility's willingness and
ability to receive and utilise the contribution with efficiency. Volunteers from local community often work as additional
staff while staff members sponsored by local people also help meet the shortage of workforce. Supplies like fuel for
generators, instant power supply (IPS), tires for ambulance, blood bags, reagents,  cards for patients (such as, antenatal
or immunisation cards), mobile phones, dustbins, drugs, etc. are generously contributed by local philanthropists, NGOs,
and people's representatives when scarce.
However, the facility seems to have flourished at the cost of the union level facilities since most of the staff working at
this upazilla health complex (UHC) originally worked at the union level. The continuing rivalry between the Health and
Family Planning wings of the MoHFW adds to the staff crisis; a single lady doctor provides all the antenatal care
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Box 9.3  Ad-din Hospitals providing quality care at low cost
Ad-din Hospitals have many attributes of a model hospital. Ad-din publicly displays its fee schedule for all services,
thereby reducing the uncertainty in terms of health care expenses faced by patients and encouraging early care seeking.
This saves money and reduces burden of dealing with unnecessary emergencies, morbidity and mortality.  Ad-din's fees
are often lower than the cost incurred in public facilities taking into account the waiting time, informal fees and supplies
required to be purchased. They started out with a low fee structure to attract more patients, particularly from the lower
socio-economic group. This has brought economies of scale and the risk has paid off.  Ad-din has also proven that low
cost doesn't necessarily mean low quality. Quality of care is considered from the technical point of view (e.g. by
appointing specialist providers for outdoor care) as well as from clients' perception (low cost, tidiness, being listened to,
honoured and respected). It has also experimented with an unconventional layout for the hospitals and incorporated
several corporate practices, such as awarding the most courteous employee of the month.  Its colourful children's
department is a refreshing break from what is commonly seen in other facilities and prompts early recovery. The hospital
is always able to maintain cleanliness despite the amount of people staying and visiting the facility. 
(averaging more than 100 a day) with long waiting time while the Family Welfare Visitor (who belongs to the Family
Planning wing) is not allowed to share the load. While these issues remain to be addressed, Chowgacha Health Complex
still deserves to be considered as a site for drawing lessons on how local level participation and good governance promote
quality health services for the common people.
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CHAPTER 10
Discussion
The third report of Bangladesh Health Watch (BHW)
is on the theme "governance in the health sector". BHW
formulated its definition of governance as the manner
in which political, economic and administrative power is
exercised by the government in the management of
national health affairs at all levels. It considered
elements of health sector governance as formulating
strategic policy direction; generating information and
intelligence and making information accessible;
ensuring equity, inclusiveness, participation, consensus
orientation;  ensuring enforcement of the rule of law,
regulatory framework and ethical standards; and
ensuring transparency, accountability, responsiveness,
effectiveness and efficiency with active involvement
of peoples' representatives, civil society and private
sector for sustainable health development. BHW also
came up with an analysis matrix by which governance of
health sector should be assessed (Annex 1). However, a
comprehensive assessment of health sector governance
would be a daunting task and for this report, BHW
tried to cover only a few aspects of the governance
analysis matrix. BHW commissioned a total of six studies
under two broad headings-governance at macro level
(stewardship) and reflection of governance in day to day
health care experiences. All the studies used primary
and secondary data; and quantitative as well as
qualitative data.
The first three chapters of the report presents the
findings of the study on health sector governance,
emphasising the stewardship function specifically in
terms of heath policy, regulatory bodies and ethical
practices. The role of health policy in good governance
of the sector is of utmost importance. An explicit health
policy defines a vision for the future outlines priorities
and expected roles of different groups, builds
consensus and informs people, and in doing so fulfils
an important role of governance (WHO 2000). Heath
policy not only sets out the long term vision of the
health sector of the country but also sets the direction
for the health system, the priorities and expected
roles of different groups who have important stakes
in the health sector. Because of its importance, the
health policy formulation process needs to inform
people; and efforts at consensus building have to be
a part of the process.
Bangladesh had its health policy for the first time formally
approved in August 2000. Its formulation process
also had a reasonable level of participation of the
important stakeholders including the common people.
However, the process neither ensured participation of
the main opposition political parties nor was it discussed
in the parliament or in the Parliamentary Standing
Committee related to the Ministry of Health and Family
Welfare. Despite these gaps, the NHP 2000 clearly spelt
out its objective of providing basic health services to
all, devised strategies to achieve this objective, recognised
the role of policy actors (public, private, NGO, traditional
medicine), provided guidance for prioritising
expenditure (for ESP and rural health), indicated
organisational arrangements for service provision
through a unified structure and specified regulatory
controls for ensuring quality.  
Soon after the approval, the NHP 2000 faced challenges
of reversal in which the political parties, bureaucrats
and professional bodies played important roles. Since
then, there have been three more initiatives in 2006,
2008 and 2009-to formulate a fresh health policy
and revise the existing one respectively. These
initiatives were undertaken with political motivation
and good intentions. In India, the last health policy
formulation process required engagement of 14
research institutes; 21 studies and almost three years
of public consultations at different levels. It enjoyed the
advantages of policy continuity and constructive roles
of the professional bodies and civil society organisations.
In the case of Bangladesh, none of the initiatives had
a substantive research base for the revision work;
and professional bodies are politicised and polarised. In
order to avoid debate and challenges, policy documents
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contain generic, broad and nicely worded statements.
Although NHP 2000 was very explicit about integration
and unification of health and family welfare services,
the newly drafted NHP 2009 is silent about this issue.
The MoHFW has also taken the initiative to revise the
National Population Policy and it is expected that the
policy will also be processed along with the health
policy.  The National Drug Policy and Nutrition Policy
are already in existence.  A critical review of all the
policies under the broad umbrella of the national
health policy in order to bring synergy along with
proper coordination will be required shortly.
While the health policy sets the overall direction for
the health sector of the country, the stewardship
function of the government adopts good regulations
and the tools for implementation to ensure account-
ability and transparency. Therefore, the roles of
regulatory and statutory bodies are mandatory to
ensure good governance in the health sector. The nexus
of functionality, stewardship and good governance is
represented in the following diagram. 
Different professional regulatory as well as statutory
bodies have been set up with a view to develop skilled
human resources (doctors, medical practitioners,
nurses and pharmacists) and ensure standard health
services by regulating the activities of professionals,
protecting people's rights and ensuring access to
health services.  In this regard, Bangladesh Medical and
Dental Council (BMDC), Bangladesh Nursing Council
(BNC), State Medical Faculty, Bangladesh Pharmacy
Council and Bangladesh Board of Unani and Ayurvedic
Systems of Medicine have evolved to play the steward-
ship role in health sector governance in Bangladesh.
In addition to this, the Parliamentary Standing Committee
is expected to play important supervisory functions of
the government to ensure transparency and accounta-
bility in the health sector. 
The study emphasised on the role of the Bangladesh
Medical and Dental Council.  However, in general the
exploration of the status and functioning of the
regulatory bodies yielded a grim picture. The organisati-
onal arrangement and functionality of these bodies
were analysed through six broad thematic lenses of
independence, democratic norms, rule of law, capability,
efficiency, and accountability.
It has become general knowledge that BMDC is virtually
a non-functional body except for its registration
function. It has failed to promote and protect
patient's rights for which it was primarily created. In
the years of 2007 and 2008 BMDC accepted 25 and 17
complaint letters respectively to initiate investigations
against medical and dental practitioners. Although
BMDC does not have enough human resources to
respond to all complaints and investigate properly it is
still surprising that BMDC could not finalise a single
investigation report since 1994. In other words, it
neither has capacity nor is it functioning. According to
the Act, the Council tenure is for three years but for
the last 18 years council elections did not take place
and no new council was formed.
BMDC cannot initiate independent investigation against
the doctors working in government/public hospitals. 
Figure 10.1: Health sector stewardship for good governance
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In those cases BMDC can only issue show-cause
notices to the directors of the hospitals concerned
and the hospital's decision will be binding on the
BMDC. The BMDC is administered by professional doctors
and in the case of investigations and regulations, these
doctors have been playing the key role. Therefore,
independent investigations and judgments are difficult
to obtain due to professional biases in favour of their
fellow colleagues. In addition, there is no clear
jurisdiction and authority between the BMDC and the
health ministry for registration process of foreign
doctors. Currently foreign doctors are supposed to get
permission from the health ministry and are later asked
to get registered from BMDC. In most of the cases
foreign doctors avoid registration from BMDC and
seek permission from the Ministry. In this aspect,
BMDC has failed to protect the interest of the doctors
of Bangladesh as well. In terms of medical education
and recognition of institutions it seems that the role
of BMDC has already been taken over by the Ministry
and Director's office of Medical Education of DGHS.
Thus, the role of BMDC has become somewhat curtailed.
Several political regimes governed the country in the
past two decades and none seemed to be interested
in addressing this. Neither have any civil society
organisation raised any significant concern about the
nonfunctional status of the BMDC.  
The rest of the regulatory bodies like Bangladesh
Nursing Council, State Medical Faculty, Bangladesh
Pharmacy Council and Bangladesh Board of Unani
and Ayurvedic Systems of Medicine demonstrated
similar features in terms of poor functionality, capacity
and accountability, democratic deficit and inadequate
independence from the government. Ultimately, their
poor governance compromises realisation of the rights
of people. While not much is happening to improve
conditions of these regulatory bodies, the 9th
Parliamentary Standing Committee has shown signs of
promise, unlike its predecessor in the 8th Parliament.  
The parliamentary supervisory role is designed to
prevent unlimited exercise of power of the executive
branch, ensure proper use of public resources and
accountability of the state agencies. However, the
Committee remains largely ineffective as the ruling
party mostly occupies committee chairmanships,
dominates committee proceedings and ignores opinions
of the opposition party. Its formation is usually delayed
and the meetings are not held regularly. Committee
member attendance per meeting was only 4.68%
(TIB 2006). The committee also fails to ensure
compliance with their recommendations. There is no
time limit for the concerned ministries, persons and
executive branches to respond to committee
recommendations and decisions. In the 8th parliament,
217 decisions were made by the parliamentary
standing committee on health ministry but only 
55 decisions (TIB 2006), less than 30%, were
implemented. The tendency to bypass committee
recommendations by the Ministry has created lack of
institutional accountability and transparency and
perpetuated irregular practices and corruption in the
health sector. The committee is seriously handicapped
by the lack of resources as they don't have any
research staff or policy aides. Fortunately, in the 9th
Parliament, the standing committees were formed
within the stipulated time. Initiatives have been taken
to resource the committees with adequate staff. The
committee had met five times till October 15, 2009,
formed three sub-committees to deal with different
issues and has issued different directives to the Ministry.
Overall, these are signs of marked improvement over
the previous performances. However, the Parliamentary
Standing Committee on health in India convened
public hearings on health and population policy and
relied on studies conducted by their reputed research
agencies for policy formulation.  In Bangladesh, the
Parliamentary Standing Committee on the Ministry of
Environment also organised public and expert hearing
on issues related to climate change and environment.
Bangladesh Health Watch, in a roundtable on the
health policy organised in August 2009, recommended
that the Parliamentary Standing Committee
undertakes public and expert hearings on the draft
health policy as a part of their review process; and
thereby ensures public participation in the national
health policy formulation process.  
Although professional regulatory bodies are supposed
to protect the rights of the patients and people in
general, it is also expected that the practice of medical
ethics through codes of conduct by medical professi-
onals will safeguard the patients and maintain minimum
standards in medical practice. However, our secondary
analysis and key informant interview based study
revealed another grim picture. A study of TIB 2007
showed that two out of five patients reported 
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harassment in receiving services from public hospitals.
Among them, almost half of the patients reported
that they had to pay a bribe to the hospitals for
service. Doctors are reported as the highest bribe
takers, and nurses are in second position. The TIB
Corruption Survey 2007 also notes that 22.7 percent
of the patients who depend on public health services
reported that they had been advised to visit the
private chamber/clinic of the doctor consulted. 
The lack of ethical practice is not caused by any
single factor rather it is deeply rooted in all elements
from medical education to health administration.
Ethics is taught in a fragmented and superficial manner
with no attention to developing behaviours and habits.
Ethics is traditionally ignored by the medical students.
The WHO Ethical Standard Course is not mandatory.
Doctors and nurses, who are liable for the poor ethical
standard in the medical profession, are not the only
ones to blame. The professional regulatory bodies
that are in charge of enforcing the practice are to be
held equally responsibile for poor ethical practices.
The management environment in which they work is
also liable. Most of the doctors are amenable to
aggressive pharmaceutical promotion. On top of this,
they are also susceptible to the promotional offers of
private laboratories, clinics and hospitals. 
While this is the scenario of health sector governance
of the country at the macro level, we had also
examined the state of governance of the health
sector from a micro perspective by commissioning
five additional studies which are summarised here.
The study on quality of care used the services of six
professors who examined cases of caesarean section
and pneumonia to determine the quality of care in
public, private and NGO facilities. The study findings
are in line with the recently conducted facility survey
2009 and other recent studies. There is widespread
perception about poor quality of health services
irrespective of the ownership of the facility by the
government, private sector or NGOs.  In the study
observation-in terms of treatment protocol-almost
all the cases of CS and pneumonia were treated with
appropriate protocol and with proper indications.
However, quality was found to be compromised through
excess or inadequate investigation, in choosing drugs
in pneumonia management by prescribing drugs with
no indication, by not prescribing drugs with clear
indication and by using third generation of antibiotics
in teaching/specialised public sector facilities. These
findings also match with the findings of our commissioned
study on essential drugs.  
Usually in the private sector, patients are subjected to
expensive health care due to high cost and unnecessary
or doubtful investigations including laboratory tests.
Yet it is interesting to see that accident and trauma
patients as well as those needing emergency attention
are least served by the private clinics and hospitals;
only public facilities provide services to them.  Complaints
about the public facilities are related to unavailability
of the designated health personnel, negligence of the
clients, unauthorised and illegal payments at public
health premises, pilferage of drugs and other essential
supplies. The centralised system with weak monitoring and
supervision aggravates the situation. Weak governance
in health service delivery causes the poor and the
vulnerable members of the society suffer the most in
terms of both cost and deficient service delivery.   
Another commissioned study examined how far the
outcome objectives of the National Drug Policy in
terms of availability, affordability, and rational use
have been achieved with respect to essential drugs in
the public and private sector PHC facilities in both
rural and urban areas of Bangladesh.  It was found in
the study that polypharmacy is on the rise (33% from
5% in 1994). There is less use of Essential Drugs in the
PHC facilities; and UHCs and urban NGO clinics do
not follow the Essential Drug List (EDL). Though the
list of essential drugs was available in 47% of the
UHCs (from 28% in 1994) and 55% of the urban
clinics none of the facilities had all the 20 listed essential
drugs. Only 6% of the UHCs and 15% of the urban
clinics had at least 15 of the 20 essential drugs. The
use of essential drugs by UHC has reduced to 63%
from 85% in 1994. Antibiotic use is on the rise and
drug shops prescribe them most (60%). The use of
antibiotics by the UHC providers has increased to 50%
in 2009 from 25% in 1994. Although Bangladesh
pioneered a National Drug Policy in 1982, Bangladesh
is behind other low-income countries in rational use of
drugs. Most importantly, anarchy prevails in the pricing
of the essential drugs with wide variation.  For example
the ratio of lowest to highest price for Iron-Folic Acid
(IFA) tablets was 1650%, for a bottle of B-Complex
tablets was 650%, for Mebendazole tablets was
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900%, for Benzylbenzoate lotion was 817%, for
Chloramphenicol ointment was 543%, for Miconazole
ointment was 592%, and for Metronidazole tablets was
500%. These findings evidently suggest a weak state
of drug governance.
The weak state of drug governance has also been
substantiated in our study on pharmaceutical promoti-
onal practices and the state of implementation of
regulatory provisions. The pharmaceutical companies in
the country have an estimated number of 20,000
medical representatives (MR) to promote and market
their products. There is fierce competition amongst
the companies to get the bigger share of the market
estimated at more than half a billion dollars. The
pharmaceutical companies maintain databases of
physicians and monitor the prescription of doctors in
terms of use of drugs.  The MRs maintain a high level
of contact with the physicians for sharing product
information and they manage to get easy access to
the physicians. The MRs were found to be highly target
oriented with attached incentives for target fulfilment. A
system of “reward” for physicians from the pharmaceu-
ticals for prescribing their drugs is in existence and
some of the adopted marketing techniques do not
comply with ethical norms. The physicians are
somewhat dependent on the MRs for product
information. Such product information may contain
fewer cautions, fewer side effects, fewer contra-
indications and more than the approved indications.  
Promotional gifts and inducement costs are ultimately
borne by the patients. Patients are also exposed to
contra-indications and side-effects of the drugs either
due to polypharmacy and/or due to biased information
of the product literature. The health cost of such
effects is yet to be determined. Most importantly,
MRs take away valuable time of the doctors in public
places where mostly poor patients go to receive
services; and thereby deprive the poor patients for
their business promotion.
The study also found that the MRs have started to
include the village doctors (palli chikitshoks) in their
sphere of influence for marketing drugs. Less known
companies rely more on the rural market and drug
sellers also prefer to sell their products since more
profit margin can be attained from them. The example
of 27 children's deaths due to paracetamol syrup in July
2009 can be cited in this context. This once again
demonstrates the appalling state of drug governance.
The operations of the Directorate of Drug Administration
(DDA) is seriously handicapped. There are only two
laboratories which cannot meet the demand of the
sector that has grown exponentially over the last 27
years. Product literature which is being used to update
medical professionals is alleged to contain biased
information for pharmaceutical promotion. The DDA
cannot screen them properly due to inadequate human
resources. The problem is not only accute at the
headquarter; DDA human resources at the district
level and below are virtually absent.
"Shortage of manpower is one of the main
constraints that we are struggling with. In 1982 we
had only 110 manufacturers in the country. At
present we have around 800 manufacturers out of
which 237 is Allopathic, 266 is Unani, around 170 is
Ayurvedic and rest are others. Annually the
manufacturers produce medicines of 5,000 crore
taka. The pharmaceutical market has expended but
not our manpower and resources to cope with this
market. Currently we have only 52% workforce.
Since 1982 only two new appointments were given.
On the other hand, many of our staffs retired which
increased the crisis of workforce. We sent a proposal
to the Ministry of Health to appoint new staffs. We
have requested for 389 of total staff in the department
to increase our capacity. Ministry of Health has accepted
our proposal and sent it to The Ministry of Establish-
ment. The proposal was sent in 2004 but till now it is
in the Ministry for the approval. The governments
changed over these years but the proposal left
unapproved."- (A DDA official, Chapter 6).
The clause 11.3 of the election manifesto of the ruling
party mentioned that "an appropriate pharmaceutical
policy to bring self-sufficiency in the production of
medicines of international standard … will be formulated."
It is high time that the Government starts acting on
its election commitment; and as the first and foremost
task in this regard it needs to give high priority to
strengthening the DDA in terms of human resources
and technical capacity.
Our study on blood transfusion revealed poor
governance in terms of implementation of the
registration requirements and regulations related to
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safe blood supply. Blood transfusion was carried out
in some facilities even if they were not registered
with the DGHS to do so. Such facilities were mostly
private commercial while some were private non-
commercial. Only seven of the enlisted 25 centres
under the Safe Blood Transfusion Programme (SBTP)
of the DGHS included in the study had facilities for
preparation of blood components. 33 out of the 37
centres (89%) reported that they screen blood for
Transfusion Transmittable Infections (TTIs). However,
only 18 centres reported screening blood for all five
TTIs as required under the SBTP. Reasons for not
screening blood included not perceiving all diseases
as important and lack of awareness about the
importance of blood screening among the relatives/
attendants of the patients, shortage of trained
manpower in the facilities, lack of funding, and
insufficient lab facilities and screening products. 
Training on SBT has been provided mostly to
government staff (19 out of 21) while the number of
trained staff in the private sector whether commercial
or non commercial were found to be much less (13 out
of 21). Guidelines on screening and selecting donors,
collecting, testing, matching, transfusing, and storing
blood, training staff, health and safety procedures,
use and maintenance of equipment, behaviour and
dress code were mostly absent in private facilities (14
out of 19 functioning centres) and in some government
centres (five out of 18 functioning centres). The majority
of the managers who supervised blood transfusion
system did not have knowledge about SBT (31 out of
42). Eight centres out of 17 private centres reported
that they only transfuse blood after due testing and
cross-matching of their own blood bank. However, an
equal proportion of centres to be reported transfusing
blood without any screening. The majority of the
centres (30 out of 37) did not have any license/
accreditation for blood transfusion service. Some private
centres reported that they have a license for blood
transfusion (12 centres out of 19) while none of the
government centres had a license. The staff in
government and private non-commercial centres 
(24 out of 37) did not perceive the need for having a
license and considered themselves above such
requirements. Though many of the centres are
supervised by DGHS personnel it is not clear why most
of the centres (30 out of 37) do not have a license yet.
The above noted findings clearly indicate that rigorous
implementation of the regulatory functions would be
critical for ensuring safe blood transfusion.  Given the
public health importance of safe blood transfusion,
training and other capacity building opportunities
should be provided to all the centres irrespective of
government, non-government or private affiliation.
The regulatory function should be bestowed upon an
independent body. It is evident from the fact that when
the regulatory function and implementation are being
carried out by the same agency, they tend to pay less
attention in complying with the required regulations.
Our study on hospital diet, perhaps the first of its
kind in Bangladesh, revealed a picture of how scarce
resources are being wasted and indicates a way
through which we can extract most out of the same
investment with knowledge based management and
good governance.
Diets given to diabetic patients in the hospitals had
25% less carbohydrate than the Recommended Dietary
Allowance (RDA) and the intake was even lower than
RDA with a shortfall of 55%. The average amount of
protein in the supplied diet was 67 grams and the
intake was only 42 grams. Thus, there was a loss of
25 grams of protein per patient per day. The situation
of fat intake was even worse with an average supply
of 22 grams opposed to RDA of 60 grams per day.
With a loss of nine grams, the intake of fat was 80%
less than the RDA. The situation in a specialised
diabetes hospital was also far from satisfactory. The
kidney patients in the hospitals were over supplied
with protein, nearly six times than that of the RDA,
and under supplied with other nutrients. However,
the real intake was short of the RDA by 27% for
protein, 91% for fat, 79% for carbohydrate and 82%
for Energy (Kcal). A significant part of the nutrients
supplied to the kidney patients was wasted. Liver
patients were supplied with diet containing a lower
amount of nutrients than the RDA. The shortfall was
56% for protein, 76% for fat, 63% for carbohydrate
and 61% for Energy (Kcal). Malnourished patients
were supplied with a diet containing lower amount of
nutrients than the RDA. The shortfall was 33% for
protein and 48% for Energy (Kcal). The appropriateness
of diets given to diabetic, kidney, liver, and malnouri-
shed patients in the specialised hospitals was no
better than the situation described above.
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Main messages and recommendations
Based on the findings emerging from the above studies
and current debates on health sector governance,
Bangladesh Health Watch (BHW) would like to provide
some key messages for policy makers. The perennial
issue of poor quality health care described in this report
was mostly an outcome of either the lack of a regulatory
framework or its ineffective implementation.
Our first message is about strengthening the
regulatory/statutory bodies for the interest of
the people; and upholding patients' rights along
with the rights of the service providers. In the
absence of strong regulatory frameworks, institutions,
regulations and strict implementation of regulatory
measures, the quality of health care will continue to
be unsatisfactory. To treat patients effectively and
efficiently, hospitals will require adequate numbers of
quality health professionals and support workforce.
Thus, the regulatory institutions responsible for health
workforce production require strengthening in terms
of course content, examination process, faculties,
registration of graduates, and periodic assessment of
performance of health care providers for renewal of
registration. Most importantly, they need to pave a
user-friendly way to address genuine grievances of
the patients and uphold patients' rights, if necessary
without waiting for further direction.  
In order to ensure the above, BHW recommends the
following actions:
z Carry out detailed review immediately on the
existing status of these regulatory bodies and
clarify their roles in order to 
 revitalise their existence, especially that of
the BMDC;
 update all the acts related to their formation
and proper functioning with extensive
consultation with the stakeholders and
based on evidence;
 strengthen their legal and logistical powers;
 enhance democratic practices through
ensuring participation of the relevant
stakeholders including representatives from
the civil society in these councils;    
 ensure a democratic process for council
governance and merit based recruitment; 
 enhance the mandates of these bodies; and
 implement the right to information act to
ensure free flow of information for the
common people.
z Develop accountability policies and processes
within regulatory bodies to ensure transparency of
information on the regulation of medical
professions and health care. 
z Strengthen management and administrative skills
and capacity to perform regular administrative
and supervisory functions. 
z Establish divisional monitoring units within BMDC
and BNC to oversee the activities of medical and
dental practitioners and publish and update the
names of the registered medical, dental and nursing
professionals with respective specialties and sub-
specialties (if any) on their respective websites. 
z Produce accessible, people-friendly annual
publications which will clearly feature how the
regulatory bodies have performed in their
supervisory and disciplinary roles and with what
outcomes, and had taken initiatives to improve
their accountability to the public.
z Encourage and strengthen the role of civil society
organisations, especially those focusing on the
rights of the citizens and consumers, to play an
active and vigilant watchdog role in monitoring
the functionality of the regulatory bodies for the
interest of the people.  
Our second message would be that inappropriate
use of drugs and lack of adherence to the list of
essential drugs is the result of weak supervisory
capacity of the regulatory mechanism and
aggressive push from the pharmaceutical
companies while marketing their products. 
In order to address the above issue, BHW recommends
the following actions:
z Completely reorganise and strengthen the
Directorate of Drug Administration (DDA) in terms
of human resource and technical capacity (e.g.,
establishment of drug testing labs). Ensure a
rigorous approval process for product literature.
Reconstitute the Committee for Implementing the
Code of Pharmaceutical Marketing Practices.
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z Ensure that the Essential Drug List is on public
display in all the PHC level facilities in the country
irrespective of urban or rural locations or public,
NGO or private attachment of the facilities. MoHFW
should send an urgent directive to this effect.
z Make available Essential Drugs for common
illnesses as listed in the national EDL at PHC level
facilities, especially the public sector facilities
throughout the country.  DGHS should ensure the
supply and monitor this regularly through their
official chain.
z Make a clear commitment in the national health
policy to education and training combined with
managerial and regulatory interventions for rational
drug dispensing at the 80,000 plus drug shops in
the country as well as public and private sector
health facilities. Combine this with an explicit
commitment to an institutional mechanism of
implementation.
z Undertake further research to determine how to
promote rational prescription, avoidance of poly-
pharmacy and overuse and misuse of antibiotics,
generic prescribing, and prescribing from the
national EDL; and on how the consulting time can
be increased for quality provider-patient interaction.
z Bring gifts-giving practice by pharmaceutical
companies under strict regulation and ensure that
parity is maintained for all civil servants. Bring
visits by medical representatives under regulation,
especially in public hospitals. 
z Find ways to make the promotional budgets of the
pharmaceutical companies transparent so that it is
clear what percentage of the drug price is channelled
towards promotional efforts. Direct audit firms
responsible for auditing these companies to look
into the promotional practices and identify any
deviations from ethical practices in their audits. 
z Take appropriate regulatory action to ensure that
pharmaceutical companies comply with the 
 IFPMA1 Code of Pharmaceutical Marketing
Practices
 WHO Ethical Criteria for Medicinal Drug
Promotion2
z Undertake a comprehensive evaluation of National
Drug Policy using structural, process and outcome
indicators to have a state-of-the-art knowledge on
the Bangladesh situation. This will provide policy
makers the necessary guidance in improving the
present condition with respect to production and
rational use of drugs.
Our third message is on safe blood transfusion
and weak implementation of the safe blood
transfusion regulations.
In order to address the above issue, BHW recommends
the following actions:
z Widely disseminate blood transfusion policy to
providers as well as to the general public.
z Bring the functioning non-SBTP private commercial
centres immediately under strict regulations and
monitoring of the government and restart services
in the non-functioning SBTP-enlisted public
facilities without delay. 
z Make licences mandatory for blood bank operation,
with renewal of licenses conditional on the
performance of the centres. Licensing criteria should
be equally applicable to the government, non-
government and private entities.
Our fourth message is about adequacy and
appropriateness of hospital diets which are neither
on the hospital agenda nor on the list of priorities
in terms of patient management protocol. This lack
of prioritisation is evident from the absence of dieticians
and nutritionists in the facilities and absence of
guidelines to be followed by the hospitals. 
In order to address this issue, BHW recommends the
following actions:
z Make the employment of qualified nutritionists
and dieticians mandatory in hospitals. 
z Introduce standard protocols for dietary manage-
ment in hospitals.
z Assess the status of diets in hospitals and 
clinics at all levels and implement systematic
monitoring and evaluation of patients' diets in
every hospital.
1 Codes promulgated by the International Federation of Pharmaceutical Manufacturers and Associations (revised in 2006). 
2 A document prepared and revised in 1985 and endorsed by the Third World Assembly in 1986.
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The fifth message would be about adherence to
ethical practices by the health professionals and
addressing the prevailing weaknesses in the
course content in order to prepare future health
professionals to combat ethical dilemmas
successfully in real life at every level of health
service delivery.
In order to ensure the above, BHW recommends the
following actions:
z Emphasise and strengthen ethics training in
medical education at undergraduate and post-
graduate levels, particularly by familiarising
students with the practical and operational side of
medical ethics and incorporating the WHO module
into the curriculum. 
z Mandate the professional bodies to introduce ethics
into continuing professional education and make this
compulsory for all registered medical practitioners.
z Ensure that the Patients' Charter/Bill of Rights is
widely publicised by rights-based organisations
and by the regulatory bodies.     
z Encourage stronger participation by human rights
and consumers rights related civil society
organisations to play a more active watchdog role
in monitoring ethical practices in the health sector.  
Our final and overarching message is about the
national health policy which would govern the
entire health sector of Bangladesh. The revision
or formulation process should ensure participation
of all the important stakeholders for its consistent
implementation. To ensure continuity as a public
policy, health policy should not be narrowly conceived
as a "policy of the ruling party" rather it should be
viewed as the policy of the state.
In order to ensure the above, BHW recommends the
following actions:
z Develop a transparent mechanism for informing
people in general about the progress of the national
health policy revision or formulation process and
ensure participation of all the important stake-
holders so that it is implemented consistently.
z In order to develop a sense of ownership and to
avoid unjustified policy revisions, ensure adequate
engagement of the opposition political parties in
the policy process, particularly through the vital
role that the Parliamentary Standing Committee
can play as a cross-party parliamentary body.  
z Ensure that policy formulation or revisions are
research-based, need-based and participatory,
rather than mere expressions of the preferences
of the political regimes. In particular, use the
mechanism of the Parliamentary Standing
Committee to organise public and specialist
hearings on the national health policy to optimise
stakeholders' participation.
z Recognising that a stronger civil society can play
an effective role in offsetting the arbitrary acts of the
ruling parties regarding policy revisions, encourage
NGOs, as a part of civil society, to act as a
watchdog over government stewardship as opposed
to remaining in a mere complementary role.
z Undertake a critical review of the approved national
policies, e.g. health policy, population policy,
nutrition policy, drug policy to bring synergy in the
sector; and if possible-prepare a synthesised
policy document.
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PRINCIPLES Strategic Vision
Equity, Inclusiveness,  Participation 
and Consensus Orientation
Rule of Law and Regulatory 
Framework
Transparency (Control of 
Corruption) and Accountabilit
Levels of 
Assessment
National Level
MoH Policy Level
MoH 
Implementation
Level
Citizens'/
Consumers Level
- Where does health rank in 
the overall development 
framework by resource 
allocation, and as 
percentage of total 
government expenditure?
- Decentralisation - analysis 
of current plans
- What priority programmes 
are being implemented 
and how do they 
correspond to the policy 
objectives?
- What are the causes of 
failure in implementation 
of national policy? 
How well are the citizen's 
needs and expectations 
reflected in the policies made 
and implemented?
- Is there a National Health              
policy/strategic plan 
available stating objectives, 
strategies with a timeframe 
and resources allocated?
- Who forms policy, why and 
how?
- How well is the system 
performing in terms of 
providing equal health care 
opportunity regardless of 
social class, gender, race, 
ethnicity, etc.?
- The level of coordination and 
participation sought among 
various stakeholders in the 
health care system.
- At district, sub-district levels 
what mechanisms are present 
for citizens’ participation? How 
active and effective is the 
cooperation between public 
and citizen at this level? What 
initiatives are taken to promote 
the interest of the  
disadvantaged groups?
- What are the citizen's 
expectations and experiences in 
terms of equal treatment, 
opportunity to participate and 
claim their basic health care 
rights?
- Financial support mechanisms, 
health insurance, voucher 
schemes, etc.
- How responsive is the policy 
making process in terms of 
mediating differing interests to 
reach a broad consensus based 
on the best interest of the 
country?
- Regulatory framework
- Public and private sector 
- How immune is the 
national health care system 
to the political situation of 
the country?
- How active is the 
enforcement of regulation 
at this level? How does the 
system work? Who is in 
charge and how do they 
report to the higher 
authority? 
- Are the citizens aware of 
the existing framework? 
Do they have the options 
to complain about 
problems regarding law 
and regulations? How 
responsive is the system 
towards citizens 
concerns?
- Service provision for public 
and private sector
- Drug regulation
- Blood supply
- Registration and 
certification of health care 
providers; particularly 
physicians
- What is the level of 
willingness, in terms of 
allocation of resources 
and policy for making 
information available
 to the public? How 
transparent is the
 process?
- What is the level of 
decentralisation?
- How to make the 
informal sector 
accountable?
- Health care provision 
monitoring rule
- Patients' rights, policy, 
practices
- Accountability of the 
leaders 
- Missing culture of 
accountability
- Expert vs. lay attitude
- Compliance with 
Hippocratic Oath
- Mechanisms for making
government, NGO,  and 
other private health  
care providers 
accountable
- Tracking mechanisms 
for utilisation of 
government and aid 
resources
Bangladesh Health Watch matrix on governance of the health sector
Adapted from the "Framework for Assessing Governance of the Health System: Gateway to Good Governance" - a presentation made by the
Eastern Mediterranean Regional Office, World Health Organisation (WHO) at a capacity building workshop on health system development for
WHO staff, Alexandria, May 20-24, 2007. 
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Responsiveness, 
Effectiveness and Efficiency
Information and Intelligence Ethics
Leadership and Governance 
Capacity
- What are existing mechanisms of  
 receiving feedback from service  
 recipients?
- How do citizens voice their rights and 
concerns?
- How responsive is the system?
- Quality control of hospitals and 
clinics
- How is the capacity of planning, 
analysis, coordination, 
implementation, and evaluation of 
the health system?
 - Barriers in creating enabling 
environment for doctors deployed 
in remote areas
- Availability of service, ensuring 
presence of health care providers; 
Availability of drugs; Referral 
linkages
- Non-medical expectations of 
patients
Human and Financial resource planning:
 - Allocation of resources in terms of 
primary, secondary and tertiary 
health care
- What are the rules and actual 
practices? Where are the gaps?
- Doctor: Nurse: Patient ratio
- HMIS: Status and use: What 
information is available about 
the health system and health in 
the country and how accessible 
is it? What is the reliability of 
information available for 
development of policies?
- Information system to track 
down placement of government 
health professionals
- Connecting upazilas with 
ICT - Status
- Access to information- policy 
and guideline. What evidence is 
there for the use of information 
in the decision making process?
- National committee on 
medical ethics
- Research ethics
- Quality of drugs
- Practices of prescribing 
drugs
- Push selling by 
pharmaceutical companies
- What are the institutional 
mechanisms to promote 
and enforce high ethical 
standards in health care?
- Are the citizens aware of 
their ethical rights? Do 
they know about the 
process and procedure of 
to access to the system for 
their rights? Do they get 
response from the system?
- Ethics committee in 
hospitals and clinics: Status 
and need
- How are the leaders 
leading?
- Policy, strategic planning, 
research unit/division?
- Leadership/management 
training
- Leadership and   
 management at hospitals/  
 upazila level health  
 facilities: current conditions  
 and recommendations
-  Do the citizens have any 
voice regarding efficient 
management and 
functioning of the local 
health system?
- Do we have any strict 
policy  for the managerial 
post at district hospitals? 
Are the guidelines 
followed?
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In order to operationalise the broad objectives of the
Bangladesh Health Watch 2009 as outlined in Chapter 1,
six independent but interconnected studies were
designed. The following gives details of the design of
each study.
Study cluster 1: Health sector
governance
Chapter 2: Health policy
Data for the issues on health policy formulation and
implementation were also collected from both the
primary and secondary sources. Primary data were
collected through in-depth and open-ended interviews.
Seventeen people were interviewed focusing on the
key players of three policy documents prepared in
2000, 2006 and 2008, and those involved in policy
implementation which included the bureaucrats,
politicians, health experts, journalists, NGO representa-
tives and medical professionals. 
Chapter 3: Functions of regulatory and
statutory bodies
Data for the section on regulatory bodies were collected
from both secondary and primary sources. Secondary
sources include review of relevant literature available
in the parliament library, Press Institute of Bangladesh
(PIB), National Archives and reputed journal websites.
For primary data, eight Key Informant Interviews (KII)
were conducted. High officials of BMDC, BMA and BNC,
health education and delivery organisations, representa-
tives from health right organizations and a former
member of the Parliamentary Standing Committee on
Health were interviewed. 
Chapter 4: Ethics in the health sector
The study on ethics in health sector required both
primary and secondary data collection. An extensive
amount of literature was consulted, including journal
articles on health education and health ethics, reports
of international organisations and NGOs, and media
reports. A structured, Key Informant Interview (KII) was
used for obtaining primary information. Nine interviews
had been conducted with current and ex-officials at
organisations like Bangladesh Medical and Dental
Council (BMDC), Centre for Medical Education (CME),
Bangladesh Medical Association (BMA), Ganashasthya
Kendra (GK), Bangladesh Paribesh Andolon (BAPA)
and Population Service and Training Centre (PSTC).
Based on the objectives of the study, interviewees
were selected from four major groups: i) medical educa-
tionalists, ii) health professionals, iii) representatives
of regulatory authorities, and iv) representatives of
health NGOs.
Study cluster 2
Chapter 5: Availability of essential drugs
and their use in the public and private
primary health care facilities
Objectives: To study how far the outcome objectives
of the National Drug Policy in terms of availability,
affordability, and rational use of essential drugs in the
public and private sectors PHC facilities in both rural
and urban areas of Bangladesh have been achieved. 
Specific objectives: 
1. Study the availability of Essential Drugs (as per
latest Essential Drugs List) in the public and
private sector health care facilities in the rural
(UHC, Drug shops) and urban (Dhaka City
Corporation) areas of Bangladesh.
2. Study the affordability of Essential Drugs by
exploring the price differentials of different
brands of drugs for common illnesses (e.g.,
diarrhea, dysentery, ARI, hyperacidity, fever,
worm infestation etc.).
ANNEX 2
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3. Study the rational use of drugs by allopathic
health care practitioners (MBBS doctors,
Medical Assistant/SACMOs, and village doctors)
through studying their prescribing behaviour
for specific illnesses including dispensing
practices by pharmacists/drug dispensers and
consumer (patient/attendants) understanding
and compliance.
Materials and methods
Study design
This study was designed as a facility-based cross-
sectional study which can be easily implemented
using science graduates as data collectors, as
experience has shown the difficulty of involving
doctors/students (medical/pharmacy) for short
assignments, especially in the rural areas. Moreover,
our purpose was not to assess the QoC of the
doctors/medical audit but to assess the specific
aspects of the behaviour of the health providers with
respect to the rational use of drugs at the grassroots.
Given the use of standard indicators (Table A2-5.1),
WHO suggests that it can be implemented "by
individuals without special training or access to many
resources" (e.g., testing drugs for quality) (INRUD &
WHO, 1993).
The study combined cross-sectional quantitative
survey with occasional observations. The different
components of the survey were: -
i. Availability of Essential Drugs in different
facilities (availability of essential drugs list;
availability of essential drugs for common
illnesses).
ii. Affordability: Mini-market survey for price of
essential drugs for common illnesses.
iii. Rational use of drugs: 
a. Prescribing practices average number of
drugs prescribed, % antibiotics prescribed, %
drugs prescribed by generic name, % Inj.
pres-cribed, % drugs prescribed from the EDL
for common illnesses by different providers
(such as the MBBS doctors, Medical Assistants,
village doctors)  at upazila and urban (City
Corporation) levels. 
b. Dispensing practices at these health facilities
(average dispensing time, % drugs actually
dispensed, % drugs adequately labelled,
information given on dose regimen).
iv. Understanding and compliance with dosage
regimen and perceptions of patients/attendants
on drugs availability, affordability, efficacy and
cost of drugs through exit interview.
Sampling
I. Rural sample: A total of 30 Upazila Health Complexes
(UHCs) was taken at random from the six divisions
proportionate to the size of the divisions (Table A2-5.2).
Table A2-5.1: WHO core indicators to investigate 
drug use in health facilities (INRUD 
and WHO 1993)
Prescribing indicators
1 Average number of drugs per encounter
2 % of drugs prescribed by generic name*
3 % of encounters with an antibiotic prescribed
4 % of encounters with an injection prescribed
5 % of drugs prescribed from essential drugs list 
Patient care indicators
6 Average consultation time
7 Average dispensing time
8 % of drugs actually dispensed
9 % of drugs adequately labelled
10 Patient's knowledge of correct dosage
Facility indicators
11 Availability of copy of essential drugs list
12 Availability of key drugs
* not recorded in this study
Table A2-5.2: Distribution of upazillas included in 
the study proportionate to the size 
of the divisions
Dhaka 120 25 8
Chittagong 96 20 6
Rajshahi 124 26 8
Khulna 59 12 4
Barisal 40 9 2
Sylhet 37 8 2
Division Total No.
of UHCs
% of
total
No. of
sample
UHCs out
of 30 
Comments
Random
selection
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Also, one drug shop each from the neighbourhood
of the UHC/market where a medical assistant/
palli chikitshak provides treatment was included
to represent the informal sector (total 30 shops). 
II. Urban sample: This was exclusively taken from
Dhaka City Corporation (DCC) area due to
constraints in resource and time. Under the
Urban PHC Project (UPHCP), eight NGOs are
providing outpatient (preventive and curative)
services in 10 areas of the DCC. Of these, DCC
and one NGO are serving in two areas each and
the rest six NGOs are working in one area each.
From each area, two clinics were randomly
chosen from a list of clinics provided by the
NGOs in their respective areas. Thus, the urban
sample comprised of a total of 20 clinics. 
III. Patients: Thirty patients attending OPD for
common acute illnesses were enrolled in the
study from each facility (UHC, drug shop, urban
clinic) from the total patients visiting in two typical
working days (consecutive) until the required
number of patients was obtained. Patients were
selected by systematic random sampling to avoid
bias from timing of the survey (rush hours in the
beginning or end of clinic sessions) or freshness or
fatigue of the health care providers/workers. For
details, see below: [Total patients = {(30+30) x30}+
{30 x 20} = (1800+ 600) = 2400]
Tools
A structured form was developed and tested to
record relevant data on prescribing and dispensing
practices from patient-provider interaction. Another
pre-tested, semi-structured questionnaire was used
for recording information from the exit interview. A
reference list of key essential drugs for common
illnesses was prepared for this study from the
government approved latest EDL dated 8 April 2008
(see Table A2-5.3 below). The common illnesses
were selected from top 20 morbidities reported by
BBS and reality check of patient registers from 
the UHCs, and the key drugs selected by the
investigators who are both medical graduates and
public health specialists. This reference list was used
to check whether key drugs for common illnesses
were available in the facilities and also, for
information on the prices of drugs (maximum and
minimum) through mini-market survey. 
The survey
The study passed through the usual institutional
review process at BRAC Research and Evaluation
Division and ethical review board of the James P
Grant School of Public Health, BRAC University for
ethical approval. Data were collected through
observation and recording information (prescribing
and dispensing practices), face-to-face interview (exit
interview) and mini-market survey (price of essential
drugs) by the interviewers after obtaining informed
verbal consent. All interviewers hired for the study
underwent a five-day training which consisted of
didactic lectures on the content of the instruments
(structured check-lists, questionnaires) followed by
repeated practice sessions outside the study areas
and long de-briefings. There were 20 interviewers
Table A2-5.3: Reference list of key essential drugs 
for common illnesses (from EDL)
1 Fever (with cold), pain Acetaminophen (Tab)
Acetylsalicylic acid (Tab)
2 Hyperacidity including Aluminium
peptic ulcer hydroxide+Magnesium hydroxide 
(Tab, Liquid)
Ranitidine (Tab)
3 Diarrhoea ORS
4 Dysentery, amoebic Metronidazole (Tab, Syrup)
5 Typhoid fever Ciprofloxacin (Cap, Tab, Syrup)
6 Worm infestation Mebendazole/albendazole (Tab)
7 ARTI including pneumonia Amoxycillin (Syrup)
Co-trimoxazole (Tab, Syrup)
8 Vitamin deficiency Iron+Folic acid (Tab)
including iron deficiency B Complex (Tab, Syrup)
Ascorbic acid (Tab)
9 Hypertension Atenolol (Tab), Nifedipine (Tab)
10 Hypersensitivity reactions Prednisolone (Tab)
11 Eye/Ear infection Chloramphenicol (Eye/Ear drops)
Chloramphenicol (Eye ointment)
12 Skin infection (fungal) Miconazole (skin ointment/cream)
13 Ascabies Benzylbenzoate lotion
14 Wound (surgical) Chlorhexidine solution (dressing)
Sl. Key drugsCommon
illnesses/conditions
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including two supervisors who were divided into six
teams. The day-to-day field activities of the teams
were overseen by a field researcher based in the
upazila field office. The whole survey activity was
supervised and managed by the authors who made
frequent field visits and provided assistance and
guidance when needed. The survey was completed
within 30 working days (18 Feb. - 24 Mar. 2009,
including training).
Prescribing and dispensing practices
For this part of the study, the randomly selected
UHC/Urban Clinic was observed for two consecutive
days (excluding any atypical day such as NID etc.)
during the usual office hours (9am to 1:30 pm). A
structured format was used to record relevant
information of the 30 OPD patients selected through
systematic random sampling. The survey team (two
members) started the day by taking permission from
the UHFPO/Clinic-in-Charge to proceed with the
study in the particular facility, exploring whether
there is an EDL (in file or posted in public) in the
facility, and going through the record of the past
seven days to get an idea about the average no. of
patients attending the facility. The latter information
was used to decide upon the interval required for
taking systematic random sample of 30 patients.
Thus, each 'n'th patient was included for observation. 
One interviewer placed himself at the door of the
Doctor's chamber and recorded the time of entry and
exit of the sampled patient by a stopwatch. The
prescribing indicators were recorded by scrutinizing
the prescription slip immediately after the doctor-
patient interaction, outside the doctor's chamber.
Another interviewer posted near the dispensary
followed the sampled patient when s/he came out of
the chamber. The time of submitting the prescription
slip to the dispenser and the time when the drugs
were served was recorded and the dispensing time
calculated. The no. of drugs in the prescription slip,
the no. of drugs served by the dispenser and the
labelling of the drugs served were recorded. Labelling
was defined as a mean by which the drug can be
identified (e.g., name of the drug inscribed on to the
cap or tab, or if disposed of in original package).
Next, the same interviewer conducted the exit interview
of the patient (attendant of the patient if minor) to
elicit information on their understanding of dosage of
the drugs dispensed, satisfaction with services, and
prices of essential drugs. The interview was
conducted in a place away from the prescribing and
dispensing sites and within the premises of the
facility. The whole process continued in this cycle
until information of 30 patients was recorded. 
Simultaneous with the activities at the UHC, the third
member of the team was posted at the most popular
private practitioners (MA/SACMOs, Palli Chikitshaks)
drug shop in the market nearest to the UHC. He had
to attend the shop both at the morning and evening
to cover the practicing time of the particular provider.
The tool used for recording information at the drug
shops was slightly modified. He recorded relevant
information on prescribing and some aspects of
dispensing (e.g., labeling of drugs sold, dosage
instruction etc.). Next, he conducted an exit interview
of the patient, a little away from the drug shop and
the provider to maintain privacy. He stopped until 30
patients were found or the expiry of two days,
whichever was earlier.
Checking drug stocks in the UHCs and Urban Clinics
The reference list of key essential drugs for common
illnesses was used to check whether the listed drugs
were available on the day of survey. The list was read
one by one before the store-keeper/dispenser and he
was asked to show the drugs, if present. When the
drug could be shown, only then it was recorded as
available.
Mini-market survey
To find the market variation in prices of essential
drugs for common illnesses, a mini-market survey
was conducted. In the vicinity of the UHC studied, 10
drug shops were randomly chosen and the prices of
the drugs using the above reference list of key
essential drugs were recorded. The prices were
obtained from the sales people at the drug shops.
Data management and analysis
SPSS PC+ version 12 was used for data analysis.
Summary statistics of the different drug use indicators
were calculated and tabulation done to present data
comparing different facilities (UHCs, Drug shops and
Urban Clinics in DCC area) and the six divisions.
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Chapter 6: Pharmaceutical promotions:
Regulatory provisions, status of
enforcement, awareness and compliance
Study Objectives
The objective of the study was to investigate the
extent to which pharmaceutical promotional practices
influence non-compliance of the regulatory guidelines,
namely, the Drug (Control) Ordinance of 1982 and
the Code of Pharmaceutical Marketing Practices,
promulgated in 1994. The objective was also to explore
the challenges in enforcing the regulations and the
factors that play into causing these challenges.
In an effort to achieve this broad study objective, the
following modalities were adopted:
z Reviewing of existing rules and regulations
regarding drug promotion practices and assess
the status of implementation, level of awareness
and compliance of these rules and codes;
z Exploring the challenges in enforcing the existing
rules and codes and identify factors that render
these regulations nearly ineffective;
z Exploring the existing drug promotion strategies
and practices currently adopted by the
pharmaceutical companies;
z Studying the perception of the doctors and regulatory
authorities on current drug promotion practices;
z Assess the factors that guide prescribing decisions
and patterns of the physicians and how that relates
to the principles of Rational Use of Drugs (RUD).
Methodology
The study investigations took place in three districts
-Dhaka, Bogra and Chittagong, to be able to identify
variations in promotional practices and level of
enforcement of regulations. The sites outside of
Dhaka were selected based on consultation with the
Technical Advisors of the study team. Bogra is one of
the important drug distribution depot for Northern
Bengal and Chittagong is a representation of South
and South-eastern regions. The study primarily
employed qualitative research method tools.
In-depth interviews: Eleven interviews were
conducted with medical representatives of various
pharmaceutical companies - local and multinational,
14 physicians, 8 rural medical practitioners (RMPs)
and palli chikitshoks (PCs), and five representatives
from regulatory authorities.
Observation: Pharmacies were observed in 16 sites,
six health care institutions (two private and four public),
10 drug stores and in all three districts combined. 
Round-table discussion: A roundtable discussion was
held with CEO's and Senior Executives (mostly from
the Marketing department) of 11 local and multinational
pharmaceutical companies were invited to a round-
table. The objective of the round-table was to gather
the industry's perspective on existing regulations for
pharmaceutical promotional activities, their role in
promoting more transparent and uniform practices,
and their views on CSR.
Prescription survey: The study team collected a
list of cardiologists who regularly prescribe drugs of a
particular pharmaceutical company. Twenty doctors
randomly selected from this list were visited and 102
prescriptions were collected from these sites located
in Dhaka, Mymensingh, Chittagong, Bogra, Syhlet and
Khulna. An analysis was done based on prescriptions
made for one particular anti-hypertensive that was
being promoted during the data collection period.
Challenges
- Generally defensive position of pharmaceutical
companies
- Securing information from medical reps due to
concern of confidentiality
- Senior executives of pharmaceuticals often
reluctant to share information
- Suspicion by guards at medical facilities during
observation
- Observing drug stores without causing concern of
the drug seller/chemist
- Reluctance of doctors in sharing information on
gifts and inducements
- While observing institutions, interactions between
medical representatives and doctors could not be
observed in most cases once the representatives
went into the chambers.
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Chapter 7: Blood supply and transfusion
services
Objectives
The objectives of the study are to assess current
situation of SBT services and to assess implementation
status of existing policies. Thus, the proposed specific
objectives are to:
a. determine existing BTS facilities of government
and private centers 
b. examine existing quality assurance system for BTS
c. identify managers who manages blood transfusion
services at the government system; and assess their
awareness of BTS policy and its implementation
d. assess the process of regulatory authorities for
licensing BTS
e. explore advocacy, educational and training
facilities and activities available for managing
blood transfusion services 
f. explore quality and safety issues of  screening
blood borne diseases; and process of blood
collection and screening in the government,
private and commercial sectors
g. identify trained personnel available in BTS
(directly involved)
h. explore factors responsible for unsafe blood
supply and transfusion
i. identify gaps, weakness, and positive deviances
to recommend policy formulation
Study design and methodology
List of health facilities in all the six Divisions in the
country with provision for blood transfusion as per
official record was collected from the office of the
Director General of Health Services. There were
3,000 of such facilities in the six Divisions. The
facilities were stratified into six strata, such as 1)
Government and private medical college hospitals (39
nos.); 2) District hospitals, specialized hospitals, and
MCWCs (128 nos.); 3) Upazila health complexes (478
nos.); 4) Non-commercial blood banks (16 nos.); 5)
Commercial blood banks (100 nos.); and 6) Private
clinics and pathology centers (2239 nos.).
Table A2-7.1:  Distribution of study centres by geographic location
Geo-location 
Dhaka Chittagong Khulna Rajshahi Dhaka Chittagong Total
Types of centres Metropolitan Metropolitan
Government (GoB) 42.9 (3) 57.1 (4) 62.5 (5) 57.1 (4) 50.0 (3) 28.6 (2) 50.0 (21)
Medical College 0.0 14.3 (1) 12.5 (1) 14.3 (1) 16.7 (1) 14.3 (1) 11.9 (5)
District Hospital 14.3 (1) 14.3 (1) 25.0 (2) 28.6 (2) 0.0 14.3 (1) 16.7 (7)
Upazila Health Complex 14.3 (1) 14.3 (1) 25.0 (2) 14.3 (1) 0.0 0.0 11.9 (5)
MCWC 14.3 (1) 14.3 (1) 0.0 0.0 0.0 0.0 4.8 (2)
Specialized Hospital 0.0 0.0 0.0 0.0 33.3 (2) 0.0 4.8 (2)
Private non-commercial 
(Pnon-C) 14.3 (1) 14.3 (1) 12.5 (1) 14.3 (1) 16.7 (1) 14.3 (1) 14.3 (6)
Red Crescent 0.0 14.3 (1) 12.5 (1) 0.0 16.7 (1) 14.3 (1) 9.5 (4)
Sandhani 14.3 (1) 0.0 0.0 14.3 (1) 0.0 0.0 4.8 (2)
Private commercial (PC) 42.9 (3) 28.6 (2) 25.0 (2) 28.6 (2) 33.3 (2) 57.1 (4) 35.7 (15)
Private Commercial Blood Bank 14.3 (1) 14.3 (1) 12.5 (1) 14.3 (1) 16.7 (1) 14.3 (1) 14.3 (6)
Private Medical Colleges 14.3 (1) 0.0 0.0 0.0 16.7 (1) 28.6 (2) 9.5 (4)
Private Clinics 14.3 (1) 0.0 0.0 14.3 (1) 0.0 0.0 4.8 (2)
Private Laboratory/ 
Pathological Centres 0.0 14.3 (1) 12.5 (1) 0.0 0.0 14.3 (1) 7.1 (3)
N 7 7 8 7 6 7 42
n is in the parentheses
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A sample of two facilities was randomly chosen from
the second category and one facility was randomly
chosen from each of the rest five categories. This has
resulted in 42 facilities for inclusion in the study
sample (Table A2-7.1). The sampling was done in a
manner that two third of selected facilities had
Government safe blood transfusion programme and
the rest without the programme.
The respondents of the study were personnel directly
involved with blood transfusion services. From each
selected centre a relevant personnel was interviewed
and also the blood collection, screening, and
transfusion system was observed. 
The training of data collectors, a physician and a social
science graduate, involved exposure to Red Crescent
and ICDDR,B. They spent a day at ICDDR,B and
three days at Red Crescent, observing the standards
maintained by the ICDDR,B and Red Crescent. The data
collection was carried out during March to June 2009. 
Chapter 8: Quality of hospital diets for
patients with selected chronic diseases
Aims
To assess appropriateness of hospital diets received by
patients and their intake in five specific disease
conditions i.e. diabetes mellitus, coronary heart disease,
renal failure, liver diseases, and severe protein energy
malnutrition in urban and rural hospitals in Bangladesh
compared to their therapeutic recommendation.
Specific aims
1. To assess the types and total food intake over 24-
hours (which diet is provided by the hospitals &
which they intake personally).
2. To assess the quality, quantity and appropriateness
of hospital diet for five different diseases.
3. To conduct the anthropometrics measurement
(weight, height) of the study participants.
4. To document the mechanism of health system for
appropriate dietary management in the hospitals.
5. To review the system of diet allocation along the
hospital policy.
Study design
The study was a prospective cross-sectional descriptive
study with five diseases in several hospitals of Bangladesh.
Study population
Study population was selected from patients who are
admitted at the study hospitals.
Inclusion criteria
z Patients of only one diagnosis was selected in this
study.
z Patients aged 30-60 years diagnosed with
Coronary Heart Disease, Renal Failure and
Nephritis, Diabetes, Liver disease (Cirrhosis &
hepatitis).
z Under five children especially for protein energy
malnutrition.
z Patients who are admitted in the hospitals.
Exclusion criteria 
z Patients < 30 years. 
z More than five years old children especially for
protein energy malnutrition.
z Mentally unfit. 
Sample size
Assumption
The sample size was estimated with the assumptions
that it would be possible to detect there has been
given more than 25 % energy from RDA to the
patients in Bangladesh.
Study period
Enrolment of the study population was begin in April
2009 and completed in May 2009.                          
Sampling frame
One large medical college hospitals and one large
district hospital was identified from each division of
Bangladesh. Subjects were selected randomly for
each disease group patients in any hospital. Subjects
were also selected from specialized hospitals e. g.
BIRDEM, NIKDU (National Institute of Kidney Disease
and Urology) and NICVD (National Institute of
Cardiovascular Disease) to fulfil the sample size for
three disease group. Protein energy malnourished
patients were selected from Dhaka Shishu Hospital
and liver disease patients will be selected from
Bangabandhu Sheikh Mujib Medical University
(BSMMU) Hospital.
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Randomisation procedure for diabetes mellitus,
kidney disease, coronary heart disease and
protein energy malnourished patients:
Sample size distribution for one disease:
6 Districts hospital = 2 patients × 6 = 12 patients
6 Divisional Medical = 2 patients× 6 = 12 patients
college hospital
Specialised Hospital = 26 patients
Total = 50 patients
Quantitative Data Collection Procedure
Anthropometry
Weight
UNISCALE had been used to take weight of the hospita-
lised patients with precision of 2 decimal places
(0.00kg). The person was placed over the scale &
weight was taken. Specially if the child was frightened,
time was allowed to settle down. The child along with
its mother was placed over the scale & reading was
taken. Then the mother was placed alone over the scale
& reading was taken. The difference between two
readings was original weight of the rachitic child. 
Height (for diabetes, kidney, heart, liver disease)
Two trained field research assistants of ICDDR,B
took height of every suspected person. One of them
acted as an assistant, another one was measurer. 
Length (for children aged 0-23 months)
Length board had been used to measure children of
0-23 months of age. The assistant laid the child
carefully over the board & placed the head against
the head board. Then the measurer fixed the knees
with left hand & placed the footplate firmly against
the child's heel to take the measurement.
MUAC
Mid upper arm circumference (MUAC) was measured
to assess the nutritional status of the rachitic child.
TALC tape had been used to measure MUAC. For
measurement, midpoint of the left upper arm had
been marked by identifying the midpoint between tip
of shoulder & elbow. Then the tape was wrapped
around mid-point to take measurement.
Questionnaire for hospitalized patients: 
After identification of a patient, full questionnaire was
completed. Patients were interviewed about current
and past feeding practices in hospitals. Issues to be
explored include dietary intake, hygiene practice,
frequency of feeding, and gender bias on feeding and
medical care practices. 
Outcome variable
z Dietary adequacy. (Deviation from recommendation).
z Proportion of patients with nutrient deficits.
z Amount of carbohydrate intake by patients with
diabetes.
z Amount of fat intake by patients with heart disease
and liver disease.
z Amount of protein intake by patients with kidney
disease.
z Body weight and height.
Quantitative data analysis 
Questionnaire data was computerised, edited and
analysed by using SPSS software. After completion 
of the study, data will be using SPSS software
(Version 11.5). The analysis will be done after the
calculation of major nutrients from the dietary intake
in each group of patients. The means of hospital
supply will be compared with recommendations by Z
test (SND). Results will be significant at 5%
probability level.       
Qualitative study was done in each hospital
In-depth interview was conducted by the trained research
assistants to understand patient-provider interfacing.
In-depth interview was conducted with the patients
to understand their observation about hospital diet:
z Quality and quantity of hospital diet
z Serving system of hospital
z Hospital diet hygiene 
z Frequency of diet  
z Awareness about high calorie food intake
z Causes and consequences about diseases (diabetes,
coronary heart disease, kidney disease etc.)
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Chapter 9:  Governance issues affecting
the quality of care
Methodology
For literature review, we searched online database and
sources for terms describing quality of care (keyword:
quality care), facilities, health system governance, doctor-
patient relationship, providers attitude, physical facilities,
waiting time, quality management and performance in
various domains (keywords: competence, health
knowledge, attitudes and practice, outcomes assessment).
We retrieved potentially relevant articles and reviewed
their reference lists to identify studies that our search
strategy may have missed. We also searched our personal
archives to identify additional studies. We included studies
if they 1) were original reports providing empirical results
and 2) measured knowledge, guideline adherence, or
some other quality-of-care process or outcome. 
In addition to documents review, key informants'
interview, discussions with top officials and facilities
managers and key providers of public and non-public
sectors (including NGOs) were conducted to assess
and analyze policy implications, effect of organisational
structure, service delivery system and resource
allocation in delivering quality of services.
Public sector facilities at different levels along with NGO
facilities and for profit private sector facilities (both in
rural and urban areas) were visited to observe physical
and other facilities. Maternal and child health services
were explored as cases. Also indoor and emergency
services were reviewed, as catastrophic illness influence
poverty issue more than mild, cold cases which are
treated as outdoor. Cases of caeserean section for
maternal health and pneumonia for child health were
reviewed to ascertain technical quality of care by adviser
investigators particularly in tertiary facilities. In public
sector, Upazila Health Complex providing Emergency
Obstetrical Care, Maternal and Child Welfare Centers
(MCWCs) at district level, District Hospitals, Medical
College Hospitals together with Azimpur Mother and Child
Health Training Institute (MCHTI), Institute of Child and
Mother Health (ICMH), Bangabandhu Sheikh Mujib
Medical University (BSMMU) Hospital were looked into.
Similarly indoor and emergency services providing NGO
and for profit facilities were also reviewed. Sampling of
the facilities was a mixture of random and purposive.
Similarly, respondents were chosen on random and pur-
posive basis. At facilities level, organizational structure,
service delivery system and resource availability were
looked into along with physical facilities. Service providers
and recipients were interviewed. Reception, registration,
waiting time before being attended, tidiness, toilet
facilities and conditions, providers' categories, availability
of drugs and other equipments, advise provided, status of
patients' bill of rights, citizens' charter, providers'
accountability and technical competence, role of
management, notions of rights and expectations, respect,
dignity, and assurance of confidentiality that the patients
receive from the service providers were also looked into.
Health promotional activities and citizens' participation
into the facilities were also investigated. Existence of
quality of care promotional system and pattern of push
from pharmaceutical companies were also explored.
Structured/semi-structured questionnaires, check-
lists were be used to collect information. Data were
analyzed qualitatively and quantitatively.  
Data collection tools, check-list/semi-
structured questionnaire guidelines
Observation
z Organisational structure - staff: Specialist, Doctor,
Nurse, Paramedics, Aya, Sweeper - no. of posts,
actually available
z Service delivery system and resource allocation:
outdoor, indoor and emergency; who provides
which services, time availability of providers
z Physical facilities-building conditions including
status of electricity and running water supply
(reception, registration, adequacy of space for
waiting and service delivery, tidiness of space,
toilet facilities, privacy, dispensing, indoor facilities
including provision of beds with adequate and
clean linen, mattress, pillow, mosquito net and
emergency facilities, diagnostic facilities)
z Availability of drugs, equipments, reagents with
amount and adequacy
z Waiting time for receiving services-advise, actual
service, including diagnostic services
z Role of management-quality of care promotion
z Clients' bill of rights, Citizens' Charter-availability
z Providers' attitude-rights to information for
patients, providers' accountability, notions of rights
and expectations, respect, dignity, assurance of
confidentiality
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z Health promotion
z Scope of community participation
Sampling
Two divisions - one from eastern part, (Khulna) and
the other from western part, (Sylhet) were chosen as
primary sampling framework:
z Randomly one upazila health complex providing
comprehensive Emergency Obstetrics Care (EOC)
services was chosen from each division (2)
z Randomly one district level MCWC was chosen
from each division (2)
z Randomly one district hospital was chosen from
each division with the consideration to capture
different bed-types within the samples (2)
z One Medical College Hospital was chosen from
each division (2)
z Azimpur MCHTI, ICMH and BSMMU Hospital were
also within samples (3)
Thus, in public sector, sampling are 11:
Upazila Health Complex-2
Chowgacha of Jessore district from Khulna 
Division, and Bianibazar of Sylhet district from 
Sylhet Division
District MCWCs-2
Meherpur from Khulna Divsion, and 
Moulovibazar from Sylhet Division
District Hospitals-2
Jessore 250 bed from Khulna Division, and 
Moulovibazar 100 bed from Sylhet Division
Medical College Hospitals-2
Khulna Medical College Hospital from Khulna 
Division, Sylhet M A G Osmani Medical College 
Hospital from Sylhet Division
Other Hospitals-3
Azimpur MCHTI, Dhaka
ICMH, Matual, Dhaka
BSMMU Hospital, Dhaka  
For the NGOs and for-profit private sector, almost
similar number of (09) facilities were chosen as
comparators:
z Square Hospital, Dhaka
z Ibrahim Memorial (BIRDEM) Hospital, Dhaka
z Shishu Hospital, Dhaka
z Ad-din Hospital, Dhaka
z MSCS UPHC CRHCC, Bashbari, Dhaka
z MSCS, Sylhet
z Ad-din, Jessore
z Lamb Hospital, Parbotipur
z Kumudini Hospital, Mirzapur
Except for Square Hospital, no other hospital from the
for-profit private sector were included in the study due
to non-availability and unwillingness to participate. Total
sampled health centres or hospitals are thus 20.
Subsection I: Definitions on quality of care (QOC)
Author/Organisation Definition
Donabedian (1980) Quality of care is the kind of care which is expected to maximise an inclusive measure of patient 
welfare, after one has taken account of the balance of expected gains and losses that attend the 
process of care in all its parts.
IOM (1990) Quality of care is the degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes and are consistent with current professional knowledge.
Department of Health (UK 1997)  Quality of care is:
z doing the right things (what)
z to the right people (to whom)  
z at the right time (when)
z and doing things right the first time.
Council of Europe (1998) Quality of care is the degree to which the treatment dispensed increases the patient’s chances of 
achieving the desired results and diminishes the chances of undesirable results, having regard to 
the current state of knowledge.
WHO (2000) Quality of care is the level of attainment of health systems’ intrinsic goals for health improvement 
and responsiveness to legitimate expectations of the population.
Notes: IOM: Institute of Medicine; WHO: World Health Organization.
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Table A3-7.1: Centres providing BTS by their SBTP enlistment status and types
Issues GoB Pnon-C PC Total GoB Pnon-C PC Total
Whether providing blood transfusion related services
Yes 85.0 (17) 100.0 (4) 100.0 (1) 88.0 (22) 100.0 (1) 100.0 (2) 85.7 (12) 88.2 (15) 88.1 (37)
No 15.0 (3) 0.0 0.0 12.0 (3) 0.0 0.0 14.3 (2) 11.8 (2) 11.9 (5)
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 20 4 1 25 1 2 14 17 42
GoB = Government ; PC = Private commercial ; Pnon-C =  Private non-commercial ; n is in the parentheses
SBTP (%)
Types of centers
Non-SBTP (%)
Types of centers Total
Table A3-7.3: Special training received on SBT by SBTP enlistment status  and types of centres
Issues GoB Pnon-C PC Total GoB Pnon-C PC Total
Have special training 
Yes 90.0 (18) 75.0 (3) 100.0 (1) 88.0 (22) 100.0 (1) 0.0 64.3 (9) 58.8 (10) 76.2 (32)
No 10.0 (2) 25.0 (1) 0.0 12.0 (3) 0.0 100.0 (2) 35.7 (5) 41.2 (7) 23.8 (10)
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 20 4 1 25 1 2 14 17 42
GoB = Government ; PC = Private commercial ; Pnon-C =  Private non-commercial ; n is in the parentheses
SBTP (%)
Types of centres
Non-SBTP (%)
Types of centres Total
Table A3-7.2: Screening of blood for TTIs among functioning centres by SBTP enlistment status and types of centres 
Issues GoB Pnon-C PC Total GoB Pnon-C PC Total
Whether screen blood for various transfusion transmissible infections (TTIs)
Yes 94.1 (16) 75.0 (3) 100.0 (1) 90.9 (20) 0.0 50.0 (1) 100.0 (12) 86.7 (13) 89.2 (33)
No 5.9 (1) 25.0 (1) 0.0 9.1 (2) 100.0 (1) 50.0 (1) 0.0 13.3 (2) 10.8 (4)
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 17 4 1 22 1 2 12 15 37
Availability of comprehensive blood screening facility for TTIs (M)
Centres that screen
for all five above 58.8 50.0 0.0 54.5 0.0 0.0 50.0 40.0 48.6 
mentioned diseases (10) (2) (12) (6) (6) (18)
Centres that screen
for at least four 88.2 75.0 100.0 86.4 0.0 50.0 (1) 75.0 66.7 78.4
diseases (15) (3) (1) (19) (9) (10) (29)
N 17 4 1 22 1 2 12 15 37
GoB = Government ; PC = Private commercial ; Pnon-C =  Private non-commercial ;  M = Multiple Responses ; n is in the parentheses
SBTP (%)
Types of centres
Non-SBTP (%)
Types of centres Total
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Table A3-7.4: Knowledge of SBT and SBT policy by SBTP enlistment status of centres and their types 
Issues GoB Pnon-C PC Total GoB Pnon-C PC Total
Knowledge about meaning of Safe Blood Transfusion (SBT)
Correct 25.0 0.0 100.0 24.0 0.0 50.0 (1) 28.6 29.4 26.2 
answer (5) (1) (6) (4) (5) (11)
Incorrect 60.0 100.0 - 76.0 100.0 50.0 64.3 64.7 71.4 
answer (15) (4) (19) (1) (1) (9) (11) (30)
Don't know 0.0 0.0 0.0 0.0 0.0 0.0 7.1 (1) 5.9 (1) 2.4 (1)
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Knowledge about safe blood transfusion policy of the government
Yes 90.0 (18) 75.0 (3) 100.0 (1) 88.0 (22) 0.0 100.0 (2) 35.7 (5) 41.2 (7) 69.0 (29)
No 10.0 (2) 25.0 (1) 0.0 12.0 (3) 100.0 (1) 0.0 57.1 (8) 52.9 (9) 28.6 (12)
Non 
response 0.0 0.0 0.0 0.0 0.0 0.0 7.1 (1) 5.9 (1) 2.4 (1)
/missing
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 20 4 1 25 1 2 14 17 42
Knowledge about government policy regarding blood screening (M)
Must  55.6 66.7 0.0 54.5 - 50.0 60.0 57.1 55.2 
screen for (10) (2) (12) (1) (3) (4) (16)
5 diseases
Don't 11.1 0.0 0.0 9.1 - 0.0 0.0 0.0 6.9 
know (2) (2) (2)
N 18 3 1 22 2 5 7 29
GoB = Government ; PC = Private commercial ; Pnon-C =  Private non-commercial ;  M = Multiple responses ; n is in the parentheses
SBTP (%)
Types of centres
Non-SBTP (%)
Types of centres Total
Table A3-7.5: Source of blood collection by SBTP enlistment status of centres and their types (Among functioning centres)
Issues GoB Pnon-C PC Total GoB Pnon-C PC Total
Sources of blood collection (M)
Professional 0.0 0.0 0.0 0.0 0.0 0.0 16.7 (2) 13.3 (2) 5.4 (2)
Blood Donor
Family/Relatives 100.0 75.0 100.0 95.5 0.0 50.0 100.0 86.7 91.9
(17) (3) (1) (21) (1) (12) (13) (34)
Voluntary donation 70.6 100.0 0.0 72.7 0.0 100.0 75.0 73.3 73.0
(12) (4) (16) (2) (9) (11) (27)
Voluntary collection 23.5 100.0  0.0 36.4 100.0  8.3 (1) 20.0  29.7
(4) (4) (8) (2) (3) (11) 
Exchange 5.9 (1) 0.0 0.0 4.5 (1) 0.0 0.0 0.0 0.0 2.7 (1)
From other 64.7 25.0 0.0 54.5 100.0 50.0 25.0 33.3 45.9
blood bank (11) (1) (12) (1) (1) (3) (5) (17)
N 17 4 1 22 1 2 12 15 37
GoB = Government ; PC = Private commercial ; Pnon-C =  Private non-commercial ;  M = Multiple responses ; n is in the parentheses ;
Voluntary collection include blood collected from donation session, Badhon, Heart Foundation
SBTP (%)
Types of centres
Non-SBTP (%)
Types of centres Total
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Table A3-7.6: Have license for blood bank by SBTP enlistment status and types of centres  (among
functioning centres)
Issues GoB Pnon-C PC Total GoB Pnon-C PC Total
Have license/approval for blood banking
Yes, permanent one 0.0 0.0 0.0 0.0 0.0 8.3 (1) 0.0 6.7 (1) 2.7 (1)
Applied for license 0.0 0.0 0.0 0.0 0.0 50.0 (6) 0.0 40.0 (6) 16.2 (6)
No 100.0 100.0 100.0 100.0 100.0 41.7 100.0 53.3 81.1
(17) (1) (4) (22) (1) (5) (2) (8) (30)
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N 17 1 4 22 1 12 2 15 37
GoB = Government ; PC = Private commercial ; Pnon-C =  Private non-commercial ; n is in the parentheses 
SBTP (%)
Types of centres
Non-SBTP (%)
Types of centres Total
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Table A4-8.1: Quantity of nutrient supplied for diabetic mellitus patients in all the studied hospitals (n=50)
Nutrients and Energy Amount supplied gram (Mean ± SD) RDA in gram Supply/RDA Intake/RDA
(% shortfall/surplus (% shortfall/surplus
from RDA)* from RDA)*
Supply Wastage Intake
Protein(g) 67±23 25±10 42±24 50 +34 -18
Fat(g) 22±11 9±10 13±7 60 -63 -80
Carbohydrate(g) 180±68 72±35 108±65 240 -25 -55
Energy(Kcal) 1114±338 481±258 633±247 1800 -38 -65
* + indicates surplus, - indicates shortfall
Table A4-8.2: Quantity of nutrient supplied for coronary heart patients in all the studied hospitals (n=50)
Nutrients and Energy Supply Wastage Intake RDA Supply/RDA Intake/RDA
(Mean ± SD) (Mean ± SD) (Mean ± SD) (% shortfall/surplus (% shortfall/surplus
from RDA)* from RDA)*
Protein(g) 53±22 29±7 24±22 50 + 6% -52%
Fat(g) 14±7 7±5 6±5 11 + 27% -45%
Carbohydrate(g) 179±14 100±45 79±17 138 + 30% -43%
Energy(Kcal) 977±321 531±135 446±193 1000 -2% -55%
* + indicates surplus, - indicates shortfall 
Table: A4-8.3: Quantity of nutrient supplied for kidney patients in all the studied hospitals
Nutrients and Energy Supply Wastage Intake RDA Supply/RDA Intake/RDA
(Mean ± SD) (Mean ± SD) (Mean ± SD) (% shortfall/surplus (% shortfall/surplus
from RDA)* from RDA)*
Protein(g) 79±30 57±13 22±10 30 +163 -27
Fat(g) 22±10 14±9 7±5 75 -71 -91
Carbohydrate(g) 199±59 136±98 62±37 300 -34 -79
Energy(Kcal) 1223±635 855±218 368±141 2000 -39 -82
* + indicates surplus, - indicates shortfall  
Tables for Chapter 8 
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Table A4-8.5: Quantity of nutrient supplied for PEM patients in all the studied hospitals (n=50)
Nutrients and Energy Amount supplied gram (Mean ± SD) RDA in gram/kg Supply/RDA Intake/RDA
bd-wt (% shortfall/surplus (% shortfall/surplus
from RDA)* from RDA)*
Supply Wastage Intake
Protein(g) 12±3 1±0.5 11±2 18 -33 -39
Energy(Kcal) 467±234 20±11 363±123 900 -48 -60
* + indicates surplus, - indicates shortfall 
Table A4-8.4: Quantity of nutrient supplied for liver patients in all the studied hospitals (n=50)
Nutrients and Energy Amount supplied gram (Mean ± SD) RDA in gram Supply/RDA Intake/RDA
(% shortfall/surplus (% shortfall/surplus
from RDA)* from RDA)*
Supply Wastage Intake
Protein(g) 44±27 25±10 18±3 100 -56 -82
Fat(g) 17±8 10±6 6±2 70 -76 -91
Carbohydrate(g) 130±95 78±16 51±13 350 -63 -85
Energy(Kcal) 868±486 562±272 305±80 2200 -61 -86
* + indicates surplus, - indicates shortfall 
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